<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:admin="http://webns.net/mvcb/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel rdf:about="https://www.mdpi.com/rss/journal/molbank">
		<title>Molbank</title>
		<description>Latest open access articles published in Molbank at https://www.mdpi.com/journal/molbank</description>
		<link>https://www.mdpi.com/journal/molbank</link>
		<admin:generatorAgent rdf:resource="https://www.mdpi.com/journal/molbank"/>
		<admin:errorReportsTo rdf:resource="mailto:support@mdpi.com"/>
		<dc:publisher>MDPI</dc:publisher>
		<dc:language>en</dc:language>
		<dc:rights>Creative Commons Attribution (CC-BY)</dc:rights>
						<prism:copyright>MDPI</prism:copyright>
		<prism:rightsAgent>support@mdpi.com</prism:rightsAgent>
		<image rdf:resource="https://pub.mdpi-res.com/img/design/mdpi-pub-logo.png?13cf3b5bd783e021?1785915150"/>
				<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2215" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2214" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2213" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2212" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2211" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2210" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2209" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2208" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2207" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2206" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2205" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2204" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2203" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2202" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2201" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2200" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2199" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2198" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2197" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2196" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2195" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/4/M2194" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2193" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2192" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2191" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2190" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2189" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2188" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2187" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2186" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2185" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2184" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2183" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2182" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2181" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2180" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2179" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2178" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2177" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2176" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2175" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2174" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2173" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2172" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2171" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2170" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2169" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2168" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/3/M2167" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2166" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2165" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2164" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2163" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2162" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2161" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2160" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2159" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2158" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2157" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2156" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2155" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2154" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2153" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2152" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2151" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2150" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2149" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2148" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2147" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2146" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2145" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2144" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/2/M2143" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2142" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2141" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2140" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2139" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2138" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2137" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2136" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2135" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2134" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2133" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2132" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2131" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2130" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2129" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2128" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2127" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2126" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2125" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2124" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2123" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2122" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2121" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2120" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2119" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2118" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2117" />
            				<rdf:li rdf:resource="https://www.mdpi.com/1422-8599/2026/1/M2116" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="https://creativecommons.org/licenses/by/4.0/" />
	</channel>

        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2215">

	<title>Molbank, Vol. 2026, Article M2215: (1E,4E)-1,5-Bis(2,4-dichlorophenyl)penta-1,4-dien-3-one Oxime</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2215</link>
	<description>The target (1E,4E)-1,5-bis(2,4-dichlorophenyl)penta-1,4-dien-3-one oxime 4 was prepared in good yield, as a key aza-precursor for the Nazarov cyclization, through a two-step sequence in this study. Initially, the starting divinyl ketone 1a was obtained via a Claisen&amp;amp;ndash;Schmidt condensation reaction between 2,4-dichlorobenzaldehyde 3 and acetone in the presence of aqueous 20% NaOH. Subsequently, treating 1a with hydroxylamine hydrochloride under thermal conditions resulted in the expected oxime in excellent yield, and its structure was confirmed by analytic and spectroscopic techniques.</description>
	<pubDate>2026-08-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2215: (1E,4E)-1,5-Bis(2,4-dichlorophenyl)penta-1,4-dien-3-one Oxime</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2215">doi: 10.3390/M2215</a></p>
	<p>Authors:
		Juan P. Montaño
		Andres F. Sánchez
		Rodrigo Abonia
		</p>
	<p>The target (1E,4E)-1,5-bis(2,4-dichlorophenyl)penta-1,4-dien-3-one oxime 4 was prepared in good yield, as a key aza-precursor for the Nazarov cyclization, through a two-step sequence in this study. Initially, the starting divinyl ketone 1a was obtained via a Claisen&amp;amp;ndash;Schmidt condensation reaction between 2,4-dichlorobenzaldehyde 3 and acetone in the presence of aqueous 20% NaOH. Subsequently, treating 1a with hydroxylamine hydrochloride under thermal conditions resulted in the expected oxime in excellent yield, and its structure was confirmed by analytic and spectroscopic techniques.</p>
	]]></content:encoded>

	<dc:title>(1E,4E)-1,5-Bis(2,4-dichlorophenyl)penta-1,4-dien-3-one Oxime</dc:title>
			<dc:creator>Juan P. Montaño</dc:creator>
			<dc:creator>Andres F. Sánchez</dc:creator>
			<dc:creator>Rodrigo Abonia</dc:creator>
		<dc:identifier>doi: 10.3390/M2215</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2215</prism:startingPage>
		<prism:doi>10.3390/M2215</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2215</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2214">

	<title>Molbank, Vol. 2026, Article M2214: Bis([1,2,5]thiadiazolo)[3,4-f:3&amp;prime;,4&amp;prime;-h]quinoxaline-8,9-dicarbonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2214</link>
	<description>Compounds containing electron-withdrawing dicyanopyrazine and 1,2,5-chalcogenadiazole fragments are promising for the design of magnetic and optoelectronic materials. In this paper, bis([1,2,5]thiadiazolo)[3,4-f:3&amp;amp;prime;,4&amp;amp;prime;-h]quinoxaline-8,9-dicarbonitrile was prepared via K&amp;amp;ouml;rner&amp;amp;ndash;Hinsberg condensation of benzo[1,2-c:3,4-c&amp;amp;prime;]bis([1,2,5]thiadiazole)-4,5-dione with 2,3-diaminomaleonitrile in the presence of catalytic amounts of TsOH in refluxing ethanol. The structure of the newly synthesized compound was established via elemental analysis, mass spectrometry, 13C NMR, and IR spectroscopy.</description>
	<pubDate>2026-08-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2214: Bis([1,2,5]thiadiazolo)[3,4-f:3&amp;prime;,4&amp;prime;-h]quinoxaline-8,9-dicarbonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2214">doi: 10.3390/M2214</a></p>
	<p>Authors:
		Anastasiya S. Yushkova
		Ekaterina A. Knyazeva
		Oleg A. Rakitin
		</p>
	<p>Compounds containing electron-withdrawing dicyanopyrazine and 1,2,5-chalcogenadiazole fragments are promising for the design of magnetic and optoelectronic materials. In this paper, bis([1,2,5]thiadiazolo)[3,4-f:3&amp;amp;prime;,4&amp;amp;prime;-h]quinoxaline-8,9-dicarbonitrile was prepared via K&amp;amp;ouml;rner&amp;amp;ndash;Hinsberg condensation of benzo[1,2-c:3,4-c&amp;amp;prime;]bis([1,2,5]thiadiazole)-4,5-dione with 2,3-diaminomaleonitrile in the presence of catalytic amounts of TsOH in refluxing ethanol. The structure of the newly synthesized compound was established via elemental analysis, mass spectrometry, 13C NMR, and IR spectroscopy.</p>
	]]></content:encoded>

	<dc:title>Bis([1,2,5]thiadiazolo)[3,4-f:3&amp;amp;prime;,4&amp;amp;prime;-h]quinoxaline-8,9-dicarbonitrile</dc:title>
			<dc:creator>Anastasiya S. Yushkova</dc:creator>
			<dc:creator>Ekaterina A. Knyazeva</dc:creator>
			<dc:creator>Oleg A. Rakitin</dc:creator>
		<dc:identifier>doi: 10.3390/M2214</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2214</prism:startingPage>
		<prism:doi>10.3390/M2214</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2214</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2213">

	<title>Molbank, Vol. 2026, Article M2213: Methyl 6-(2,3-Dimethoxybenzamido)-2,3-dihydroxybenzoate</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2213</link>
	<description>Gymnaconitum gymnandrum, a Tibetan medicinal herb, is distributed across high-altitude regions of China. Despite its high toxicity, it exhibits analgesic, anti-inflammatory, antitumor, and other pharmacological activities. It is used topically for skin conditions and orally for rheumatism. Its main bioactive components are alkaloids. A new organic amine alkaloid has been isolated from the plant and structurally identified using HRMS, NMR, and X-ray diffraction.</description>
	<pubDate>2026-08-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2213: Methyl 6-(2,3-Dimethoxybenzamido)-2,3-dihydroxybenzoate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2213">doi: 10.3390/M2213</a></p>
	<p>Authors:
		Guo-Li Li
		Zhi-Dong Yu
		Na Gao
		Hong-Ying Yang
		Yi-Lin He
		Tong Shen
		</p>
	<p>Gymnaconitum gymnandrum, a Tibetan medicinal herb, is distributed across high-altitude regions of China. Despite its high toxicity, it exhibits analgesic, anti-inflammatory, antitumor, and other pharmacological activities. It is used topically for skin conditions and orally for rheumatism. Its main bioactive components are alkaloids. A new organic amine alkaloid has been isolated from the plant and structurally identified using HRMS, NMR, and X-ray diffraction.</p>
	]]></content:encoded>

	<dc:title>Methyl 6-(2,3-Dimethoxybenzamido)-2,3-dihydroxybenzoate</dc:title>
			<dc:creator>Guo-Li Li</dc:creator>
			<dc:creator>Zhi-Dong Yu</dc:creator>
			<dc:creator>Na Gao</dc:creator>
			<dc:creator>Hong-Ying Yang</dc:creator>
			<dc:creator>Yi-Lin He</dc:creator>
			<dc:creator>Tong Shen</dc:creator>
		<dc:identifier>doi: 10.3390/M2213</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2213</prism:startingPage>
		<prism:doi>10.3390/M2213</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2213</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2212">

	<title>Molbank, Vol. 2026, Article M2212: (Z)-3&amp;prime;-(3-Chloro-4-fluorophenyl)-5-fluoro-5&amp;prime;-((6-methoxypyridin-3-yl)methylene)spiro[indoline-3,2&amp;prime;-thiazolidine]-2,4&amp;prime;-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2212</link>
	<description>A novel spiro[indoline-3,2&amp;amp;prime;-thiazolidine]-2,4&amp;amp;prime;-dione derivative incorporating 3-chloro-4-fluorophenyl and 6-methoxypyridin-3-yl fragments was synthesized and characterized. The synthetic route involved a two-step procedure, including the preparation of the spirocyclic scaffold via cyclocondensation of 5-fluoroisatin with 3-chloro-4-fluoroaniline in the presence of mercaptoacetic acid, followed by Knoevenagel condensation with 6-methoxypyridine-3-carbaldehyde. The reactions were carried out under reflux conditions and afforded the desired product in a satisfactory yield after purification by recrystallization. The structure of the synthesized compound was confirmed by 1H and 13C NMR spectroscopy, LC&amp;amp;ndash;MS analysis, FT-IR and elemental analysis, all of which were consistent with the proposed molecular structure. The presence of multiple pharmacologically relevant heterocyclic motifs within a single framework suggests that this compound may serve as a useful scaffold for further biological evaluation.</description>
	<pubDate>2026-08-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2212: (Z)-3&amp;prime;-(3-Chloro-4-fluorophenyl)-5-fluoro-5&amp;prime;-((6-methoxypyridin-3-yl)methylene)spiro[indoline-3,2&amp;prime;-thiazolidine]-2,4&amp;prime;-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2212">doi: 10.3390/M2212</a></p>
	<p>Authors:
		Dominika Kuceł
		Jarosław Sobstyl
		Serhii Holota
		Dmytro Khylyuk
		</p>
	<p>A novel spiro[indoline-3,2&amp;amp;prime;-thiazolidine]-2,4&amp;amp;prime;-dione derivative incorporating 3-chloro-4-fluorophenyl and 6-methoxypyridin-3-yl fragments was synthesized and characterized. The synthetic route involved a two-step procedure, including the preparation of the spirocyclic scaffold via cyclocondensation of 5-fluoroisatin with 3-chloro-4-fluoroaniline in the presence of mercaptoacetic acid, followed by Knoevenagel condensation with 6-methoxypyridine-3-carbaldehyde. The reactions were carried out under reflux conditions and afforded the desired product in a satisfactory yield after purification by recrystallization. The structure of the synthesized compound was confirmed by 1H and 13C NMR spectroscopy, LC&amp;amp;ndash;MS analysis, FT-IR and elemental analysis, all of which were consistent with the proposed molecular structure. The presence of multiple pharmacologically relevant heterocyclic motifs within a single framework suggests that this compound may serve as a useful scaffold for further biological evaluation.</p>
	]]></content:encoded>

	<dc:title>(Z)-3&amp;amp;prime;-(3-Chloro-4-fluorophenyl)-5-fluoro-5&amp;amp;prime;-((6-methoxypyridin-3-yl)methylene)spiro[indoline-3,2&amp;amp;prime;-thiazolidine]-2,4&amp;amp;prime;-dione</dc:title>
			<dc:creator>Dominika Kuceł</dc:creator>
			<dc:creator>Jarosław Sobstyl</dc:creator>
			<dc:creator>Serhii Holota</dc:creator>
			<dc:creator>Dmytro Khylyuk</dc:creator>
		<dc:identifier>doi: 10.3390/M2212</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2212</prism:startingPage>
		<prism:doi>10.3390/M2212</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2212</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2211">

	<title>Molbank, Vol. 2026, Article M2211: N-Demethyl-N-nitrosolevofloxacin</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2211</link>
	<description>Levofloxacin is an antibiotic belonging to the fluoroquinolone family. N-Demethyllevofloxacin, a metabolite and an impurity of levofloxacin, features a secondary amine that is susceptible to N-nitrosation, raising concerns about the formation of a potentially toxic nitrosamine. The corresponding N-nitrosamine was synthesized in two steps and characterized using HRMS, NMR spectroscopy, IR spectroscopy, UV absorption and emission spectroscopies and powder X-ray diffraction. This work provides a reliable reference for the quantitation and control of nitrosamine impurities associated with levofloxacin in chemical and pharmaceutical contexts.</description>
	<pubDate>2026-08-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2211: N-Demethyl-N-nitrosolevofloxacin</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2211">doi: 10.3390/M2211</a></p>
	<p>Authors:
		Claudio Maestri
		Mattia Lopresti
		Ivana Miletto
		Attila Benyei
		Marzia Petreti
		Luisa Zangirolami
		Camilla Cavallotti
		Giovanni B. Giovenzana
		</p>
	<p>Levofloxacin is an antibiotic belonging to the fluoroquinolone family. N-Demethyllevofloxacin, a metabolite and an impurity of levofloxacin, features a secondary amine that is susceptible to N-nitrosation, raising concerns about the formation of a potentially toxic nitrosamine. The corresponding N-nitrosamine was synthesized in two steps and characterized using HRMS, NMR spectroscopy, IR spectroscopy, UV absorption and emission spectroscopies and powder X-ray diffraction. This work provides a reliable reference for the quantitation and control of nitrosamine impurities associated with levofloxacin in chemical and pharmaceutical contexts.</p>
	]]></content:encoded>

	<dc:title>N-Demethyl-N-nitrosolevofloxacin</dc:title>
			<dc:creator>Claudio Maestri</dc:creator>
			<dc:creator>Mattia Lopresti</dc:creator>
			<dc:creator>Ivana Miletto</dc:creator>
			<dc:creator>Attila Benyei</dc:creator>
			<dc:creator>Marzia Petreti</dc:creator>
			<dc:creator>Luisa Zangirolami</dc:creator>
			<dc:creator>Camilla Cavallotti</dc:creator>
			<dc:creator>Giovanni B. Giovenzana</dc:creator>
		<dc:identifier>doi: 10.3390/M2211</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2211</prism:startingPage>
		<prism:doi>10.3390/M2211</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2211</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2210">

	<title>Molbank, Vol. 2026, Article M2210: N4-Benzoyl-N3-benzyl-2&amp;prime;-deoxycytidine</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2210</link>
	<description>We have recently demonstrated that the pendant tert-butyldiphenylsilyl (TBDPS) groups in the short oligonucleotides TBDPS-5&amp;amp;prime;-CG-3&amp;amp;prime;-3&amp;amp;prime;-GC-5&amp;amp;prime;-TBDPS and TBDPS-5&amp;amp;prime;-CGG-3&amp;amp;prime;-3&amp;amp;prime;-GGC-5&amp;amp;prime;-TBDPS promoted the formation of new lipophilic and stable tetramolecular G-quadruplexes (GQs). Encouraged by these findings, we sought to investigate the effect of alternative lipophilic substituents at the flanking cytidine residues on GQ formation and properties. Herein, we reported on the synthesis and spectroscopic characterization of the new N4-benzoyl-N3-benzyl-2&amp;amp;prime;-deoxycytidine, which was obtained during our attempts to synthesize N4-benzoyl-5&amp;amp;prime;-O-benzyl-2&amp;amp;prime;-deoxycytidine.</description>
	<pubDate>2026-08-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2210: N4-Benzoyl-N3-benzyl-2&amp;prime;-deoxycytidine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2210">doi: 10.3390/M2210</a></p>
	<p>Authors:
		Andrea Patrizia Falanga
		Maria Marzano
		Stefano D’Errico
		</p>
	<p>We have recently demonstrated that the pendant tert-butyldiphenylsilyl (TBDPS) groups in the short oligonucleotides TBDPS-5&amp;amp;prime;-CG-3&amp;amp;prime;-3&amp;amp;prime;-GC-5&amp;amp;prime;-TBDPS and TBDPS-5&amp;amp;prime;-CGG-3&amp;amp;prime;-3&amp;amp;prime;-GGC-5&amp;amp;prime;-TBDPS promoted the formation of new lipophilic and stable tetramolecular G-quadruplexes (GQs). Encouraged by these findings, we sought to investigate the effect of alternative lipophilic substituents at the flanking cytidine residues on GQ formation and properties. Herein, we reported on the synthesis and spectroscopic characterization of the new N4-benzoyl-N3-benzyl-2&amp;amp;prime;-deoxycytidine, which was obtained during our attempts to synthesize N4-benzoyl-5&amp;amp;prime;-O-benzyl-2&amp;amp;prime;-deoxycytidine.</p>
	]]></content:encoded>

	<dc:title>N4-Benzoyl-N3-benzyl-2&amp;amp;prime;-deoxycytidine</dc:title>
			<dc:creator>Andrea Patrizia Falanga</dc:creator>
			<dc:creator>Maria Marzano</dc:creator>
			<dc:creator>Stefano D’Errico</dc:creator>
		<dc:identifier>doi: 10.3390/M2210</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2210</prism:startingPage>
		<prism:doi>10.3390/M2210</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2210</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2209">

	<title>Molbank, Vol. 2026, Article M2209: A New Bis(8-hydroxyquinolinylmethyl) Perhydrobenzimidazole Obtained from a Cyclic Aminal Derived from trans-1,2-Diaminocyclohexane and 8-Hydroxyquinoline</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2209</link>
	<description>The reaction of 8-hydroxyquinoline and (2R,7R,11S,16S)-1,8,10,17-tetraazapentacyclo [8.8.1.1.8,170.2,70.11,16]icosane under Mannich-type conditions afforded a new quinoline-functionalized diazabicyclic derivative in 27% yield. The structure of the product was established by FT-IR, 1H and 13C NMR, HSQC, HMBC, and ESI-MS analyses, which confirmed the connectivity between the two quinoline units and the perhydrobenzimidazole heterocyclic fragment. The conformational strain of the perhydroimidazolidine fragment prevents the rearrangement pathway previously reported for related systems, such as cyclic aminal 1,3,6,8-tetraazatricyclo [4.4.1.13,8]dodecane (TATD), leading to a different reaction outcome. The results demonstrate that the conformationally constrained aminal exhibits reactivity distinct from that reported for TATD-derived systems, providing new insight into the behavior of cyclic aminals in Mannich-type reactions.</description>
	<pubDate>2026-08-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2209: A New Bis(8-hydroxyquinolinylmethyl) Perhydrobenzimidazole Obtained from a Cyclic Aminal Derived from trans-1,2-Diaminocyclohexane and 8-Hydroxyquinoline</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2209">doi: 10.3390/M2209</a></p>
	<p>Authors:
		Augusto Rivera
		Jaime Ríos-Motta
		Diego Quiroga
		</p>
	<p>The reaction of 8-hydroxyquinoline and (2R,7R,11S,16S)-1,8,10,17-tetraazapentacyclo [8.8.1.1.8,170.2,70.11,16]icosane under Mannich-type conditions afforded a new quinoline-functionalized diazabicyclic derivative in 27% yield. The structure of the product was established by FT-IR, 1H and 13C NMR, HSQC, HMBC, and ESI-MS analyses, which confirmed the connectivity between the two quinoline units and the perhydrobenzimidazole heterocyclic fragment. The conformational strain of the perhydroimidazolidine fragment prevents the rearrangement pathway previously reported for related systems, such as cyclic aminal 1,3,6,8-tetraazatricyclo [4.4.1.13,8]dodecane (TATD), leading to a different reaction outcome. The results demonstrate that the conformationally constrained aminal exhibits reactivity distinct from that reported for TATD-derived systems, providing new insight into the behavior of cyclic aminals in Mannich-type reactions.</p>
	]]></content:encoded>

	<dc:title>A New Bis(8-hydroxyquinolinylmethyl) Perhydrobenzimidazole Obtained from a Cyclic Aminal Derived from trans-1,2-Diaminocyclohexane and 8-Hydroxyquinoline</dc:title>
			<dc:creator>Augusto Rivera</dc:creator>
			<dc:creator>Jaime Ríos-Motta</dc:creator>
			<dc:creator>Diego Quiroga</dc:creator>
		<dc:identifier>doi: 10.3390/M2209</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2209</prism:startingPage>
		<prism:doi>10.3390/M2209</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2209</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2208">

	<title>Molbank, Vol. 2026, Article M2208: Correction: Pasdar et al. Eco-Friendly Synthesis of Perimidine Derivatives Using Recyclable Fe3O4@Nano-Cellulose/Ti(IV). Molbank 2026, 2026, M2181</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2208</link>
	<description>In the original publication [...]</description>
	<pubDate>2026-08-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2208: Correction: Pasdar et al. Eco-Friendly Synthesis of Perimidine Derivatives Using Recyclable Fe3O4@Nano-Cellulose/Ti(IV). Molbank 2026, 2026, M2181</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2208">doi: 10.3390/M2208</a></p>
	<p>Authors:
		Ghaffar Pasdar
		Abdolhamid Bamoniri
		Bi Bi Fatemeh Mirjalili
		</p>
	<p>In the original publication [...]</p>
	]]></content:encoded>

	<dc:title>Correction: Pasdar et al. Eco-Friendly Synthesis of Perimidine Derivatives Using Recyclable Fe3O4@Nano-Cellulose/Ti(IV). Molbank 2026, 2026, M2181</dc:title>
			<dc:creator>Ghaffar Pasdar</dc:creator>
			<dc:creator>Abdolhamid Bamoniri</dc:creator>
			<dc:creator>Bi Bi Fatemeh Mirjalili</dc:creator>
		<dc:identifier>doi: 10.3390/M2208</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-08-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-08-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Correction</prism:section>
	<prism:startingPage>M2208</prism:startingPage>
		<prism:doi>10.3390/M2208</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2208</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2207">

	<title>Molbank, Vol. 2026, Article M2207: Synthesis and X-Ray Characterization of a New 1,2-Dichloroethane Solvate of 5,10,15,20-Tetraphenylporphyrin-21,23-Diium Dichloride</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2207</link>
	<description>1,2-Dichloroethane was found to stabilize the lattice of chloride anions associated with the protonated porphyrin of formula [C44H32N4]Cl2&amp;amp;middot;4C2H4Cl2. The synthesis and X-ray characterization of this compound are reported and compared with analogous solvates. The porphyrin macrocycle displays a distorted saddle conformation, with chloride anions positioned above and below the mean plane of the ring, further surrounded by two dichloroethane molecules that stabilize the crystal packing. The Second-Harmonic Generation response was evaluated using the Kurtz&amp;amp;ndash;Perry powder technique with a ND:YAG laser (1064 nm).</description>
	<pubDate>2026-07-30</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2207: Synthesis and X-Ray Characterization of a New 1,2-Dichloroethane Solvate of 5,10,15,20-Tetraphenylporphyrin-21,23-Diium Dichloride</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2207">doi: 10.3390/M2207</a></p>
	<p>Authors:
		Domenica Marabello
		Paola Benzi
		Elena Cariati
		</p>
	<p>1,2-Dichloroethane was found to stabilize the lattice of chloride anions associated with the protonated porphyrin of formula [C44H32N4]Cl2&amp;amp;middot;4C2H4Cl2. The synthesis and X-ray characterization of this compound are reported and compared with analogous solvates. The porphyrin macrocycle displays a distorted saddle conformation, with chloride anions positioned above and below the mean plane of the ring, further surrounded by two dichloroethane molecules that stabilize the crystal packing. The Second-Harmonic Generation response was evaluated using the Kurtz&amp;amp;ndash;Perry powder technique with a ND:YAG laser (1064 nm).</p>
	]]></content:encoded>

	<dc:title>Synthesis and X-Ray Characterization of a New 1,2-Dichloroethane Solvate of 5,10,15,20-Tetraphenylporphyrin-21,23-Diium Dichloride</dc:title>
			<dc:creator>Domenica Marabello</dc:creator>
			<dc:creator>Paola Benzi</dc:creator>
			<dc:creator>Elena Cariati</dc:creator>
		<dc:identifier>doi: 10.3390/M2207</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-30</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-30</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2207</prism:startingPage>
		<prism:doi>10.3390/M2207</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2207</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2206">

	<title>Molbank, Vol. 2026, Article M2206: (4aS,5R,6aS,7R,11aS,11bR)-9-(1-Benzyl-1H-benzo[d]imidazol-2-yl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-5-yl Acetate</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2206</link>
	<description>A new benzimidazole&amp;amp;ndash;6&amp;amp;beta;-acetoxyvouacapane (4aS,5R,6aS,7R,11aS,11bR)-9-(1-benzyl-1H-benzo[d]imidazol-2-yl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-5-yl acetate was synthesized through the semisynthetic functionalization of the natural product 6&amp;amp;beta;-acetoxyvouacapane. The target compound was obtained via a liquid-assisted mechanochemical condensation of aldehyde 6&amp;amp;beta;-acetoxyvouacapane with N-benzyl-o-phenylenediamine, followed by cyclization and oxidative aromatization under mild reaction conditions. The structure of the new compound was established by FT-IR, 1D and 2D NMR spectroscopy (COSY, HSQC, and HMBC), and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2026-07-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2206: (4aS,5R,6aS,7R,11aS,11bR)-9-(1-Benzyl-1H-benzo[d]imidazol-2-yl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-5-yl Acetate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2206">doi: 10.3390/M2206</a></p>
	<p>Authors:
		Jessica A. Perez-Rangel
		Alejandro Islas-Jácome
		Luis Chacón-García
		Armando Talavera-Alemán
		Carlos J. Cortés-García
		</p>
	<p>A new benzimidazole&amp;amp;ndash;6&amp;amp;beta;-acetoxyvouacapane (4aS,5R,6aS,7R,11aS,11bR)-9-(1-benzyl-1H-benzo[d]imidazol-2-yl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-5-yl acetate was synthesized through the semisynthetic functionalization of the natural product 6&amp;amp;beta;-acetoxyvouacapane. The target compound was obtained via a liquid-assisted mechanochemical condensation of aldehyde 6&amp;amp;beta;-acetoxyvouacapane with N-benzyl-o-phenylenediamine, followed by cyclization and oxidative aromatization under mild reaction conditions. The structure of the new compound was established by FT-IR, 1D and 2D NMR spectroscopy (COSY, HSQC, and HMBC), and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>(4aS,5R,6aS,7R,11aS,11bR)-9-(1-Benzyl-1H-benzo[d]imidazol-2-yl)-4,4,7,11b-tetramethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-5-yl Acetate</dc:title>
			<dc:creator>Jessica A. Perez-Rangel</dc:creator>
			<dc:creator>Alejandro Islas-Jácome</dc:creator>
			<dc:creator>Luis Chacón-García</dc:creator>
			<dc:creator>Armando Talavera-Alemán</dc:creator>
			<dc:creator>Carlos J. Cortés-García</dc:creator>
		<dc:identifier>doi: 10.3390/M2206</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-17</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-17</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2206</prism:startingPage>
		<prism:doi>10.3390/M2206</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2206</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2205">

	<title>Molbank, Vol. 2026, Article M2205: 1,5,9-tri(Phenylethynyl)-4,8,12-trioxaphosphangulene</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2205</link>
	<description>4,8,12-Trioxaphosphangulene is a bowl-shaped phosphorus-containing &amp;amp;pi;-conjugated molecule whose molecular geometry is highly sensitive to the substituent attached to the phosphorus atom. Herein, we report the synthesis of a new tungsten pentacarbonyl complex of a chiral 4,8,12-trioxaphosphangulene bearing three phenylethynyl groups. The complex was prepared by coordination of the phosphine center to an in situ generated W(CO)5 fragment and was characterized by multinuclear NMR spectroscopy and elemental analysis. The NMR spectra revealed that the phosphangulene framework retains its threefold symmetry in solution. Comparison of the NMR parameters with those of a previously reported phosphangulene&amp;amp;ndash;tungsten complex indicates that incorporation of the phenylethynyl substituents has little effect on either the coordination environment around the phosphorus atom or the phosphine&amp;amp;ndash;tungsten interaction. These findings demonstrate that the characteristic bowl-shaped phosphangulene framework is preserved upon tungsten coordination despite &amp;amp;pi;-extension of the molecular framework.</description>
	<pubDate>2026-07-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2205: 1,5,9-tri(Phenylethynyl)-4,8,12-trioxaphosphangulene</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2205">doi: 10.3390/M2205</a></p>
	<p>Authors:
		Kimiya Sukegawa
		Masaki Yamamura
		Tatsuya Nabeshima
		</p>
	<p>4,8,12-Trioxaphosphangulene is a bowl-shaped phosphorus-containing &amp;amp;pi;-conjugated molecule whose molecular geometry is highly sensitive to the substituent attached to the phosphorus atom. Herein, we report the synthesis of a new tungsten pentacarbonyl complex of a chiral 4,8,12-trioxaphosphangulene bearing three phenylethynyl groups. The complex was prepared by coordination of the phosphine center to an in situ generated W(CO)5 fragment and was characterized by multinuclear NMR spectroscopy and elemental analysis. The NMR spectra revealed that the phosphangulene framework retains its threefold symmetry in solution. Comparison of the NMR parameters with those of a previously reported phosphangulene&amp;amp;ndash;tungsten complex indicates that incorporation of the phenylethynyl substituents has little effect on either the coordination environment around the phosphorus atom or the phosphine&amp;amp;ndash;tungsten interaction. These findings demonstrate that the characteristic bowl-shaped phosphangulene framework is preserved upon tungsten coordination despite &amp;amp;pi;-extension of the molecular framework.</p>
	]]></content:encoded>

	<dc:title>1,5,9-tri(Phenylethynyl)-4,8,12-trioxaphosphangulene</dc:title>
			<dc:creator>Kimiya Sukegawa</dc:creator>
			<dc:creator>Masaki Yamamura</dc:creator>
			<dc:creator>Tatsuya Nabeshima</dc:creator>
		<dc:identifier>doi: 10.3390/M2205</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2205</prism:startingPage>
		<prism:doi>10.3390/M2205</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2205</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2204">

	<title>Molbank, Vol. 2026, Article M2204: Synthesis of Azirinylammonium Salts via Alkylation of DABCO with 2-Halo-2H-azirines</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2204</link>
	<description>Tertiary (2H-azirin-2-yl)ammonium salts were prepared from methyl 2-halo-3-aryl-2H-azirine-2-carboxylates and 1,4-diazabicyclo[2.2.2]octane in very good to excellent yields. Both iodide and bromide salts are stable enough in crystalline form to be stored in a freezer for up to several months. The structures of the obtained salts were confirmed by NMR spectroscopy and HRMS.</description>
	<pubDate>2026-07-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2204: Synthesis of Azirinylammonium Salts via Alkylation of DABCO with 2-Halo-2H-azirines</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2204">doi: 10.3390/M2204</a></p>
	<p>Authors:
		Maksim A. Valiarovskii
		Alexander V. Vorob’ev
		Anastasiya V. Agafonova
		Mikhail S. Novikov
		</p>
	<p>Tertiary (2H-azirin-2-yl)ammonium salts were prepared from methyl 2-halo-3-aryl-2H-azirine-2-carboxylates and 1,4-diazabicyclo[2.2.2]octane in very good to excellent yields. Both iodide and bromide salts are stable enough in crystalline form to be stored in a freezer for up to several months. The structures of the obtained salts were confirmed by NMR spectroscopy and HRMS.</p>
	]]></content:encoded>

	<dc:title>Synthesis of Azirinylammonium Salts via Alkylation of DABCO with 2-Halo-2H-azirines</dc:title>
			<dc:creator>Maksim A. Valiarovskii</dc:creator>
			<dc:creator>Alexander V. Vorob’ev</dc:creator>
			<dc:creator>Anastasiya V. Agafonova</dc:creator>
			<dc:creator>Mikhail S. Novikov</dc:creator>
		<dc:identifier>doi: 10.3390/M2204</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-14</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2204</prism:startingPage>
		<prism:doi>10.3390/M2204</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2204</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2203">

	<title>Molbank, Vol. 2026, Article M2203: 10-(3,5-Di-tert-butylphenyl)-9-methylacridinium Tetrafluoroborate</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2203</link>
	<description>A 9-methylacridinium salt, 10-(3,5-di-tert-butylphenyl)-9-methylacridin-10-ium tetrafluoroborate (2), was synthesized from the corresponding acridone by treatment with methylmagnesium bromide followed by tetrafluoroboric acid. Compound 2 was obtained as a yellow solid in 95% yield and characterized by NMR spectroscopy and high-resolution mass spectrometry. Electrochemical measurements revealed irreversible reduction behavior, with a reduction potential of &amp;amp;minus;0.52 V vs. SCE determined by second-harmonic alternating-current voltammetry. Compound 2 exhibited absorption extending into the visible region and fluorescence at 492 nm with a lifetime of 4.6 ns. Unlike the previously reported 9-mesityl analogue, compound 2 was fluorescent, a difference that may reflect the absence of the high-lying donor orbital associated with the 9-mesityl group. Its singlet excited-state reduction potential was estimated to be +2.21 V vs. SCE, indicating substantial photooxidizing ability. DFT and TD-DFT calculations provided complementary insight into its frontier molecular orbital distributions and principal electronic transitions. These findings highlight the influence of the 9-substituent on the electronic and emissive properties of acridinium-based photoactive molecules.</description>
	<pubDate>2026-07-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2203: 10-(3,5-Di-tert-butylphenyl)-9-methylacridinium Tetrafluoroborate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2203">doi: 10.3390/M2203</a></p>
	<p>Authors:
		Yuki Itabashi
		Kei Ohkubo
		</p>
	<p>A 9-methylacridinium salt, 10-(3,5-di-tert-butylphenyl)-9-methylacridin-10-ium tetrafluoroborate (2), was synthesized from the corresponding acridone by treatment with methylmagnesium bromide followed by tetrafluoroboric acid. Compound 2 was obtained as a yellow solid in 95% yield and characterized by NMR spectroscopy and high-resolution mass spectrometry. Electrochemical measurements revealed irreversible reduction behavior, with a reduction potential of &amp;amp;minus;0.52 V vs. SCE determined by second-harmonic alternating-current voltammetry. Compound 2 exhibited absorption extending into the visible region and fluorescence at 492 nm with a lifetime of 4.6 ns. Unlike the previously reported 9-mesityl analogue, compound 2 was fluorescent, a difference that may reflect the absence of the high-lying donor orbital associated with the 9-mesityl group. Its singlet excited-state reduction potential was estimated to be +2.21 V vs. SCE, indicating substantial photooxidizing ability. DFT and TD-DFT calculations provided complementary insight into its frontier molecular orbital distributions and principal electronic transitions. These findings highlight the influence of the 9-substituent on the electronic and emissive properties of acridinium-based photoactive molecules.</p>
	]]></content:encoded>

	<dc:title>10-(3,5-Di-tert-butylphenyl)-9-methylacridinium Tetrafluoroborate</dc:title>
			<dc:creator>Yuki Itabashi</dc:creator>
			<dc:creator>Kei Ohkubo</dc:creator>
		<dc:identifier>doi: 10.3390/M2203</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-14</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2203</prism:startingPage>
		<prism:doi>10.3390/M2203</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2203</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2202">

	<title>Molbank, Vol. 2026, Article M2202: (5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2202</link>
	<description>4-aminoquinazoline derivatives exhibit unique physiological activities, including antitumor, anti-inflammatory, and antibacterial biological activities. Afatinib (BIBW-2992), the representative tyrosine kinase inhibitor, has been developed for the treatment of non-small cell lung cancer. Following our expanded medical chemistry research program, we report a novel 4-aminoquinazoline derivative named JSLN-P (1), (5S)-5-[(2-(5-bromo-2-methoxyphenyl) quinazolin-4-ylamino)methyl]-3-(3-fluoro-4-morpholino phenyl) oxazolidin-2-one, aimed for developing new drugs with antiglioma properties. The title compound JSLN-P (1) was successfully synthesized by amination approaches following benzylamination and oxazolone cyclization, further condensation with 4-(4-bromo-2-fluorophenyl) morpholine, reduction in debenzylation and halogenated amination of quinazolin. The structure of JSLN-P (1) was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2026-07-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2202: (5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2202">doi: 10.3390/M2202</a></p>
	<p>Authors:
		Mingguang Zhang
		Siyu Hao
		Baiyang Mao
		Yongxu Piao
		</p>
	<p>4-aminoquinazoline derivatives exhibit unique physiological activities, including antitumor, anti-inflammatory, and antibacterial biological activities. Afatinib (BIBW-2992), the representative tyrosine kinase inhibitor, has been developed for the treatment of non-small cell lung cancer. Following our expanded medical chemistry research program, we report a novel 4-aminoquinazoline derivative named JSLN-P (1), (5S)-5-[(2-(5-bromo-2-methoxyphenyl) quinazolin-4-ylamino)methyl]-3-(3-fluoro-4-morpholino phenyl) oxazolidin-2-one, aimed for developing new drugs with antiglioma properties. The title compound JSLN-P (1) was successfully synthesized by amination approaches following benzylamination and oxazolone cyclization, further condensation with 4-(4-bromo-2-fluorophenyl) morpholine, reduction in debenzylation and halogenated amination of quinazolin. The structure of JSLN-P (1) was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>(5S)-5-[(2-(5-Bromo-2-methoxyphenyl)quinazolin-4-yl Amino)methyl]-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one</dc:title>
			<dc:creator>Mingguang Zhang</dc:creator>
			<dc:creator>Siyu Hao</dc:creator>
			<dc:creator>Baiyang Mao</dc:creator>
			<dc:creator>Yongxu Piao</dc:creator>
		<dc:identifier>doi: 10.3390/M2202</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2202</prism:startingPage>
		<prism:doi>10.3390/M2202</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2202</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2201">

	<title>Molbank, Vol. 2026, Article M2201: (E)-4-(3-Oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)prop-1-en-1-yl)benzaldehyde</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2201</link>
	<description>In the present study, (E)-4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)prop-1-en-1-yl)benzaldehyde (2) was synthesized via a base-catalyzed Claisen&amp;amp;ndash;Schmidt condensation of 6-acetylbenzo[d]oxazol-2(3H)-one (1) and terephthalaldehyde and characterized by spectroscopic methods.</description>
	<pubDate>2026-07-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2201: (E)-4-(3-Oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)prop-1-en-1-yl)benzaldehyde</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2201">doi: 10.3390/M2201</a></p>
	<p>Authors:
		Yordanka B. Ivanova
		Daniel Y. Yordanov
		Ognyan I. Petrov
		</p>
	<p>In the present study, (E)-4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)prop-1-en-1-yl)benzaldehyde (2) was synthesized via a base-catalyzed Claisen&amp;amp;ndash;Schmidt condensation of 6-acetylbenzo[d]oxazol-2(3H)-one (1) and terephthalaldehyde and characterized by spectroscopic methods.</p>
	]]></content:encoded>

	<dc:title>(E)-4-(3-Oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)prop-1-en-1-yl)benzaldehyde</dc:title>
			<dc:creator>Yordanka B. Ivanova</dc:creator>
			<dc:creator>Daniel Y. Yordanov</dc:creator>
			<dc:creator>Ognyan I. Petrov</dc:creator>
		<dc:identifier>doi: 10.3390/M2201</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2201</prism:startingPage>
		<prism:doi>10.3390/M2201</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2201</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2200">

	<title>Molbank, Vol. 2026, Article M2200: N-(4-fluorobenzyl)-N&amp;prime;-(4-fluorobenzylidene)-4-methylbenzenesulfonohydrazide</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2200</link>
	<description>Herein, we present the synthesis of N-(4-fluorobenzyl)-N&amp;amp;rsquo;-(4-fluorobenzylidene)-4-methylbenzenesulfonohydrazide. The compound has been thoroughly characterized through melting-point determination, 1H and 13C NMR spectroscopy and mass spectrometry. The structure was unequivocally determined by X-ray analysis. The comprehensive analytical data obtained from these techniques confirm the successful preparation and structural integrity of the newly synthesized molecule.</description>
	<pubDate>2026-07-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2200: N-(4-fluorobenzyl)-N&amp;prime;-(4-fluorobenzylidene)-4-methylbenzenesulfonohydrazide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2200">doi: 10.3390/M2200</a></p>
	<p>Authors:
		Lei Gao
		Li Xu
		Zheng Zhang
		Jinchang Zhang
		Diangang Bai
		Xiangrong Wang
		Yue Zhang
		</p>
	<p>Herein, we present the synthesis of N-(4-fluorobenzyl)-N&amp;amp;rsquo;-(4-fluorobenzylidene)-4-methylbenzenesulfonohydrazide. The compound has been thoroughly characterized through melting-point determination, 1H and 13C NMR spectroscopy and mass spectrometry. The structure was unequivocally determined by X-ray analysis. The comprehensive analytical data obtained from these techniques confirm the successful preparation and structural integrity of the newly synthesized molecule.</p>
	]]></content:encoded>

	<dc:title>N-(4-fluorobenzyl)-N&amp;amp;prime;-(4-fluorobenzylidene)-4-methylbenzenesulfonohydrazide</dc:title>
			<dc:creator>Lei Gao</dc:creator>
			<dc:creator>Li Xu</dc:creator>
			<dc:creator>Zheng Zhang</dc:creator>
			<dc:creator>Jinchang Zhang</dc:creator>
			<dc:creator>Diangang Bai</dc:creator>
			<dc:creator>Xiangrong Wang</dc:creator>
			<dc:creator>Yue Zhang</dc:creator>
		<dc:identifier>doi: 10.3390/M2200</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2200</prism:startingPage>
		<prism:doi>10.3390/M2200</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2200</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2199">

	<title>Molbank, Vol. 2026, Article M2199: Methyl 3-(Propan-2-ylidene)-3a,9a-dihydro-3H-cyclopenta[a]azulene-9-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2199</link>
	<description>Methyl 3-(propan-2-ylidene)-3a,9a-dihydro-3H-cyclopenta[a]azulene-9-carboxylate (2) was synthesized in moderate yield via an [8 + 2] cycloaddition of methyl 2-oxo-2H-cyclohepta[b]furan-3-carboxylate (1) with 6,6-dimethylfulvene. The resulting compound was characterized by 1H and 13C NMR spectroscopy, high-resolution mass spectrometry, and single-crystal X-ray diffraction analysis.</description>
	<pubDate>2026-07-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2199: Methyl 3-(Propan-2-ylidene)-3a,9a-dihydro-3H-cyclopenta[a]azulene-9-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2199">doi: 10.3390/M2199</a></p>
	<p>Authors:
		Miku Yoshida
		Masafumi Yasunami
		Ryuta Sekiguchi
		Shunji Ito
		Taku Shoji
		</p>
	<p>Methyl 3-(propan-2-ylidene)-3a,9a-dihydro-3H-cyclopenta[a]azulene-9-carboxylate (2) was synthesized in moderate yield via an [8 + 2] cycloaddition of methyl 2-oxo-2H-cyclohepta[b]furan-3-carboxylate (1) with 6,6-dimethylfulvene. The resulting compound was characterized by 1H and 13C NMR spectroscopy, high-resolution mass spectrometry, and single-crystal X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>Methyl 3-(Propan-2-ylidene)-3a,9a-dihydro-3H-cyclopenta[a]azulene-9-carboxylate</dc:title>
			<dc:creator>Miku Yoshida</dc:creator>
			<dc:creator>Masafumi Yasunami</dc:creator>
			<dc:creator>Ryuta Sekiguchi</dc:creator>
			<dc:creator>Shunji Ito</dc:creator>
			<dc:creator>Taku Shoji</dc:creator>
		<dc:identifier>doi: 10.3390/M2199</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2199</prism:startingPage>
		<prism:doi>10.3390/M2199</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2199</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2198">

	<title>Molbank, Vol. 2026, Article M2198: Synthesis of 8-Bromo-2-(chloromethyl)-6-methoxy-5-nitroimidazo[1,2-a]pyridine and 8-Bromo-2-(chloromethyl)-6-methoxy-3,5-dinitroimidazo[1,2-a]pyridine</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2198</link>
	<description>A novel synthetic approach was developed to synthesize 6-methoxy substituted imidazo[1,2-a]pyridine derivatives, with the objective of obtaining analogs of previously identified antileishmanial hit compounds. The nitration of 8-bromo-2-(chloromethyl)-6-methoxyimidazo[1,2-a]pyridine under classical nitric acid/sulfuric acid conditions resulted in selective nitration at position 5 and the corresponding 3,5-dinitrated derivative. The structures of these compounds were established through a combination of experimental methods, including 1H and 13C NMR, HRMS, HSQC, and HMBC experiments. These structural determinations were subsequently confirmed through single-crystal X-ray diffraction. These compounds represent the first examples of 5-nitrated and 3,5-dinitrated 6-methoxyimidazo[1,2-a]pyridines.</description>
	<pubDate>2026-07-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2198: Synthesis of 8-Bromo-2-(chloromethyl)-6-methoxy-5-nitroimidazo[1,2-a]pyridine and 8-Bromo-2-(chloromethyl)-6-methoxy-3,5-dinitroimidazo[1,2-a]pyridine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2198">doi: 10.3390/M2198</a></p>
	<p>Authors:
		Inès Jacquet
		Romain Paoli-Lombardo
		Caroline Castera-Ducros
		Patrice Vanelle
		Nicolas Primas
		</p>
	<p>A novel synthetic approach was developed to synthesize 6-methoxy substituted imidazo[1,2-a]pyridine derivatives, with the objective of obtaining analogs of previously identified antileishmanial hit compounds. The nitration of 8-bromo-2-(chloromethyl)-6-methoxyimidazo[1,2-a]pyridine under classical nitric acid/sulfuric acid conditions resulted in selective nitration at position 5 and the corresponding 3,5-dinitrated derivative. The structures of these compounds were established through a combination of experimental methods, including 1H and 13C NMR, HRMS, HSQC, and HMBC experiments. These structural determinations were subsequently confirmed through single-crystal X-ray diffraction. These compounds represent the first examples of 5-nitrated and 3,5-dinitrated 6-methoxyimidazo[1,2-a]pyridines.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 8-Bromo-2-(chloromethyl)-6-methoxy-5-nitroimidazo[1,2-a]pyridine and 8-Bromo-2-(chloromethyl)-6-methoxy-3,5-dinitroimidazo[1,2-a]pyridine</dc:title>
			<dc:creator>Inès Jacquet</dc:creator>
			<dc:creator>Romain Paoli-Lombardo</dc:creator>
			<dc:creator>Caroline Castera-Ducros</dc:creator>
			<dc:creator>Patrice Vanelle</dc:creator>
			<dc:creator>Nicolas Primas</dc:creator>
		<dc:identifier>doi: 10.3390/M2198</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2198</prism:startingPage>
		<prism:doi>10.3390/M2198</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2198</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2197">

	<title>Molbank, Vol. 2026, Article M2197: Olean-18&amp;alpha;-19&amp;beta;,28-epoxy-3&amp;beta;-benzoate</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2197</link>
	<description>Allobetulin 3-benzoate was obtained as an unexpected byproduct during the acid-mediated protection&amp;amp;ndash;deprotection of betulin. Single-crystal X-ray diffraction analysis shows that it crystallizes in the triclinic space group P1 with Z = 2 and contains two crystallographically independent molecules in the asymmetric unit. Compared with allobetulin (P21, Z = 4) and allobetulin 3-acetate (C2, Z = 4), the benzoyl substitution at C-3 induces distinct molecular packing and intermolecular interaction patterns, highlighting the influence of steric and electronic effects on crystal architecture.</description>
	<pubDate>2026-07-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2197: Olean-18&amp;alpha;-19&amp;beta;,28-epoxy-3&amp;beta;-benzoate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2197">doi: 10.3390/M2197</a></p>
	<p>Authors:
		Xiqiang Gao
		Jung Hoon Park
		Bohua Lu
		Jinxing Zhai
		Xiaoyi Sun
		Yuanhui Wang
		Lak Shin Jeong
		Qiang Wang
		</p>
	<p>Allobetulin 3-benzoate was obtained as an unexpected byproduct during the acid-mediated protection&amp;amp;ndash;deprotection of betulin. Single-crystal X-ray diffraction analysis shows that it crystallizes in the triclinic space group P1 with Z = 2 and contains two crystallographically independent molecules in the asymmetric unit. Compared with allobetulin (P21, Z = 4) and allobetulin 3-acetate (C2, Z = 4), the benzoyl substitution at C-3 induces distinct molecular packing and intermolecular interaction patterns, highlighting the influence of steric and electronic effects on crystal architecture.</p>
	]]></content:encoded>

	<dc:title>Olean-18&amp;amp;alpha;-19&amp;amp;beta;,28-epoxy-3&amp;amp;beta;-benzoate</dc:title>
			<dc:creator>Xiqiang Gao</dc:creator>
			<dc:creator>Jung Hoon Park</dc:creator>
			<dc:creator>Bohua Lu</dc:creator>
			<dc:creator>Jinxing Zhai</dc:creator>
			<dc:creator>Xiaoyi Sun</dc:creator>
			<dc:creator>Yuanhui Wang</dc:creator>
			<dc:creator>Lak Shin Jeong</dc:creator>
			<dc:creator>Qiang Wang</dc:creator>
		<dc:identifier>doi: 10.3390/M2197</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-01</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2197</prism:startingPage>
		<prism:doi>10.3390/M2197</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2197</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2196">

	<title>Molbank, Vol. 2026, Article M2196: The Crystal Structure of N,N&amp;prime;-bis(3,5-di-tert-Butylsalicylidene)propane-1,2-diamine)-oxidovanadium(IV) and Its Parent Ligand</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2196</link>
	<description>The asymmetric salen ligand N,N&amp;amp;prime;-bis(3,5-di-tert-butylsalicylidene)propane-1,2-diamine (1) with a single chiral center and its vanadyl complex (2) have been prepared and characterized by single-crystal X-ray diffraction.</description>
	<pubDate>2026-07-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2196: The Crystal Structure of N,N&amp;prime;-bis(3,5-di-tert-Butylsalicylidene)propane-1,2-diamine)-oxidovanadium(IV) and Its Parent Ligand</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2196">doi: 10.3390/M2196</a></p>
	<p>Authors:
		Kirsten S. Graham
		Aidan P. McKay
		David B. Cordes
		Brian A. Chalmers
		</p>
	<p>The asymmetric salen ligand N,N&amp;amp;prime;-bis(3,5-di-tert-butylsalicylidene)propane-1,2-diamine (1) with a single chiral center and its vanadyl complex (2) have been prepared and characterized by single-crystal X-ray diffraction.</p>
	]]></content:encoded>

	<dc:title>The Crystal Structure of N,N&amp;amp;prime;-bis(3,5-di-tert-Butylsalicylidene)propane-1,2-diamine)-oxidovanadium(IV) and Its Parent Ligand</dc:title>
			<dc:creator>Kirsten S. Graham</dc:creator>
			<dc:creator>Aidan P. McKay</dc:creator>
			<dc:creator>David B. Cordes</dc:creator>
			<dc:creator>Brian A. Chalmers</dc:creator>
		<dc:identifier>doi: 10.3390/M2196</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-01</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2196</prism:startingPage>
		<prism:doi>10.3390/M2196</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2196</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2195">

	<title>Molbank, Vol. 2026, Article M2195: 3-(4-Hydroxynaphthalen-1-yl)-3-(1-hydroxynaphthalen-2-yl)isobenzofuran-1(3H)-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2195</link>
	<description>3-(4-hydroxynaphthalen-1-yl)-3-(1-hydroxynaphthalen-2-yl)isobenzofuran-1(3H)-one is a previously unknown derivative of the well-known acid/base indicator naphtholphthalein. We report the synthesis and the molecular structure of the title compound, as determined by single-crystal X-ray diffraction. 1H and 13C NMR spectroscopy data, IR spectroscopy data, and mass spectrometry data are provided.</description>
	<pubDate>2026-07-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2195: 3-(4-Hydroxynaphthalen-1-yl)-3-(1-hydroxynaphthalen-2-yl)isobenzofuran-1(3H)-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2195">doi: 10.3390/M2195</a></p>
	<p>Authors:
		Brian A. Chalmers
		David B. Cordes
		Tomas Lebl
		Aidan P. McKay
		Iain L. J. Patterson
		Nadiia Vladymyrova
		Iain A. Smellie
		</p>
	<p>3-(4-hydroxynaphthalen-1-yl)-3-(1-hydroxynaphthalen-2-yl)isobenzofuran-1(3H)-one is a previously unknown derivative of the well-known acid/base indicator naphtholphthalein. We report the synthesis and the molecular structure of the title compound, as determined by single-crystal X-ray diffraction. 1H and 13C NMR spectroscopy data, IR spectroscopy data, and mass spectrometry data are provided.</p>
	]]></content:encoded>

	<dc:title>3-(4-Hydroxynaphthalen-1-yl)-3-(1-hydroxynaphthalen-2-yl)isobenzofuran-1(3H)-one</dc:title>
			<dc:creator>Brian A. Chalmers</dc:creator>
			<dc:creator>David B. Cordes</dc:creator>
			<dc:creator>Tomas Lebl</dc:creator>
			<dc:creator>Aidan P. McKay</dc:creator>
			<dc:creator>Iain L. J. Patterson</dc:creator>
			<dc:creator>Nadiia Vladymyrova</dc:creator>
			<dc:creator>Iain A. Smellie</dc:creator>
		<dc:identifier>doi: 10.3390/M2195</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-01</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2195</prism:startingPage>
		<prism:doi>10.3390/M2195</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2195</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/4/M2194">

	<title>Molbank, Vol. 2026, Article M2194: Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate</title>
	<link>https://www.mdpi.com/1422-8599/2026/4/M2194</link>
	<description>The cyclobutane ring has attractive properties as a scaffold in medicinal chemistry but is underused, potentially due to the limited methods available for synthesising highly functionalised cyclobutanes. This short note describes the synthesis of the 1,3-cis disubstituted cyclobutane, methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate using a one-pot thermal stepwise cycloaddition reaction and its characterisation by NMR spectroscopy and HRMS.</description>
	<pubDate>2026-07-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2194: Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/4/M2194">doi: 10.3390/M2194</a></p>
	<p>Authors:
		Helen M. Sheldrake
		</p>
	<p>The cyclobutane ring has attractive properties as a scaffold in medicinal chemistry but is underused, potentially due to the limited methods available for synthesising highly functionalised cyclobutanes. This short note describes the synthesis of the 1,3-cis disubstituted cyclobutane, methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate using a one-pot thermal stepwise cycloaddition reaction and its characterisation by NMR spectroscopy and HRMS.</p>
	]]></content:encoded>

	<dc:title>Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate</dc:title>
			<dc:creator>Helen M. Sheldrake</dc:creator>
		<dc:identifier>doi: 10.3390/M2194</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-07-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-07-01</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2194</prism:startingPage>
		<prism:doi>10.3390/M2194</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/4/M2194</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2193">

	<title>Molbank, Vol. 2026, Article M2193: 1&amp;alpha;-Methoxy-3-oxo-8&amp;alpha;-hydroxy-10&amp;alpha;H-eremophila-7(11)-en-12,8&amp;beta;-olide from Ligularia fischeri</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2193</link>
	<description>One unreported eremophilane sesquiterpenoid, 1&amp;amp;alpha;-methoxy-3-oxo-8&amp;amp;alpha;-hydroxy-10&amp;amp;alpha;H- eremophila-7(11)-en-12,8&amp;amp;beta;-olide (1), was isolated from Ligularia fischeri. The structure of 1 was identified by detailed 1D and 2D NMR and HRMS analyses.</description>
	<pubDate>2026-06-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2193: 1&amp;alpha;-Methoxy-3-oxo-8&amp;alpha;-hydroxy-10&amp;alpha;H-eremophila-7(11)-en-12,8&amp;beta;-olide from Ligularia fischeri</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2193">doi: 10.3390/M2193</a></p>
	<p>Authors:
		Xiangrong Zhang
		Dingkuo Liu
		Fang Liu
		Cheng Yang
		Jingjing Gao
		Chunfeng Xie
		</p>
	<p>One unreported eremophilane sesquiterpenoid, 1&amp;amp;alpha;-methoxy-3-oxo-8&amp;amp;alpha;-hydroxy-10&amp;amp;alpha;H- eremophila-7(11)-en-12,8&amp;amp;beta;-olide (1), was isolated from Ligularia fischeri. The structure of 1 was identified by detailed 1D and 2D NMR and HRMS analyses.</p>
	]]></content:encoded>

	<dc:title>1&amp;amp;alpha;-Methoxy-3-oxo-8&amp;amp;alpha;-hydroxy-10&amp;amp;alpha;H-eremophila-7(11)-en-12,8&amp;amp;beta;-olide from Ligularia fischeri</dc:title>
			<dc:creator>Xiangrong Zhang</dc:creator>
			<dc:creator>Dingkuo Liu</dc:creator>
			<dc:creator>Fang Liu</dc:creator>
			<dc:creator>Cheng Yang</dc:creator>
			<dc:creator>Jingjing Gao</dc:creator>
			<dc:creator>Chunfeng Xie</dc:creator>
		<dc:identifier>doi: 10.3390/M2193</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-12</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-12</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2193</prism:startingPage>
		<prism:doi>10.3390/M2193</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2193</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2192">

	<title>Molbank, Vol. 2026, Article M2192: 4-Methyl-N-(4-methylbenzyl)-N&amp;rsquo;-(4-methylbenzylidene) benzenesulfonohydrazide</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2192</link>
	<description>4-Methyl-N-(4-methylbenzyl)-N&amp;amp;rsquo;-(4-methylbenzylidene)benzenesulfonohydrazide was synthesized via N-alkylation. The compound was characterized by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Its molecular structure was unambiguously established by single-crystal X-ray diffraction analysis. The comprehensive spectral and crystallographic data conclusively verify the successful synthesis and structural integrity of this newly prepared compound.</description>
	<pubDate>2026-06-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2192: 4-Methyl-N-(4-methylbenzyl)-N&amp;rsquo;-(4-methylbenzylidene) benzenesulfonohydrazide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2192">doi: 10.3390/M2192</a></p>
	<p>Authors:
		Yue Zhang
		Xiangrong Wang
		Zhihan Liu
		Zheng Zhang
		Xiaoxu Tan
		Lei Gao
		</p>
	<p>4-Methyl-N-(4-methylbenzyl)-N&amp;amp;rsquo;-(4-methylbenzylidene)benzenesulfonohydrazide was synthesized via N-alkylation. The compound was characterized by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Its molecular structure was unambiguously established by single-crystal X-ray diffraction analysis. The comprehensive spectral and crystallographic data conclusively verify the successful synthesis and structural integrity of this newly prepared compound.</p>
	]]></content:encoded>

	<dc:title>4-Methyl-N-(4-methylbenzyl)-N&amp;amp;rsquo;-(4-methylbenzylidene) benzenesulfonohydrazide</dc:title>
			<dc:creator>Yue Zhang</dc:creator>
			<dc:creator>Xiangrong Wang</dc:creator>
			<dc:creator>Zhihan Liu</dc:creator>
			<dc:creator>Zheng Zhang</dc:creator>
			<dc:creator>Xiaoxu Tan</dc:creator>
			<dc:creator>Lei Gao</dc:creator>
		<dc:identifier>doi: 10.3390/M2192</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2192</prism:startingPage>
		<prism:doi>10.3390/M2192</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2192</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2191">

	<title>Molbank, Vol. 2026, Article M2191: Uranyl Complex of 1,3-bis(ditertbutylphosphinoxidomethyl)benzene</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2191</link>
	<description>This short note presents a new molecule isolated and characterized from the reaction of uranyl nitrate with the PCP-type pincer ligand 1,3-bis(ditertbutylphosphinomethyl)benzene in the presence of UV light under ambient conditions. The new dinuclear uranyl-PCP complex was characterized by using FT-IR spectroscopy and single-crystal X-ray crystallography. As revealed by the crystal structure, the new complex had oxygen atoms coordinating from the phosphinoxides that were oxidized under ambient conditions. Each uranium atom of this dinuclear complex was found to exhibit pentagonal bipyramidal coordination geometry.</description>
	<pubDate>2026-06-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2191: Uranyl Complex of 1,3-bis(ditertbutylphosphinoxidomethyl)benzene</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2191">doi: 10.3390/M2191</a></p>
	<p>Authors:
		Maha M. Alotaibi
		Md Abdul Goni
		Eric Reinheimer
		Tasneem A. Siddiquee
		</p>
	<p>This short note presents a new molecule isolated and characterized from the reaction of uranyl nitrate with the PCP-type pincer ligand 1,3-bis(ditertbutylphosphinomethyl)benzene in the presence of UV light under ambient conditions. The new dinuclear uranyl-PCP complex was characterized by using FT-IR spectroscopy and single-crystal X-ray crystallography. As revealed by the crystal structure, the new complex had oxygen atoms coordinating from the phosphinoxides that were oxidized under ambient conditions. Each uranium atom of this dinuclear complex was found to exhibit pentagonal bipyramidal coordination geometry.</p>
	]]></content:encoded>

	<dc:title>Uranyl Complex of 1,3-bis(ditertbutylphosphinoxidomethyl)benzene</dc:title>
			<dc:creator>Maha M. Alotaibi</dc:creator>
			<dc:creator>Md Abdul Goni</dc:creator>
			<dc:creator>Eric Reinheimer</dc:creator>
			<dc:creator>Tasneem A. Siddiquee</dc:creator>
		<dc:identifier>doi: 10.3390/M2191</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2191</prism:startingPage>
		<prism:doi>10.3390/M2191</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2191</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2190">

	<title>Molbank, Vol. 2026, Article M2190: Correction: Chen et al. N-(2,5-Difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine. Molbank 2026, 2026, M2174</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2190</link>
	<description>There was an error in the original publication [...]</description>
	<pubDate>2026-06-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2190: Correction: Chen et al. N-(2,5-Difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine. Molbank 2026, 2026, M2174</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2190">doi: 10.3390/M2190</a></p>
	<p>Authors:
		Tiffany L. Chen
		Manisha Sharma
		Nicholas E. Leadbeater
		</p>
	<p>There was an error in the original publication [...]</p>
	]]></content:encoded>

	<dc:title>Correction: Chen et al. N-(2,5-Difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine. Molbank 2026, 2026, M2174</dc:title>
			<dc:creator>Tiffany L. Chen</dc:creator>
			<dc:creator>Manisha Sharma</dc:creator>
			<dc:creator>Nicholas E. Leadbeater</dc:creator>
		<dc:identifier>doi: 10.3390/M2190</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Correction</prism:section>
	<prism:startingPage>M2190</prism:startingPage>
		<prism:doi>10.3390/M2190</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2190</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2189">

	<title>Molbank, Vol. 2026, Article M2189: 2-Chloro-4,5,6,7-tetrafluoro-2-(methylthio)-1H-indene-1,3(2H)-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2189</link>
	<description>We report the synthesis of the new compound 2-chloro-4,5,6,7-tetrafluoro-2-(methylthio)-1H-indene-1,3(2H)-dione (Compound 3), which presents an important type of fluoro-containing heterocycles and is a useful intermediate product in organic synthesis. The structure of the compound was confirmed by the NMR and elemental analysis. A quantum-chemical comparison (DFT) of 2-chloro-2-(methylthio)-1H-indene-1,3(2H)-dione (with C-H bonds, compound 4) and its 4,5,6,7-tetrafluoro derivative (with C-F bonds, compound 3) at the M06-2X/6-311++G(d,p) level in THF showed that the introduction of four fluorine atoms into the benzene ring causes a systematic shortening of the C=O, C-Cl, and C-C bonds of the five-membered ring, as well as an almost twofold decrease in the dipole moment. Replacing hydrogen with fluorine leads to a simultaneous stabilization of the frontier orbitals and a narrowing of the HOMO&amp;amp;ndash;LUMO energy gap, while the electron affinity increases by 0.39 eV and the electrophilicity index increases from 2.77 to 3.24 eV, making compound 3 a strong electrophile. Analysis of donor&amp;amp;ndash;acceptor interactions (NBOs) and condensed Fukui indices confirms that perfluorination selectively increases the electrophilicity of the sp3-carbon center of C-Cl, making it more susceptible to nucleophilic attack. At the same time, the isodesmic reaction with 1,2,4,5-tetrafluorobenzene yields a positive free energy change (&amp;amp;Delta;G = +13.4 kcal/mol), indicating that the increased reactivity of compound 3 is kinetic rather than thermodynamic in nature. The synthesized 1,3-indandione derivative thus represents a promising precursor for tetrafluoroninhydrin and can be considered a biologically active compound. Thus, perfluorination of the indandione skeleton is an effective tool for targeted enhancement of electrophilic properties without fundamentally changing the geometry of the molecule, which opens up prospects for the design of new highly reactive reagents.</description>
	<pubDate>2026-06-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2189: 2-Chloro-4,5,6,7-tetrafluoro-2-(methylthio)-1H-indene-1,3(2H)-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2189">doi: 10.3390/M2189</a></p>
	<p>Authors:
		Anastasia R. Kovrizhina
		Andrei I. Khlebnikov
		</p>
	<p>We report the synthesis of the new compound 2-chloro-4,5,6,7-tetrafluoro-2-(methylthio)-1H-indene-1,3(2H)-dione (Compound 3), which presents an important type of fluoro-containing heterocycles and is a useful intermediate product in organic synthesis. The structure of the compound was confirmed by the NMR and elemental analysis. A quantum-chemical comparison (DFT) of 2-chloro-2-(methylthio)-1H-indene-1,3(2H)-dione (with C-H bonds, compound 4) and its 4,5,6,7-tetrafluoro derivative (with C-F bonds, compound 3) at the M06-2X/6-311++G(d,p) level in THF showed that the introduction of four fluorine atoms into the benzene ring causes a systematic shortening of the C=O, C-Cl, and C-C bonds of the five-membered ring, as well as an almost twofold decrease in the dipole moment. Replacing hydrogen with fluorine leads to a simultaneous stabilization of the frontier orbitals and a narrowing of the HOMO&amp;amp;ndash;LUMO energy gap, while the electron affinity increases by 0.39 eV and the electrophilicity index increases from 2.77 to 3.24 eV, making compound 3 a strong electrophile. Analysis of donor&amp;amp;ndash;acceptor interactions (NBOs) and condensed Fukui indices confirms that perfluorination selectively increases the electrophilicity of the sp3-carbon center of C-Cl, making it more susceptible to nucleophilic attack. At the same time, the isodesmic reaction with 1,2,4,5-tetrafluorobenzene yields a positive free energy change (&amp;amp;Delta;G = +13.4 kcal/mol), indicating that the increased reactivity of compound 3 is kinetic rather than thermodynamic in nature. The synthesized 1,3-indandione derivative thus represents a promising precursor for tetrafluoroninhydrin and can be considered a biologically active compound. Thus, perfluorination of the indandione skeleton is an effective tool for targeted enhancement of electrophilic properties without fundamentally changing the geometry of the molecule, which opens up prospects for the design of new highly reactive reagents.</p>
	]]></content:encoded>

	<dc:title>2-Chloro-4,5,6,7-tetrafluoro-2-(methylthio)-1H-indene-1,3(2H)-dione</dc:title>
			<dc:creator>Anastasia R. Kovrizhina</dc:creator>
			<dc:creator>Andrei I. Khlebnikov</dc:creator>
		<dc:identifier>doi: 10.3390/M2189</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-08</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-08</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2189</prism:startingPage>
		<prism:doi>10.3390/M2189</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2189</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2188">

	<title>Molbank, Vol. 2026, Article M2188: 2-((((R)-3-(((9E,17Z)-18-Bromooctadeca-9,17-dien-7,15-diynoyl)oxy)-2-hydroxypropoxy)(hydroxy)phosphoryl)oxy)-N,N,N-trimethylethan-1-aminium</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2188</link>
	<description>The Saudi Arabian Red Sea has been a focus of ongoing scientific exploration due to its extensive, largely untapped marine biodiversity, particularly marine sponges. Marine sponges have long been recognised as a valuable source of unique compounds. In this study, we isolated a new brominated compound (1) from the marine sponge Aiolochroia crassa, collected from the Saudi Arabian Sea, using chromatographic analyses. Molecular networking analysis revealed the presence of brominated molecules in the extract. The identified compound belongs to a class of phosphatidylcholine derivatives. The structure of compound 1 was elucidated using 1D and 2D NMR spectroscopy and high-resolution ESI-Q-TOF mass spectrometry. Further structure confirmation studies were performed using MS/MS fragmentation analysis and DFT calculations for the 1H and 13C NMR chemical shifts. This is the first report of 1 from this species of marine sponges.</description>
	<pubDate>2026-06-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2188: 2-((((R)-3-(((9E,17Z)-18-Bromooctadeca-9,17-dien-7,15-diynoyl)oxy)-2-hydroxypropoxy)(hydroxy)phosphoryl)oxy)-N,N,N-trimethylethan-1-aminium</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2188">doi: 10.3390/M2188</a></p>
	<p>Authors:
		Abdu Al Nashrey
		Emmanuel T. Oluwabusola
		Hussin D. Almalki
		Gagan Preet
		Dawrin Pech-Puch
		Abel M. Forero
		Jaime Rodriguez
		Rainer Ebel
		Marcel Jaspars
		</p>
	<p>The Saudi Arabian Red Sea has been a focus of ongoing scientific exploration due to its extensive, largely untapped marine biodiversity, particularly marine sponges. Marine sponges have long been recognised as a valuable source of unique compounds. In this study, we isolated a new brominated compound (1) from the marine sponge Aiolochroia crassa, collected from the Saudi Arabian Sea, using chromatographic analyses. Molecular networking analysis revealed the presence of brominated molecules in the extract. The identified compound belongs to a class of phosphatidylcholine derivatives. The structure of compound 1 was elucidated using 1D and 2D NMR spectroscopy and high-resolution ESI-Q-TOF mass spectrometry. Further structure confirmation studies were performed using MS/MS fragmentation analysis and DFT calculations for the 1H and 13C NMR chemical shifts. This is the first report of 1 from this species of marine sponges.</p>
	]]></content:encoded>

	<dc:title>2-((((R)-3-(((9E,17Z)-18-Bromooctadeca-9,17-dien-7,15-diynoyl)oxy)-2-hydroxypropoxy)(hydroxy)phosphoryl)oxy)-N,N,N-trimethylethan-1-aminium</dc:title>
			<dc:creator>Abdu Al Nashrey</dc:creator>
			<dc:creator>Emmanuel T. Oluwabusola</dc:creator>
			<dc:creator>Hussin D. Almalki</dc:creator>
			<dc:creator>Gagan Preet</dc:creator>
			<dc:creator>Dawrin Pech-Puch</dc:creator>
			<dc:creator>Abel M. Forero</dc:creator>
			<dc:creator>Jaime Rodriguez</dc:creator>
			<dc:creator>Rainer Ebel</dc:creator>
			<dc:creator>Marcel Jaspars</dc:creator>
		<dc:identifier>doi: 10.3390/M2188</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2188</prism:startingPage>
		<prism:doi>10.3390/M2188</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2188</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2187">

	<title>Molbank, Vol. 2026, Article M2187: (2R,3R,4S,5R,6S,8R,13R,16S,17R)-11-Ethyl-13-methyl-4,6,8,9,16-pentamethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2187</link>
	<description>The Delphinium albocoeruleum Maxim is a perennial herbaceous plant of the Ranunculaceae family, genus Delphinium. It typically grows in well-drained alpine meadows or shrublands at elevations of 2500&amp;amp;ndash;4000 m, which shapes the species&amp;amp;rsquo; unique environmental adaptation mechanism and endows it with high medicinal value. There are a few reports on the chemical constituents and biological activities of this plant. Therefore, this study focuses on the chemical constituents of the plant in order to discover structurally novel alkaloids. This paper reports on the isolation and structural characterization, using HRMS and 1D and 2D NMR, of a new alkaloid that came from the plant.</description>
	<pubDate>2026-06-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2187: (2R,3R,4S,5R,6S,8R,13R,16S,17R)-11-Ethyl-13-methyl-4,6,8,9,16-pentamethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2187">doi: 10.3390/M2187</a></p>
	<p>Authors:
		Na Gao
		Guo-Li Li
		Lei Wang
		Hong-Ying Yang
		Yi-Lin He
		Tong Shen
		</p>
	<p>The Delphinium albocoeruleum Maxim is a perennial herbaceous plant of the Ranunculaceae family, genus Delphinium. It typically grows in well-drained alpine meadows or shrublands at elevations of 2500&amp;amp;ndash;4000 m, which shapes the species&amp;amp;rsquo; unique environmental adaptation mechanism and endows it with high medicinal value. There are a few reports on the chemical constituents and biological activities of this plant. Therefore, this study focuses on the chemical constituents of the plant in order to discover structurally novel alkaloids. This paper reports on the isolation and structural characterization, using HRMS and 1D and 2D NMR, of a new alkaloid that came from the plant.</p>
	]]></content:encoded>

	<dc:title>(2R,3R,4S,5R,6S,8R,13R,16S,17R)-11-Ethyl-13-methyl-4,6,8,9,16-pentamethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane</dc:title>
			<dc:creator>Na Gao</dc:creator>
			<dc:creator>Guo-Li Li</dc:creator>
			<dc:creator>Lei Wang</dc:creator>
			<dc:creator>Hong-Ying Yang</dc:creator>
			<dc:creator>Yi-Lin He</dc:creator>
			<dc:creator>Tong Shen</dc:creator>
		<dc:identifier>doi: 10.3390/M2187</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2187</prism:startingPage>
		<prism:doi>10.3390/M2187</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2187</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2186">

	<title>Molbank, Vol. 2026, Article M2186: 3-(Methylthio)-1-[(4-nitrophenyl)sulfonyl]-1H-1,2,4-triazol-5-amine</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2186</link>
	<description>We report a highly chemoselective N-sulfonylation of 3-(methylthio)-1H-1,2,4-triazol-5-amine with 4-nitrobenzenesulfonyl chloride promoted by N,N-diisopropylethylamine in acetonitrile under mild conditions. This transformation selectively affords N-(4-nitrophenyl)sulfonylation at the N1 position of the 1,2,4-triazole ring over the exocyclic amine functionality. The product was fully characterized by IR, 1D and 2D NMR spectroscopy, as well as high-resolution mass spectrometry, unequivocally confirming its molecular structure.</description>
	<pubDate>2026-06-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2186: 3-(Methylthio)-1-[(4-nitrophenyl)sulfonyl]-1H-1,2,4-triazol-5-amine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2186">doi: 10.3390/M2186</a></p>
	<p>Authors:
		Diana Becerra
		Mario A. Macías
		Juan-Carlos Castillo
		</p>
	<p>We report a highly chemoselective N-sulfonylation of 3-(methylthio)-1H-1,2,4-triazol-5-amine with 4-nitrobenzenesulfonyl chloride promoted by N,N-diisopropylethylamine in acetonitrile under mild conditions. This transformation selectively affords N-(4-nitrophenyl)sulfonylation at the N1 position of the 1,2,4-triazole ring over the exocyclic amine functionality. The product was fully characterized by IR, 1D and 2D NMR spectroscopy, as well as high-resolution mass spectrometry, unequivocally confirming its molecular structure.</p>
	]]></content:encoded>

	<dc:title>3-(Methylthio)-1-[(4-nitrophenyl)sulfonyl]-1H-1,2,4-triazol-5-amine</dc:title>
			<dc:creator>Diana Becerra</dc:creator>
			<dc:creator>Mario A. Macías</dc:creator>
			<dc:creator>Juan-Carlos Castillo</dc:creator>
		<dc:identifier>doi: 10.3390/M2186</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2186</prism:startingPage>
		<prism:doi>10.3390/M2186</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2186</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2185">

	<title>Molbank, Vol. 2026, Article M2185: A Three-Step Synthesis of (3aR,7aR)-1,3-bis(4-Aminobenzyl)octahydro-2H-benzo[d]imidazole-2-thione from trans-(R, R)-diaminocyclohexane</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2185</link>
	<description>Imidazolidin-2-thiones are versatile sulfur-containing heterocycles with broad biological relevance. The synthesis of (3aR,7aR)-1,3-bis(4-aminobenzyl)octahydro-2H-benzo[d]imidazole-2-thione (an imidazolidin-2-thione derivative) from trans-(R, R)-diaminocyclohexane is presented via a three-step sequence: formation of a Schiff base from 1,2-diamine and 4-nitrobenzaldehyde, followed by reduction with NaBH4; thiocarbonylation under microwave irradiation (MW) to generate the imidazolidin-2-thione core; and reduction of the nitro substituents to amines using an iron/CaCl2 system. The structure of the final compound was confirmed by detailed 1H and 13C NMR analyses, demonstrating the preservation of the bicyclic backbone and the successful conversion of the nitro functional group. The overall yield of the sequence was 28%, with the reduction of the nitro group identified as the rate-limiting step. This protocol represents a viable synthetic strategy for obtaining functionalized imidazolidin-2-thiones useful for the development of novel bioactive sulfur-containing heterocycles.</description>
	<pubDate>2026-06-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2185: A Three-Step Synthesis of (3aR,7aR)-1,3-bis(4-Aminobenzyl)octahydro-2H-benzo[d]imidazole-2-thione from trans-(R, R)-diaminocyclohexane</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2185">doi: 10.3390/M2185</a></p>
	<p>Authors:
		Catalina Hoyos-Orozco
		Ericsson Coy-Barrera
		Diego Quiroga
		</p>
	<p>Imidazolidin-2-thiones are versatile sulfur-containing heterocycles with broad biological relevance. The synthesis of (3aR,7aR)-1,3-bis(4-aminobenzyl)octahydro-2H-benzo[d]imidazole-2-thione (an imidazolidin-2-thione derivative) from trans-(R, R)-diaminocyclohexane is presented via a three-step sequence: formation of a Schiff base from 1,2-diamine and 4-nitrobenzaldehyde, followed by reduction with NaBH4; thiocarbonylation under microwave irradiation (MW) to generate the imidazolidin-2-thione core; and reduction of the nitro substituents to amines using an iron/CaCl2 system. The structure of the final compound was confirmed by detailed 1H and 13C NMR analyses, demonstrating the preservation of the bicyclic backbone and the successful conversion of the nitro functional group. The overall yield of the sequence was 28%, with the reduction of the nitro group identified as the rate-limiting step. This protocol represents a viable synthetic strategy for obtaining functionalized imidazolidin-2-thiones useful for the development of novel bioactive sulfur-containing heterocycles.</p>
	]]></content:encoded>

	<dc:title>A Three-Step Synthesis of (3aR,7aR)-1,3-bis(4-Aminobenzyl)octahydro-2H-benzo[d]imidazole-2-thione from trans-(R, R)-diaminocyclohexane</dc:title>
			<dc:creator>Catalina Hoyos-Orozco</dc:creator>
			<dc:creator>Ericsson Coy-Barrera</dc:creator>
			<dc:creator>Diego Quiroga</dc:creator>
		<dc:identifier>doi: 10.3390/M2185</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2185</prism:startingPage>
		<prism:doi>10.3390/M2185</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2185</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2184">

	<title>Molbank, Vol. 2026, Article M2184: Development of New Aryl-Substituted 1,2,3-Triazole Derivatives of Celastrol: Synthetic Approaches and Structural Characterization</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2184</link>
	<description>In this report, we describe the synthesis of two new celastrol derivatives featuring aryl-substituted 1,2,3-triazole fragments attached to the celastrol scaffold via an ester linkage. The target compounds, incorporating 4-methoxyphenyl and p-tert-butylphenyl groups, were characterized by 1H and 13C NMR spectroscopy, FTIR, UV-Vis, HRMS, melting point determination, and specific rotation measurements.</description>
	<pubDate>2026-06-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2184: Development of New Aryl-Substituted 1,2,3-Triazole Derivatives of Celastrol: Synthetic Approaches and Structural Characterization</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2184">doi: 10.3390/M2184</a></p>
	<p>Authors:
		Yuhan Xie
		Nayara Macêdo Peixoto Araujo
		Stanislau Bogusz Junior
		Deepa Alex
		Paolo Coghi
		</p>
	<p>In this report, we describe the synthesis of two new celastrol derivatives featuring aryl-substituted 1,2,3-triazole fragments attached to the celastrol scaffold via an ester linkage. The target compounds, incorporating 4-methoxyphenyl and p-tert-butylphenyl groups, were characterized by 1H and 13C NMR spectroscopy, FTIR, UV-Vis, HRMS, melting point determination, and specific rotation measurements.</p>
	]]></content:encoded>

	<dc:title>Development of New Aryl-Substituted 1,2,3-Triazole Derivatives of Celastrol: Synthetic Approaches and Structural Characterization</dc:title>
			<dc:creator>Yuhan Xie</dc:creator>
			<dc:creator>Nayara Macêdo Peixoto Araujo</dc:creator>
			<dc:creator>Stanislau Bogusz Junior</dc:creator>
			<dc:creator>Deepa Alex</dc:creator>
			<dc:creator>Paolo Coghi</dc:creator>
		<dc:identifier>doi: 10.3390/M2184</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2184</prism:startingPage>
		<prism:doi>10.3390/M2184</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2184</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2183">

	<title>Molbank, Vol. 2026, Article M2183: Synthesis and Structures of Trifluoromethylborates [pinB(Aryl)CF3]&amp;minus;: pinB = 4,4,5,5-Tetramethyl-1,3,2-dioxaborolane</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2183</link>
	<description>Fluoroalkyl-substituted organoboron compounds are valuable building blocks for organic synthesis and for the development of functional molecules in medicinal chemistry, agrochemicals, and materials science. Building on our previous work on difluoromethyl-substituted borates, we report the synthesis and structural characterization of trifluoromethylated borates, 2-aryl-4,4,5,5-tetramethyl-2-(trifluoromethyl)-1,3,2-dioxaborolan-2-uide salts ([pinB(Aryl)CF3]&amp;amp;minus;). Treatment of pinB&amp;amp;ndash;Aryl boronates (pinB = 4,4,5,5-tetramethyl-1,3,2-dioxaborolane) with trimethyl(trifluoromethyl)silane (Ruppert&amp;amp;ndash;Prakash reagent) in the presence of potassium tert-butoxide and 18-crown-6 ether (18-C-6) afforded the corresponding trifluoromethylated borates as isolable crystalline compounds. Compared with the related difluoromethylated borates, the CF3 substituent increases the tendency of [pinB(Aryl)CF3]&amp;amp;minus; to exhibit hygroscopic behavior, as supported by a hydrated crystal structure and the formation of a hygroscopic product. The isolable trifluoromethylborates can serve as reservoirs of electrophilic trifluoromethyl radicals upon oxidation.</description>
	<pubDate>2026-06-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2183: Synthesis and Structures of Trifluoromethylborates [pinB(Aryl)CF3]&amp;minus;: pinB = 4,4,5,5-Tetramethyl-1,3,2-dioxaborolane</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2183">doi: 10.3390/M2183</a></p>
	<p>Authors:
		Yu-En Huang
		Shigekazu Ito
		</p>
	<p>Fluoroalkyl-substituted organoboron compounds are valuable building blocks for organic synthesis and for the development of functional molecules in medicinal chemistry, agrochemicals, and materials science. Building on our previous work on difluoromethyl-substituted borates, we report the synthesis and structural characterization of trifluoromethylated borates, 2-aryl-4,4,5,5-tetramethyl-2-(trifluoromethyl)-1,3,2-dioxaborolan-2-uide salts ([pinB(Aryl)CF3]&amp;amp;minus;). Treatment of pinB&amp;amp;ndash;Aryl boronates (pinB = 4,4,5,5-tetramethyl-1,3,2-dioxaborolane) with trimethyl(trifluoromethyl)silane (Ruppert&amp;amp;ndash;Prakash reagent) in the presence of potassium tert-butoxide and 18-crown-6 ether (18-C-6) afforded the corresponding trifluoromethylated borates as isolable crystalline compounds. Compared with the related difluoromethylated borates, the CF3 substituent increases the tendency of [pinB(Aryl)CF3]&amp;amp;minus; to exhibit hygroscopic behavior, as supported by a hydrated crystal structure and the formation of a hygroscopic product. The isolable trifluoromethylborates can serve as reservoirs of electrophilic trifluoromethyl radicals upon oxidation.</p>
	]]></content:encoded>

	<dc:title>Synthesis and Structures of Trifluoromethylborates [pinB(Aryl)CF3]&amp;amp;minus;: pinB = 4,4,5,5-Tetramethyl-1,3,2-dioxaborolane</dc:title>
			<dc:creator>Yu-En Huang</dc:creator>
			<dc:creator>Shigekazu Ito</dc:creator>
		<dc:identifier>doi: 10.3390/M2183</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-06-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-06-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2183</prism:startingPage>
		<prism:doi>10.3390/M2183</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2183</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2182">

	<title>Molbank, Vol. 2026, Article M2182: 3-(Diphenylamino)-4-ethoxycyclobut-3-ene-1,2-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2182</link>
	<description>The title compound, 3-(diphenylamino)-4-ethoxycyclobut-3-ene-1,2-dione (6), was prepared by reaction of diphenylamine (2) with diethyl squarate (DES; 5) as part of our ongoing studies on monosquarate-amides. Following purification and recrystallisation, the product was isolated as a green crystalline solid. Its structure was established by spectroscopic methods, including FTIR, 1H NMR, 13C NMR and HRMS, and was unambiguously confirmed by single-crystal X-ray diffraction. This work provides access to a previously unreported diphenylamino-substituted squaric acid derivative.</description>
	<pubDate>2026-05-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2182: 3-(Diphenylamino)-4-ethoxycyclobut-3-ene-1,2-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2182">doi: 10.3390/M2182</a></p>
	<p>Authors:
		Nathan Long
		Emanuela Paval
		Joseph C. Bear
		Jeremy K. Cockcroft
		Stephen P. Wren
		</p>
	<p>The title compound, 3-(diphenylamino)-4-ethoxycyclobut-3-ene-1,2-dione (6), was prepared by reaction of diphenylamine (2) with diethyl squarate (DES; 5) as part of our ongoing studies on monosquarate-amides. Following purification and recrystallisation, the product was isolated as a green crystalline solid. Its structure was established by spectroscopic methods, including FTIR, 1H NMR, 13C NMR and HRMS, and was unambiguously confirmed by single-crystal X-ray diffraction. This work provides access to a previously unreported diphenylamino-substituted squaric acid derivative.</p>
	]]></content:encoded>

	<dc:title>3-(Diphenylamino)-4-ethoxycyclobut-3-ene-1,2-dione</dc:title>
			<dc:creator>Nathan Long</dc:creator>
			<dc:creator>Emanuela Paval</dc:creator>
			<dc:creator>Joseph C. Bear</dc:creator>
			<dc:creator>Jeremy K. Cockcroft</dc:creator>
			<dc:creator>Stephen P. Wren</dc:creator>
		<dc:identifier>doi: 10.3390/M2182</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-25</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-25</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2182</prism:startingPage>
		<prism:doi>10.3390/M2182</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2182</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2181">

	<title>Molbank, Vol. 2026, Article M2181: Eco-Friendly Synthesis of Perimidine Derivatives Using Recyclable Fe3O4@Nano-Cellulose/Ti(IV)</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2181</link>
	<description>A novel bio-capable method has been implemented for the synthesis of newly substituted derivatives of perimidine using Fe3O4@nano-cellulose/Ti(IV) as a magnetic, sustainable, and eco-friendly Lewis acid nanocatalyst. The catalyst was thoroughly characterized by XRD, FESEM, and TGA analyses, confirming its crystalline structure, uniform nanoscale morphology, and high thermal stability. The reaction proceeded smoothly in eco-friendly solvents, providing outstanding yields under mild and rapid conditions, especially with ultrasonics. The catalyst, derived from renewable materials, exhibited remarkable activity, easy magnetic recovery, and excellent reusability over several cycles without significant loss of efficiency. Spectral characterization, IR, 1H NMR, 13C NMR, 19F NMR, and HRMS analyses verified that perimidine derivatives were synthesized properly. This sustainable and efficient approach demonstrates the prospect of green Lewis acid nanocatalysts for the sustainable synthesis of valuable heterocyclic compounds.</description>
	<pubDate>2026-05-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2181: Eco-Friendly Synthesis of Perimidine Derivatives Using Recyclable Fe3O4@Nano-Cellulose/Ti(IV)</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2181">doi: 10.3390/M2181</a></p>
	<p>Authors:
		Ghaffar Pasdar
		Abdolhamid Bamoniri
		Bi Bi Fatemeh Mirjalili
		</p>
	<p>A novel bio-capable method has been implemented for the synthesis of newly substituted derivatives of perimidine using Fe3O4@nano-cellulose/Ti(IV) as a magnetic, sustainable, and eco-friendly Lewis acid nanocatalyst. The catalyst was thoroughly characterized by XRD, FESEM, and TGA analyses, confirming its crystalline structure, uniform nanoscale morphology, and high thermal stability. The reaction proceeded smoothly in eco-friendly solvents, providing outstanding yields under mild and rapid conditions, especially with ultrasonics. The catalyst, derived from renewable materials, exhibited remarkable activity, easy magnetic recovery, and excellent reusability over several cycles without significant loss of efficiency. Spectral characterization, IR, 1H NMR, 13C NMR, 19F NMR, and HRMS analyses verified that perimidine derivatives were synthesized properly. This sustainable and efficient approach demonstrates the prospect of green Lewis acid nanocatalysts for the sustainable synthesis of valuable heterocyclic compounds.</p>
	]]></content:encoded>

	<dc:title>Eco-Friendly Synthesis of Perimidine Derivatives Using Recyclable Fe3O4@Nano-Cellulose/Ti(IV)</dc:title>
			<dc:creator>Ghaffar Pasdar</dc:creator>
			<dc:creator>Abdolhamid Bamoniri</dc:creator>
			<dc:creator>Bi Bi Fatemeh Mirjalili</dc:creator>
		<dc:identifier>doi: 10.3390/M2181</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-21</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-21</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2181</prism:startingPage>
		<prism:doi>10.3390/M2181</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2181</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2180">

	<title>Molbank, Vol. 2026, Article M2180: Synthesis and Characterization of Piperazine-Linked Eugenol Derivative</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2180</link>
	<description>In the present work, we synthesize 2-(4-allyl-2-methoxyphenoxy)-1-(4-phenylpiperazin-1-yl)ethan-1-one, a semisynthetic derivative of the natural product eugenol. The compound was synthesized via a three-step synthetic pathway involving esterification, hydrolysis, and subsequent coupling with 4-phenylpiperazine, as confirmed by FTIR, 1H NMR, 13C NMR, and mass spectrometric data.</description>
	<pubDate>2026-05-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2180: Synthesis and Characterization of Piperazine-Linked Eugenol Derivative</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2180">doi: 10.3390/M2180</a></p>
	<p>Authors:
		Munishama Gowda Yenagunte Narayanaswamy
		Sujeet Kumar
		Siddamsetty Ramachandra Setty
		Basavaraj Metikurki
		Chaluvaraju Kalamuddanadoddi Chaluvegowda
		</p>
	<p>In the present work, we synthesize 2-(4-allyl-2-methoxyphenoxy)-1-(4-phenylpiperazin-1-yl)ethan-1-one, a semisynthetic derivative of the natural product eugenol. The compound was synthesized via a three-step synthetic pathway involving esterification, hydrolysis, and subsequent coupling with 4-phenylpiperazine, as confirmed by FTIR, 1H NMR, 13C NMR, and mass spectrometric data.</p>
	]]></content:encoded>

	<dc:title>Synthesis and Characterization of Piperazine-Linked Eugenol Derivative</dc:title>
			<dc:creator>Munishama Gowda Yenagunte Narayanaswamy</dc:creator>
			<dc:creator>Sujeet Kumar</dc:creator>
			<dc:creator>Siddamsetty Ramachandra Setty</dc:creator>
			<dc:creator>Basavaraj Metikurki</dc:creator>
			<dc:creator>Chaluvaraju Kalamuddanadoddi Chaluvegowda</dc:creator>
		<dc:identifier>doi: 10.3390/M2180</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-20</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2180</prism:startingPage>
		<prism:doi>10.3390/M2180</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2180</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2179">

	<title>Molbank, Vol. 2026, Article M2179: Preparative Enzymatic Desymmetrization of (Acetyl-Leu-Pro-Lys)2-R110 Using Bovine Trypsin Variant D189S</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2179</link>
	<description>Rhodamine 110 (R110) peptide conjugates are widely used fluorogenic substrates in proteolytic assays; however, their inherent symmetry results in two identical hydrolysis sites, complicating their application as well-defined substrates. Here, we report a preparative enzymatic strategy for the desymmetrization of the symmetric derivative (Acetyl-Leu-Pro-Lys)2-R110 using the bovine trypsin variant D189S. Due to pronounced differences in the rates of the two sequential hydrolysis steps, a mono-substituted intermediate accumulates under controlled reaction conditions. On a preparative scale, Acetyl-Leu-Pro-Lys-R110 was generated by partial hydrolysis and isolated by preparative HPLC in 28.8% yield and 95.8% purity. The structure of the asymmetric product was fully characterized by NMR and high-resolution mass spectrometry. This work demonstrates that selective enzymatic hydrolysis provides a simple and effective preparative route to asymmetric Rhodamine 110 derivatives, offering a practical alternative to conventional multistep synthetic approaches and enabling improved substrate design for kinetic studies.</description>
	<pubDate>2026-05-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2179: Preparative Enzymatic Desymmetrization of (Acetyl-Leu-Pro-Lys)2-R110 Using Bovine Trypsin Variant D189S</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2179">doi: 10.3390/M2179</a></p>
	<p>Authors:
		Sarah Stoppe
		Marianne Hahn
		Martin Dauner
		Frank Bordusa
		</p>
	<p>Rhodamine 110 (R110) peptide conjugates are widely used fluorogenic substrates in proteolytic assays; however, their inherent symmetry results in two identical hydrolysis sites, complicating their application as well-defined substrates. Here, we report a preparative enzymatic strategy for the desymmetrization of the symmetric derivative (Acetyl-Leu-Pro-Lys)2-R110 using the bovine trypsin variant D189S. Due to pronounced differences in the rates of the two sequential hydrolysis steps, a mono-substituted intermediate accumulates under controlled reaction conditions. On a preparative scale, Acetyl-Leu-Pro-Lys-R110 was generated by partial hydrolysis and isolated by preparative HPLC in 28.8% yield and 95.8% purity. The structure of the asymmetric product was fully characterized by NMR and high-resolution mass spectrometry. This work demonstrates that selective enzymatic hydrolysis provides a simple and effective preparative route to asymmetric Rhodamine 110 derivatives, offering a practical alternative to conventional multistep synthetic approaches and enabling improved substrate design for kinetic studies.</p>
	]]></content:encoded>

	<dc:title>Preparative Enzymatic Desymmetrization of (Acetyl-Leu-Pro-Lys)2-R110 Using Bovine Trypsin Variant D189S</dc:title>
			<dc:creator>Sarah Stoppe</dc:creator>
			<dc:creator>Marianne Hahn</dc:creator>
			<dc:creator>Martin Dauner</dc:creator>
			<dc:creator>Frank Bordusa</dc:creator>
		<dc:identifier>doi: 10.3390/M2179</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-20</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2179</prism:startingPage>
		<prism:doi>10.3390/M2179</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2179</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2178">

	<title>Molbank, Vol. 2026, Article M2178: 2-Methoxy-4-[5-(2-oxo-1,3-dioxolan-4-yl)-4,5-dihydroisoxazol-3-yl]phenyl 4-n-decyloxybenzoate</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2178</link>
	<description>This study addresses the synthesis of a new liquid crystalline compound featuring a 3,5-disubstituted isoxazoline and a 1,3-dioxolan-2-one ring, and renewable aromatic building blocks derived from vanilin and benzoic acid. The target compound was synthesized through a multistep synthetic route involving alkylation, esterification, oxime formation, and a 1,3-dipolar cycloaddition reaction. The synthesized compound, 2-methoxy-4-[5-(2-oxo-1,3-dioxolan-4-yl)-4,5-dihydroisoxazol-3-yl]phenyl 4-n-decyloxybenzoate, was isolated and fully characterized by spectroscopic techniques. Liquid crystal behavior was evaluated by DSC and POM. The monotropic mesomorphic behavior of the title compound was dictated by the interplay between molecular architecture and intermolecular organization, with the methoxy substituent and the 1,3-dioxolan-2-one ring critically influencing phase stability and texture morphology. These findings suggest a structure–property relationship and guide ongoing synthetic optimization toward achieving a stable enantiotropic liquid-crystalline phase and further ion-conduction experiments.</description>
	<pubDate>2026-05-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2178: 2-Methoxy-4-[5-(2-oxo-1,3-dioxolan-4-yl)-4,5-dihydroisoxazol-3-yl]phenyl 4-n-decyloxybenzoate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2178">doi: 10.3390/M2178</a></p>
	<p>Authors:
		Itamar Gonçalves
		Aloir Merlo
		Bruna Batistel
		Leonardo Rossner Wbatuba
		Henrique de Aguiar Mello
		</p>
	<p>This study addresses the synthesis of a new liquid crystalline compound featuring a 3,5-disubstituted isoxazoline and a 1,3-dioxolan-2-one ring, and renewable aromatic building blocks derived from vanilin and benzoic acid. The target compound was synthesized through a multistep synthetic route involving alkylation, esterification, oxime formation, and a 1,3-dipolar cycloaddition reaction. The synthesized compound, 2-methoxy-4-[5-(2-oxo-1,3-dioxolan-4-yl)-4,5-dihydroisoxazol-3-yl]phenyl 4-n-decyloxybenzoate, was isolated and fully characterized by spectroscopic techniques. Liquid crystal behavior was evaluated by DSC and POM. The monotropic mesomorphic behavior of the title compound was dictated by the interplay between molecular architecture and intermolecular organization, with the methoxy substituent and the 1,3-dioxolan-2-one ring critically influencing phase stability and texture morphology. These findings suggest a structure–property relationship and guide ongoing synthetic optimization toward achieving a stable enantiotropic liquid-crystalline phase and further ion-conduction experiments.</p>
	]]></content:encoded>

	<dc:title>2-Methoxy-4-[5-(2-oxo-1,3-dioxolan-4-yl)-4,5-dihydroisoxazol-3-yl]phenyl 4-n-decyloxybenzoate</dc:title>
			<dc:creator>Itamar Gonçalves</dc:creator>
			<dc:creator>Aloir Merlo</dc:creator>
			<dc:creator>Bruna Batistel</dc:creator>
			<dc:creator>Leonardo Rossner Wbatuba</dc:creator>
			<dc:creator>Henrique de Aguiar Mello</dc:creator>
		<dc:identifier>doi: 10.3390/M2178</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2178</prism:startingPage>
		<prism:doi>10.3390/M2178</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2178</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2177">

	<title>Molbank, Vol. 2026, Article M2177: 2,2&amp;prime;-(Methylenebis(3,4-dimethoxy-6,1-phenylene))diacetic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2177</link>
	<description>The formation of side products is often unavoidable in organic synthesis; however, analyzing these secondary species provides practical insights into reaction pathways, mechanisms, and competing processes. This understanding is essential for optimizing reaction conditions, increasing product yields, and improving overall safety and efficiency. Additionally, side products can sometimes reveal unexpected molecular structures with valuable properties. In this study, we present the characterization of a compound that formed as a side product in a modified Pictet-Spengler reaction. The molecular structure of 2,2&amp;amp;prime;-(methylenebis(3,4-dimethoxy-6,1-phenylene))diacetic acid was elucidated using a combination of NMR, FTIR and UV&amp;amp;ndash;Vis spectroscopic techniques, as well as HRMS analysis.</description>
	<pubDate>2026-05-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2177: 2,2&amp;prime;-(Methylenebis(3,4-dimethoxy-6,1-phenylene))diacetic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2177">doi: 10.3390/M2177</a></p>
	<p>Authors:
		Savina Stoyanova
		Milen G. Bogdanov
		</p>
	<p>The formation of side products is often unavoidable in organic synthesis; however, analyzing these secondary species provides practical insights into reaction pathways, mechanisms, and competing processes. This understanding is essential for optimizing reaction conditions, increasing product yields, and improving overall safety and efficiency. Additionally, side products can sometimes reveal unexpected molecular structures with valuable properties. In this study, we present the characterization of a compound that formed as a side product in a modified Pictet-Spengler reaction. The molecular structure of 2,2&amp;amp;prime;-(methylenebis(3,4-dimethoxy-6,1-phenylene))diacetic acid was elucidated using a combination of NMR, FTIR and UV&amp;amp;ndash;Vis spectroscopic techniques, as well as HRMS analysis.</p>
	]]></content:encoded>

	<dc:title>2,2&amp;amp;prime;-(Methylenebis(3,4-dimethoxy-6,1-phenylene))diacetic Acid</dc:title>
			<dc:creator>Savina Stoyanova</dc:creator>
			<dc:creator>Milen G. Bogdanov</dc:creator>
		<dc:identifier>doi: 10.3390/M2177</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2177</prism:startingPage>
		<prism:doi>10.3390/M2177</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2177</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2176">

	<title>Molbank, Vol. 2026, Article M2176: Crystal Structures of Two 4-Alkyl-8-hydroxyquinolines</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2176</link>
	<description>4-Methyl- (1) and 4-ethyl-8-hydroxyquinoline (2) crystallize from a mixture of diethyl ether and chloroform in the triclinic space group P1&amp;amp;macr;. X-ray analysis reveals that both compounds form discrete molecular dimers stabilized by intermolecular O-H&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;N and C-H&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;O hydrogen bonds, resulting in R22(5) cyclic synthons. This pattern of hydrogen bonds is further stabilized by intramolecular O-H&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;N bonds so that the quinoline nitrogen atom acts as a bifurcated binding site. The dimers exhibit a planar geometry and arrange into layer-like structures held together by &amp;amp;pi;&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;&amp;amp;pi; stacking and van der Waals forces. While the fundamental bonding motifs are similar, the increased steric demand of the ethyl group in compound 2 induces a shift in the crystallographic orientation of the layers and alters the degree of &amp;amp;pi;-overlap compared to the methyl-substituted analogue 1.</description>
	<pubDate>2026-05-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2176: Crystal Structures of Two 4-Alkyl-8-hydroxyquinolines</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2176">doi: 10.3390/M2176</a></p>
	<p>Authors:
		Sara Braun
		Anke Schwarzer
		Monika Mazik
		</p>
	<p>4-Methyl- (1) and 4-ethyl-8-hydroxyquinoline (2) crystallize from a mixture of diethyl ether and chloroform in the triclinic space group P1&amp;amp;macr;. X-ray analysis reveals that both compounds form discrete molecular dimers stabilized by intermolecular O-H&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;N and C-H&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;O hydrogen bonds, resulting in R22(5) cyclic synthons. This pattern of hydrogen bonds is further stabilized by intramolecular O-H&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;N bonds so that the quinoline nitrogen atom acts as a bifurcated binding site. The dimers exhibit a planar geometry and arrange into layer-like structures held together by &amp;amp;pi;&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;&amp;amp;pi; stacking and van der Waals forces. While the fundamental bonding motifs are similar, the increased steric demand of the ethyl group in compound 2 induces a shift in the crystallographic orientation of the layers and alters the degree of &amp;amp;pi;-overlap compared to the methyl-substituted analogue 1.</p>
	]]></content:encoded>

	<dc:title>Crystal Structures of Two 4-Alkyl-8-hydroxyquinolines</dc:title>
			<dc:creator>Sara Braun</dc:creator>
			<dc:creator>Anke Schwarzer</dc:creator>
			<dc:creator>Monika Mazik</dc:creator>
		<dc:identifier>doi: 10.3390/M2176</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2176</prism:startingPage>
		<prism:doi>10.3390/M2176</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2176</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2175">

	<title>Molbank, Vol. 2026, Article M2175: Formation of a &amp;beta;-(3-Chlorobenzoyloxy)-&amp;alpha;-hydroxyketone from a TBS-Protected Chalcone upon Oxidation with m-Chloroperbenzoic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2175</link>
	<description>A new tert-butyldimethylsilyl-protected polyoxygenated chalcone was prepared by Claisen&amp;amp;ndash;Schmidt condensation of suitably protected acetophenone and benzaldehyde derivatives. Treatment of this chalcone with m-chloroperbenzoic acid (mCPBA) afforded &amp;amp;beta;-(3-chlorobenzoyloxy)-&amp;amp;alpha;-hydroxyketone 5, which was fully characterized by spectroscopic methods. The structure of 5 is consistent with initial epoxidation of the enone double bond followed by in situ nucleophilic opening of the transient epoxide by m-chlorobenzoate generated in the reaction medium. This work reports the preparation of the chalcone precursor and the characterization of the unexpected oxidation product 5.</description>
	<pubDate>2026-05-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2175: Formation of a &amp;beta;-(3-Chlorobenzoyloxy)-&amp;alpha;-hydroxyketone from a TBS-Protected Chalcone upon Oxidation with m-Chloroperbenzoic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2175">doi: 10.3390/M2175</a></p>
	<p>Authors:
		Sonia Berenguel-Gómez
		Irene Moreno-Gutiérrez
		Jenifer Acien-García
		Manuel Muñoz-Dorado
		Míriam Álvarez-Corral
		Ignacio Rodríguez-García
		</p>
	<p>A new tert-butyldimethylsilyl-protected polyoxygenated chalcone was prepared by Claisen&amp;amp;ndash;Schmidt condensation of suitably protected acetophenone and benzaldehyde derivatives. Treatment of this chalcone with m-chloroperbenzoic acid (mCPBA) afforded &amp;amp;beta;-(3-chlorobenzoyloxy)-&amp;amp;alpha;-hydroxyketone 5, which was fully characterized by spectroscopic methods. The structure of 5 is consistent with initial epoxidation of the enone double bond followed by in situ nucleophilic opening of the transient epoxide by m-chlorobenzoate generated in the reaction medium. This work reports the preparation of the chalcone precursor and the characterization of the unexpected oxidation product 5.</p>
	]]></content:encoded>

	<dc:title>Formation of a &amp;amp;beta;-(3-Chlorobenzoyloxy)-&amp;amp;alpha;-hydroxyketone from a TBS-Protected Chalcone upon Oxidation with m-Chloroperbenzoic Acid</dc:title>
			<dc:creator>Sonia Berenguel-Gómez</dc:creator>
			<dc:creator>Irene Moreno-Gutiérrez</dc:creator>
			<dc:creator>Jenifer Acien-García</dc:creator>
			<dc:creator>Manuel Muñoz-Dorado</dc:creator>
			<dc:creator>Míriam Álvarez-Corral</dc:creator>
			<dc:creator>Ignacio Rodríguez-García</dc:creator>
		<dc:identifier>doi: 10.3390/M2175</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2175</prism:startingPage>
		<prism:doi>10.3390/M2175</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2175</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2174">

	<title>Molbank, Vol. 2026, Article M2174: N-(2,5-Difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2174</link>
	<description>The conversion of 2,5-difluorobenzylamine to N-(2,5-difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine using an oxoammonium salt bearing the nitrate anion is reported. The reaction is operationally simple, and the product is obtained with good yield.</description>
	<pubDate>2026-05-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2174: N-(2,5-Difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2174">doi: 10.3390/M2174</a></p>
	<p>Authors:
		Tiffany L. Chen
		Manisha Sharma
		Nicholas E. Leadbeater
		</p>
	<p>The conversion of 2,5-difluorobenzylamine to N-(2,5-difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine using an oxoammonium salt bearing the nitrate anion is reported. The reaction is operationally simple, and the product is obtained with good yield.</p>
	]]></content:encoded>

	<dc:title>N-(2,5-Difluorobenzylidene)-1-(2,5-difluorobenzyl)methanimine</dc:title>
			<dc:creator>Tiffany L. Chen</dc:creator>
			<dc:creator>Manisha Sharma</dc:creator>
			<dc:creator>Nicholas E. Leadbeater</dc:creator>
		<dc:identifier>doi: 10.3390/M2174</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-08</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-08</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2174</prism:startingPage>
		<prism:doi>10.3390/M2174</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2174</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2173">

	<title>Molbank, Vol. 2026, Article M2173: (R)-10-((((2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl)(methyl)carbamoyl)oxy)methyl)-1,3,5,5,7,9-hexamethyl-5H-dipyrrolo[1,2-c:2&amp;prime;,1&amp;prime;-f][1,3,2]diazaborinin-4-ium-5-uide</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2173</link>
	<description>The BODIPY core has emerged as a versatile scaffold for the design of photoremovable protecting groups (PPGs). Herein, we report the synthesis of a novel BODIPY&amp;amp;ndash;epinephrine conjugate linked via a carbamate moiety, enabling light-triggered release of the active compound (epinephrine, also known as adrenaline). The structure of the obtained product was confirmed by 1H and M 13C NMR spectroscopy as well as high-resolution mass spectrometry (HRMS). The described conjugate represents a potential tool for the photoactivated modulation of biologically relevant processes.</description>
	<pubDate>2026-05-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2173: (R)-10-((((2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl)(methyl)carbamoyl)oxy)methyl)-1,3,5,5,7,9-hexamethyl-5H-dipyrrolo[1,2-c:2&amp;prime;,1&amp;prime;-f][1,3,2]diazaborinin-4-ium-5-uide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2173">doi: 10.3390/M2173</a></p>
	<p>Authors:
		Mikhail A. Panfilov
		Alexey Yu. Vorob’ev
		Alexander E. Moskalensky
		</p>
	<p>The BODIPY core has emerged as a versatile scaffold for the design of photoremovable protecting groups (PPGs). Herein, we report the synthesis of a novel BODIPY&amp;amp;ndash;epinephrine conjugate linked via a carbamate moiety, enabling light-triggered release of the active compound (epinephrine, also known as adrenaline). The structure of the obtained product was confirmed by 1H and M 13C NMR spectroscopy as well as high-resolution mass spectrometry (HRMS). The described conjugate represents a potential tool for the photoactivated modulation of biologically relevant processes.</p>
	]]></content:encoded>

	<dc:title>(R)-10-((((2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl)(methyl)carbamoyl)oxy)methyl)-1,3,5,5,7,9-hexamethyl-5H-dipyrrolo[1,2-c:2&amp;amp;prime;,1&amp;amp;prime;-f][1,3,2]diazaborinin-4-ium-5-uide</dc:title>
			<dc:creator>Mikhail A. Panfilov</dc:creator>
			<dc:creator>Alexey Yu. Vorob’ev</dc:creator>
			<dc:creator>Alexander E. Moskalensky</dc:creator>
		<dc:identifier>doi: 10.3390/M2173</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-07</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-07</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2173</prism:startingPage>
		<prism:doi>10.3390/M2173</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2173</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2172">

	<title>Molbank, Vol. 2026, Article M2172: 4-(6-Chloropyridin-3-yl)-6-cyclopropylpyrimidin-2-amine</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2172</link>
	<description>A novel nitrogen-containing heterocyclic compound, 4-(6-Chloropyridin-3-yl)-6-cyclopropylpyrimidin-2-amine, was designed and synthesized using 6-chloropyridin-3-aldehyde and cyclopropyl methyl ketone as starting materials. The structure of the target compound was characterized by 1H NMR, 13C NMR and HRMS, and the spectral data were consistent with the expected structure, confirming the correctness of the product.</description>
	<pubDate>2026-05-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2172: 4-(6-Chloropyridin-3-yl)-6-cyclopropylpyrimidin-2-amine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2172">doi: 10.3390/M2172</a></p>
	<p>Authors:
		Yusen Wang
		Jian Lv
		Yukun Qin
		</p>
	<p>A novel nitrogen-containing heterocyclic compound, 4-(6-Chloropyridin-3-yl)-6-cyclopropylpyrimidin-2-amine, was designed and synthesized using 6-chloropyridin-3-aldehyde and cyclopropyl methyl ketone as starting materials. The structure of the target compound was characterized by 1H NMR, 13C NMR and HRMS, and the spectral data were consistent with the expected structure, confirming the correctness of the product.</p>
	]]></content:encoded>

	<dc:title>4-(6-Chloropyridin-3-yl)-6-cyclopropylpyrimidin-2-amine</dc:title>
			<dc:creator>Yusen Wang</dc:creator>
			<dc:creator>Jian Lv</dc:creator>
			<dc:creator>Yukun Qin</dc:creator>
		<dc:identifier>doi: 10.3390/M2172</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2172</prism:startingPage>
		<prism:doi>10.3390/M2172</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2172</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2171">

	<title>Molbank, Vol. 2026, Article M2171: Synthesis of (Z)-6-Heneicosen-11-one, a Possible Pheromone Component of the Hickory Tussock Moth, Lophocampa caryae</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2171</link>
	<description>The compound (Z)-6-heneicosen-11-one, a possible pheromone component of the hickory tussock moth, Lophocampa caryae, and a known pheromone component of the Douglas fir tussock moth, Orgyia pseudotsugata, was synthesized by a new four-step procedure with a 39% overall yield and a six-step procedure incorporating a protecting group with a 28% overall yield. This new synthesis is comparable to other similar syntheses for this molecule in the literature.</description>
	<pubDate>2026-05-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2171: Synthesis of (Z)-6-Heneicosen-11-one, a Possible Pheromone Component of the Hickory Tussock Moth, Lophocampa caryae</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2171">doi: 10.3390/M2171</a></p>
	<p>Authors:
		Peter Mayo
		Sumudu Deepa Abeysekera
		</p>
	<p>The compound (Z)-6-heneicosen-11-one, a possible pheromone component of the hickory tussock moth, Lophocampa caryae, and a known pheromone component of the Douglas fir tussock moth, Orgyia pseudotsugata, was synthesized by a new four-step procedure with a 39% overall yield and a six-step procedure incorporating a protecting group with a 28% overall yield. This new synthesis is comparable to other similar syntheses for this molecule in the literature.</p>
	]]></content:encoded>

	<dc:title>Synthesis of (Z)-6-Heneicosen-11-one, a Possible Pheromone Component of the Hickory Tussock Moth, Lophocampa caryae</dc:title>
			<dc:creator>Peter Mayo</dc:creator>
			<dc:creator>Sumudu Deepa Abeysekera</dc:creator>
		<dc:identifier>doi: 10.3390/M2171</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2171</prism:startingPage>
		<prism:doi>10.3390/M2171</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2171</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2170">

	<title>Molbank, Vol. 2026, Article M2170: Synthesis of Three Bent Bis(imido-ferrocidiphenols)</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2170</link>
	<description>The ferrocidiphenol family brings together anticancer molecules featuring a [ferrocene-alkene-(p-phenol)2] motif that can form upon oxidation a quinone methide metabolite targeting cellular proteins. Adding an imide group (imido-ferrocidiphenol) dramatically enhanced the anticancer activity of ferrocidiphenol. We aimed to explore whether molecules with two ferrociphenol motifs connected by bisimide moieties could provide even more effective compounds. Using amino-ferrocidiphenol and commercial bisanhydrides at reflux, for the first time, three symmetrical and bent bis(imido-ferrocidiphenols) were synthesized, with moderate yields, and characterized. However, these compounds were insoluble in most common organic solvents and unstable. This likely explains why their anticancer activity was nil.</description>
	<pubDate>2026-05-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2170: Synthesis of Three Bent Bis(imido-ferrocidiphenols)</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2170">doi: 10.3390/M2170</a></p>
	<p>Authors:
		Pascal Pigeon
		</p>
	<p>The ferrocidiphenol family brings together anticancer molecules featuring a [ferrocene-alkene-(p-phenol)2] motif that can form upon oxidation a quinone methide metabolite targeting cellular proteins. Adding an imide group (imido-ferrocidiphenol) dramatically enhanced the anticancer activity of ferrocidiphenol. We aimed to explore whether molecules with two ferrociphenol motifs connected by bisimide moieties could provide even more effective compounds. Using amino-ferrocidiphenol and commercial bisanhydrides at reflux, for the first time, three symmetrical and bent bis(imido-ferrocidiphenols) were synthesized, with moderate yields, and characterized. However, these compounds were insoluble in most common organic solvents and unstable. This likely explains why their anticancer activity was nil.</p>
	]]></content:encoded>

	<dc:title>Synthesis of Three Bent Bis(imido-ferrocidiphenols)</dc:title>
			<dc:creator>Pascal Pigeon</dc:creator>
		<dc:identifier>doi: 10.3390/M2170</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2170</prism:startingPage>
		<prism:doi>10.3390/M2170</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2170</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2169">

	<title>Molbank, Vol. 2026, Article M2169: New Pyridinium Salt Bioconjugates of Cholesterol and Methylpyridine Derivatives: Synthesis and Characterization</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2169</link>
	<description>The synthesis of three novel, valuable bioconjugates obtained by coupling cholesterol bromoacetate with pyridine derivatives via an SN2 reaction was successfully carried out. Each of the products was fully characterized by magnetic nuclear resonance (1H, 13C, APT, 1H&amp;amp;minus;1H COSY, 1H&amp;amp;ndash;13C HMBC, 1H&amp;amp;ndash;13C HSQC), infrared spectroscopy (IR), and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2026-05-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2169: New Pyridinium Salt Bioconjugates of Cholesterol and Methylpyridine Derivatives: Synthesis and Characterization</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2169">doi: 10.3390/M2169</a></p>
	<p>Authors:
		José María Peña-Martínez
		Jesús Alberto Rojas Morales
		Luis Ramiro Caso-Vargas
		Elizabeth Bautista-Rodríguez
		Joel L. Terán
		Alan Carrasco-Carballo
		</p>
	<p>The synthesis of three novel, valuable bioconjugates obtained by coupling cholesterol bromoacetate with pyridine derivatives via an SN2 reaction was successfully carried out. Each of the products was fully characterized by magnetic nuclear resonance (1H, 13C, APT, 1H&amp;amp;minus;1H COSY, 1H&amp;amp;ndash;13C HMBC, 1H&amp;amp;ndash;13C HSQC), infrared spectroscopy (IR), and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>New Pyridinium Salt Bioconjugates of Cholesterol and Methylpyridine Derivatives: Synthesis and Characterization</dc:title>
			<dc:creator>José María Peña-Martínez</dc:creator>
			<dc:creator>Jesús Alberto Rojas Morales</dc:creator>
			<dc:creator>Luis Ramiro Caso-Vargas</dc:creator>
			<dc:creator>Elizabeth Bautista-Rodríguez</dc:creator>
			<dc:creator>Joel L. Terán</dc:creator>
			<dc:creator>Alan Carrasco-Carballo</dc:creator>
		<dc:identifier>doi: 10.3390/M2169</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-05-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-05-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2169</prism:startingPage>
		<prism:doi>10.3390/M2169</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2169</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2168">

	<title>Molbank, Vol. 2026, Article M2168: Synthesis of 2-(2-Methoxyphenyl)-4-methyl-6-nitroquinoline and 2-(2-Methoxyphenyl)-4-methylquinolin-6-amine</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2168</link>
	<description>A new compound, 2-(2-methoxyphenyl)-4-methyl-6-nitroquinoline, was obtained via Suzuki reaction. An unexpected side product, 2-(2-methoxyphenyl)-4-methylquinolin-6-amine, was isolated. The structures of the novel compounds were confirmed by 1H, 13C and 2D-NMR. Their optical properties were also studied.</description>
	<pubDate>2026-04-30</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2168: Synthesis of 2-(2-Methoxyphenyl)-4-methyl-6-nitroquinoline and 2-(2-Methoxyphenyl)-4-methylquinolin-6-amine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2168">doi: 10.3390/M2168</a></p>
	<p>Authors:
		Rumen Lyapchev
		Maria Ivanova
		Iskra Z. Koleva
		Dimitar Shandurkov
		</p>
	<p>A new compound, 2-(2-methoxyphenyl)-4-methyl-6-nitroquinoline, was obtained via Suzuki reaction. An unexpected side product, 2-(2-methoxyphenyl)-4-methylquinolin-6-amine, was isolated. The structures of the novel compounds were confirmed by 1H, 13C and 2D-NMR. Their optical properties were also studied.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 2-(2-Methoxyphenyl)-4-methyl-6-nitroquinoline and 2-(2-Methoxyphenyl)-4-methylquinolin-6-amine</dc:title>
			<dc:creator>Rumen Lyapchev</dc:creator>
			<dc:creator>Maria Ivanova</dc:creator>
			<dc:creator>Iskra Z. Koleva</dc:creator>
			<dc:creator>Dimitar Shandurkov</dc:creator>
		<dc:identifier>doi: 10.3390/M2168</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-30</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-30</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2168</prism:startingPage>
		<prism:doi>10.3390/M2168</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2168</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/3/M2167">

	<title>Molbank, Vol. 2026, Article M2167: Synthesis of (R)-(+)-3-(1-Hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a Novel Tetramic Acid Analog</title>
	<link>https://www.mdpi.com/1422-8599/2026/3/M2167</link>
	<description>Herein, starting from (R)-(+)-&amp;amp;alpha;-methylbenzylamine, we report an efficient synthesis and full characterization of a new (R)-3-(1-hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a new tetramic acid analog. The key steps involved a non-classical Corey&amp;amp;ndash;Chaykovsky intramolecular cyclization reaction to access the corresponding zwitterion, followed by a sequential desulfurization/reduction and condensation procedure. The titled product was obtained in five steps, and the desired product 7 with an overall 58% yield.</description>
	<pubDate>2026-04-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2167: Synthesis of (R)-(+)-3-(1-Hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a Novel Tetramic Acid Analog</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/3/M2167">doi: 10.3390/M2167</a></p>
	<p>Authors:
		Alan Aguilar-Aguilar
		Ángel Palillero-Cisneros
		Félix May-Moreno
		Jorge R. Juarez-Posadas
		Joel L. Terán
		David M. Aparicio
		</p>
	<p>Herein, starting from (R)-(+)-&amp;amp;alpha;-methylbenzylamine, we report an efficient synthesis and full characterization of a new (R)-3-(1-hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a new tetramic acid analog. The key steps involved a non-classical Corey&amp;amp;ndash;Chaykovsky intramolecular cyclization reaction to access the corresponding zwitterion, followed by a sequential desulfurization/reduction and condensation procedure. The titled product was obtained in five steps, and the desired product 7 with an overall 58% yield.</p>
	]]></content:encoded>

	<dc:title>Synthesis of (R)-(+)-3-(1-Hydroxyethylidene)-1-(1-phenylethyl)piperidine-2,4-dione, a Novel Tetramic Acid Analog</dc:title>
			<dc:creator>Alan Aguilar-Aguilar</dc:creator>
			<dc:creator>Ángel Palillero-Cisneros</dc:creator>
			<dc:creator>Félix May-Moreno</dc:creator>
			<dc:creator>Jorge R. Juarez-Posadas</dc:creator>
			<dc:creator>Joel L. Terán</dc:creator>
			<dc:creator>David M. Aparicio</dc:creator>
		<dc:identifier>doi: 10.3390/M2167</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-27</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-27</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2167</prism:startingPage>
		<prism:doi>10.3390/M2167</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/3/M2167</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2166">

	<title>Molbank, Vol. 2026, Article M2166: Synthesis of (S)-4-Benzyl-3-butyl-1-(2-cycloheptylethyl)imidazolidine</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2166</link>
	<description>LiAlH4 reduction of tert-butyl (S)-butyl(1-((2-cycloheptylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (1) gave imidazolidine 2, while treatment with lithium diisopropylamide furnished the &amp;amp;beta;-elimination product, cinnamamide 3. Both products were fully characterized. Reductive cyclization of N-alkylated-N-Boc-protected amino acid amides with LiAlH4 may be a viable synthetic method for trisubstituted chiral imidazolidines.</description>
	<pubDate>2026-04-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2166: Synthesis of (S)-4-Benzyl-3-butyl-1-(2-cycloheptylethyl)imidazolidine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2166">doi: 10.3390/M2166</a></p>
	<p>Authors:
		Matevž Schweiger
		Luka Ciber
		Nejc Petek
		Franc Požgan
		Jurij Svete
		Bogdan Štefane
		Uroš Grošelj
		</p>
	<p>LiAlH4 reduction of tert-butyl (S)-butyl(1-((2-cycloheptylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (1) gave imidazolidine 2, while treatment with lithium diisopropylamide furnished the &amp;amp;beta;-elimination product, cinnamamide 3. Both products were fully characterized. Reductive cyclization of N-alkylated-N-Boc-protected amino acid amides with LiAlH4 may be a viable synthetic method for trisubstituted chiral imidazolidines.</p>
	]]></content:encoded>

	<dc:title>Synthesis of (S)-4-Benzyl-3-butyl-1-(2-cycloheptylethyl)imidazolidine</dc:title>
			<dc:creator>Matevž Schweiger</dc:creator>
			<dc:creator>Luka Ciber</dc:creator>
			<dc:creator>Nejc Petek</dc:creator>
			<dc:creator>Franc Požgan</dc:creator>
			<dc:creator>Jurij Svete</dc:creator>
			<dc:creator>Bogdan Štefane</dc:creator>
			<dc:creator>Uroš Grošelj</dc:creator>
		<dc:identifier>doi: 10.3390/M2166</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2166</prism:startingPage>
		<prism:doi>10.3390/M2166</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2166</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2165">

	<title>Molbank, Vol. 2026, Article M2165: Synthesis of 2-Aminonicotinonitriles via Photodecarboxylation of Azirine-2-Carboxylic Acids</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2165</link>
	<description>2-Aminonicotinonitriles represent an important class of heterocycles with diverse biological activities. Herein, we report an unexpected photochemical transformation of azirine-2-carboxylic acids leading to the formation of 2-aminonicotinonitrile derivatives. Optimization of the reaction conditions enabled the synthesis of the target products in moderate yields. The structure of the obtained product was confirmed by NMR spectroscopy, HRMS, and single-crystal X-ray diffraction analysis.</description>
	<pubDate>2026-04-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2165: Synthesis of 2-Aminonicotinonitriles via Photodecarboxylation of Azirine-2-Carboxylic Acids</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2165">doi: 10.3390/M2165</a></p>
	<p>Authors:
		Julia I. Pavlenko
		Mikhail S. Novikov
		Anastasiya V. Agafonova
		</p>
	<p>2-Aminonicotinonitriles represent an important class of heterocycles with diverse biological activities. Herein, we report an unexpected photochemical transformation of azirine-2-carboxylic acids leading to the formation of 2-aminonicotinonitrile derivatives. Optimization of the reaction conditions enabled the synthesis of the target products in moderate yields. The structure of the obtained product was confirmed by NMR spectroscopy, HRMS, and single-crystal X-ray diffraction analysis.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 2-Aminonicotinonitriles via Photodecarboxylation of Azirine-2-Carboxylic Acids</dc:title>
			<dc:creator>Julia I. Pavlenko</dc:creator>
			<dc:creator>Mikhail S. Novikov</dc:creator>
			<dc:creator>Anastasiya V. Agafonova</dc:creator>
		<dc:identifier>doi: 10.3390/M2165</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-14</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2165</prism:startingPage>
		<prism:doi>10.3390/M2165</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2165</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2164">

	<title>Molbank, Vol. 2026, Article M2164: A Bulky Aryl&amp;ndash;Substituted Acridinium Salt: 10-(3,5-Di-tert-butylphenyl)-9-mesitylacridinium Tetrafluoroborate</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2164</link>
	<description>9-Mesitylacridinium salts are widely recognized as efficient organic photoredox catalysts owing to their strong excited-state oxidizing power and stability under visible-light irradiation. In this study, a new mesityl acridinium derivative bearing a di-tert-butylphenyl substituent on the nitrogen atom was synthesized. The introduction of tert-butyl groups on the N-aryl moiety was primarily aimed at improving solubility and chemical stability of the acridinium salt. Starting from a 9(10H)-acridinone precursor, the target compound was obtained in high overall yield through a concise synthetic sequence. The synthesis consists of a copper-catalyzed C&amp;amp;ndash;N coupling reaction to install the aryl substituent on the nitrogen atom, followed by a Grignard reaction and subsequent acid treatment to afford the corresponding acridinium salt. All transformations proceeded smoothly, providing efficient access to the desired novel acridinium derivative. This work presents a practical example of the structural modification of mesitylacridinium derivatives directed toward enhanced solubility and stability, and provides a useful synthetic platform for the preparation of structurally diverse acridinium salts.</description>
	<pubDate>2026-04-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2164: A Bulky Aryl&amp;ndash;Substituted Acridinium Salt: 10-(3,5-Di-tert-butylphenyl)-9-mesitylacridinium Tetrafluoroborate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2164">doi: 10.3390/M2164</a></p>
	<p>Authors:
		Yuki Itabashi
		Kei Ohkubo
		</p>
	<p>9-Mesitylacridinium salts are widely recognized as efficient organic photoredox catalysts owing to their strong excited-state oxidizing power and stability under visible-light irradiation. In this study, a new mesityl acridinium derivative bearing a di-tert-butylphenyl substituent on the nitrogen atom was synthesized. The introduction of tert-butyl groups on the N-aryl moiety was primarily aimed at improving solubility and chemical stability of the acridinium salt. Starting from a 9(10H)-acridinone precursor, the target compound was obtained in high overall yield through a concise synthetic sequence. The synthesis consists of a copper-catalyzed C&amp;amp;ndash;N coupling reaction to install the aryl substituent on the nitrogen atom, followed by a Grignard reaction and subsequent acid treatment to afford the corresponding acridinium salt. All transformations proceeded smoothly, providing efficient access to the desired novel acridinium derivative. This work presents a practical example of the structural modification of mesitylacridinium derivatives directed toward enhanced solubility and stability, and provides a useful synthetic platform for the preparation of structurally diverse acridinium salts.</p>
	]]></content:encoded>

	<dc:title>A Bulky Aryl&amp;amp;ndash;Substituted Acridinium Salt: 10-(3,5-Di-tert-butylphenyl)-9-mesitylacridinium Tetrafluoroborate</dc:title>
			<dc:creator>Yuki Itabashi</dc:creator>
			<dc:creator>Kei Ohkubo</dc:creator>
		<dc:identifier>doi: 10.3390/M2164</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-14</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-14</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2164</prism:startingPage>
		<prism:doi>10.3390/M2164</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2164</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2163">

	<title>Molbank, Vol. 2026, Article M2163: Synthesis of 2-Methylcamalexin</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2163</link>
	<description>2-methylcamalexin, a novel derivative of the phytoalexin Camalexin, was synthesized for the first time, using a convenient two-step approach. The approach realizes coupling of two aromatic heterocyclic moieties (2-methylindole and thiazole) by sequential &amp;amp;alpha;-amidoalkylation/oxidative re-aromatization. The target product was obtained in a cost-effective manner, with 88% yield over two steps. The structure of the synthesized product was unequivocally determined on the basis of NMR, HRMS and FTIR spectral measurments.</description>
	<pubDate>2026-04-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2163: Synthesis of 2-Methylcamalexin</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2163">doi: 10.3390/M2163</a></p>
	<p>Authors:
		Yordan Stremski
		Maria Bachvarova
		Stela Statkova-Abeghe
		Plamen Angelov
		</p>
	<p>2-methylcamalexin, a novel derivative of the phytoalexin Camalexin, was synthesized for the first time, using a convenient two-step approach. The approach realizes coupling of two aromatic heterocyclic moieties (2-methylindole and thiazole) by sequential &amp;amp;alpha;-amidoalkylation/oxidative re-aromatization. The target product was obtained in a cost-effective manner, with 88% yield over two steps. The structure of the synthesized product was unequivocally determined on the basis of NMR, HRMS and FTIR spectral measurments.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 2-Methylcamalexin</dc:title>
			<dc:creator>Yordan Stremski</dc:creator>
			<dc:creator>Maria Bachvarova</dc:creator>
			<dc:creator>Stela Statkova-Abeghe</dc:creator>
			<dc:creator>Plamen Angelov</dc:creator>
		<dc:identifier>doi: 10.3390/M2163</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2163</prism:startingPage>
		<prism:doi>10.3390/M2163</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2163</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2162">

	<title>Molbank, Vol. 2026, Article M2162: [2-{(5&amp;prime;-Amino-2&amp;prime;-fluoroacetophenone)-5-nitro}]acetophenone</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2162</link>
	<description>Herein we reported on a one-pot nitro reduction/nucleophilic aromatic substitution on 1-(2-fluoro-5-nitrophenyl)ethan-1-one using a mixture of acetic acid and iron powder in ethanol. The resultant target compound, a nitrated N bis-acetophenone, has many reactive handles; as such, it is a novel intermediate that can be deployed for the syntheses of a vast array of compounds not reported before. This compound is fully characterized using 1H and 13C NMR spectroscopy, and HRMS.</description>
	<pubDate>2026-04-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2162: [2-{(5&amp;prime;-Amino-2&amp;prime;-fluoroacetophenone)-5-nitro}]acetophenone</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2162">doi: 10.3390/M2162</a></p>
	<p>Authors:
		Richard M. Beteck
		Lesetja J. Legoabe
		</p>
	<p>Herein we reported on a one-pot nitro reduction/nucleophilic aromatic substitution on 1-(2-fluoro-5-nitrophenyl)ethan-1-one using a mixture of acetic acid and iron powder in ethanol. The resultant target compound, a nitrated N bis-acetophenone, has many reactive handles; as such, it is a novel intermediate that can be deployed for the syntheses of a vast array of compounds not reported before. This compound is fully characterized using 1H and 13C NMR spectroscopy, and HRMS.</p>
	]]></content:encoded>

	<dc:title>[2-{(5&amp;amp;prime;-Amino-2&amp;amp;prime;-fluoroacetophenone)-5-nitro}]acetophenone</dc:title>
			<dc:creator>Richard M. Beteck</dc:creator>
			<dc:creator>Lesetja J. Legoabe</dc:creator>
		<dc:identifier>doi: 10.3390/M2162</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2162</prism:startingPage>
		<prism:doi>10.3390/M2162</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2162</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2161">

	<title>Molbank, Vol. 2026, Article M2161: Racemic-Benzimidazolyl Pentafluorobenzyl Sulfoxide</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2161</link>
	<description>As a part of our research on the presence of conglomerates among the aryl benzyl sulfoxides, racemic-benzimidazolyl pentafluorobenzyl sulfoxide was synthesised, and its crystal structure was determined by a single crystal X-ray diffraction experiment. The main interactions building up the crystal structure were recognised and compared with those of similar compounds. Since the crystal structures of racemic and enantiopure benzimidazolyl pentafluorobenzyl sulfoxides are different, the presence of a conglomerate is excluded in the present case.</description>
	<pubDate>2026-04-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2161: Racemic-Benzimidazolyl Pentafluorobenzyl Sulfoxide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2161">doi: 10.3390/M2161</a></p>
	<p>Authors:
		Maria Annunziata M. Capozzi
		Cosimo Cardellicchio
		</p>
	<p>As a part of our research on the presence of conglomerates among the aryl benzyl sulfoxides, racemic-benzimidazolyl pentafluorobenzyl sulfoxide was synthesised, and its crystal structure was determined by a single crystal X-ray diffraction experiment. The main interactions building up the crystal structure were recognised and compared with those of similar compounds. Since the crystal structures of racemic and enantiopure benzimidazolyl pentafluorobenzyl sulfoxides are different, the presence of a conglomerate is excluded in the present case.</p>
	]]></content:encoded>

	<dc:title>Racemic-Benzimidazolyl Pentafluorobenzyl Sulfoxide</dc:title>
			<dc:creator>Maria Annunziata M. Capozzi</dc:creator>
			<dc:creator>Cosimo Cardellicchio</dc:creator>
		<dc:identifier>doi: 10.3390/M2161</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2161</prism:startingPage>
		<prism:doi>10.3390/M2161</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2161</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2160">

	<title>Molbank, Vol. 2026, Article M2160: 1-Phenyl-4-p-tolyl-[1,2,3]triazole</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2160</link>
	<description>1-Phenyl-4-p-tolyl-[1,2,3]triazole was obtained via a CuAAC reaction involving phenyl azide and 1-ethynyl-4-methylbenzene. The NMR spectra of the compound are discussed, and its crystal structure was studied by X-ray analysis. According to the latter analysis and a Hirshfeld surface analysis, the predominant intermolecular C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;N and C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;&amp;amp;pi; interactions in this molecule are responsible for crystal packing.</description>
	<pubDate>2026-04-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2160: 1-Phenyl-4-p-tolyl-[1,2,3]triazole</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2160">doi: 10.3390/M2160</a></p>
	<p>Authors:
		Eder Y. Nolasco-Terrón
		David Gómez-Colín
		Nelly González-Rivas
		Diego Martínez-Otero
		Erick Cuevas-Yañez
		</p>
	<p>1-Phenyl-4-p-tolyl-[1,2,3]triazole was obtained via a CuAAC reaction involving phenyl azide and 1-ethynyl-4-methylbenzene. The NMR spectra of the compound are discussed, and its crystal structure was studied by X-ray analysis. According to the latter analysis and a Hirshfeld surface analysis, the predominant intermolecular C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;N and C-H&amp;amp;sdot;&amp;amp;sdot;&amp;amp;sdot;&amp;amp;pi; interactions in this molecule are responsible for crystal packing.</p>
	]]></content:encoded>

	<dc:title>1-Phenyl-4-p-tolyl-[1,2,3]triazole</dc:title>
			<dc:creator>Eder Y. Nolasco-Terrón</dc:creator>
			<dc:creator>David Gómez-Colín</dc:creator>
			<dc:creator>Nelly González-Rivas</dc:creator>
			<dc:creator>Diego Martínez-Otero</dc:creator>
			<dc:creator>Erick Cuevas-Yañez</dc:creator>
		<dc:identifier>doi: 10.3390/M2160</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-08</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-08</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2160</prism:startingPage>
		<prism:doi>10.3390/M2160</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2160</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2159">

	<title>Molbank, Vol. 2026, Article M2159: Synthesis of a Calix[4]semitube with a Selectively Dinitrated Face</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2159</link>
	<description>This paper describes the synthesis and characterisation of the calix semitube 5. The calix[4]semitube consists of two calix[4]arenes connected through their lower rim from two phenol groups in distal positions. One calix[4]arene is unsubstituted on its upper rim, while the upper rim of the other calix[4]arene has two nitro groups in the 1,3- position and two tert-butyl groups in the remaining ones. The synthesis procedure yielded an amorphous structure, which did not provide a single crystal. The final compound was comprehensively characterised by infrared spectroscopy, mass spectrometry, and 1H and 13C NMR spectroscopy. The results of the 1H NMR spectroscopy confirmed that the calix[4]arene units adopted a cone conformation. This was confirmed by COSY and 1H-13C HMBC. The results obtained confirm that the compound was successfully synthesised. The IUPAC name of 5 is 2,34-di-tert-butyl-39,49-dinitro-6,7,8,9,27,28,29,30-octahydro-15H,21H,36H,42H-4,32:11,25-bis(methano [1,3]benzenomethano)-16,20:37,41-di(metheno)tetrabenzo[g,g1,p,x][1,6,18,23] tetraoxacyclotetratriacontine-43,46,54,60-tetraol.</description>
	<pubDate>2026-04-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2159: Synthesis of a Calix[4]semitube with a Selectively Dinitrated Face</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2159">doi: 10.3390/M2159</a></p>
	<p>Authors:
		Roderick Abdilla
		Stefano Volpi
		Alessandro Casnati
		Maria A. Cardona
		Ruben Gatt
		</p>
	<p>This paper describes the synthesis and characterisation of the calix semitube 5. The calix[4]semitube consists of two calix[4]arenes connected through their lower rim from two phenol groups in distal positions. One calix[4]arene is unsubstituted on its upper rim, while the upper rim of the other calix[4]arene has two nitro groups in the 1,3- position and two tert-butyl groups in the remaining ones. The synthesis procedure yielded an amorphous structure, which did not provide a single crystal. The final compound was comprehensively characterised by infrared spectroscopy, mass spectrometry, and 1H and 13C NMR spectroscopy. The results of the 1H NMR spectroscopy confirmed that the calix[4]arene units adopted a cone conformation. This was confirmed by COSY and 1H-13C HMBC. The results obtained confirm that the compound was successfully synthesised. The IUPAC name of 5 is 2,34-di-tert-butyl-39,49-dinitro-6,7,8,9,27,28,29,30-octahydro-15H,21H,36H,42H-4,32:11,25-bis(methano [1,3]benzenomethano)-16,20:37,41-di(metheno)tetrabenzo[g,g1,p,x][1,6,18,23] tetraoxacyclotetratriacontine-43,46,54,60-tetraol.</p>
	]]></content:encoded>

	<dc:title>Synthesis of a Calix[4]semitube with a Selectively Dinitrated Face</dc:title>
			<dc:creator>Roderick Abdilla</dc:creator>
			<dc:creator>Stefano Volpi</dc:creator>
			<dc:creator>Alessandro Casnati</dc:creator>
			<dc:creator>Maria A. Cardona</dc:creator>
			<dc:creator>Ruben Gatt</dc:creator>
		<dc:identifier>doi: 10.3390/M2159</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-07</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-07</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2159</prism:startingPage>
		<prism:doi>10.3390/M2159</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2159</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2158">

	<title>Molbank, Vol. 2026, Article M2158: (1S,2R,3aR,6S,8aS)-1-Isopropyl-3a,6-Dimethyldecahydroazulene-1,2,6-Triol from Trichoderma virens</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2158</link>
	<description>A novel derivative from carotene-type sesquiterpene, (1S,2R,3aR,6S,8aS)-1-isopropyl-3a,6-dimethyldecahydroazulene-1,2,6-triol (1), was successfully isolated from filamentous fungus Trichoderma virens NBRC 31959. The structure and molecular formula of 1 were determined by interpretation of 1D and 2D NMR and HRMS data. The absolute configuration was established unambiguously by single-crystal X-ray diffraction, with the Flack parameter supporting the assignment. This study adds to the chemical diversity of sesquiterpene-type CAF603 derivatives of Trichoderma virens.</description>
	<pubDate>2026-04-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2158: (1S,2R,3aR,6S,8aS)-1-Isopropyl-3a,6-Dimethyldecahydroazulene-1,2,6-Triol from Trichoderma virens</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2158">doi: 10.3390/M2158</a></p>
	<p>Authors:
		Desita Triana Aziz
		Resky Nugraha
		Marwah Wirda Ningsih
		Zetryana Puteri Tachrim
		Yuta Murai
		Makoto Hashimoto
		</p>
	<p>A novel derivative from carotene-type sesquiterpene, (1S,2R,3aR,6S,8aS)-1-isopropyl-3a,6-dimethyldecahydroazulene-1,2,6-triol (1), was successfully isolated from filamentous fungus Trichoderma virens NBRC 31959. The structure and molecular formula of 1 were determined by interpretation of 1D and 2D NMR and HRMS data. The absolute configuration was established unambiguously by single-crystal X-ray diffraction, with the Flack parameter supporting the assignment. This study adds to the chemical diversity of sesquiterpene-type CAF603 derivatives of Trichoderma virens.</p>
	]]></content:encoded>

	<dc:title>(1S,2R,3aR,6S,8aS)-1-Isopropyl-3a,6-Dimethyldecahydroazulene-1,2,6-Triol from Trichoderma virens</dc:title>
			<dc:creator>Desita Triana Aziz</dc:creator>
			<dc:creator>Resky Nugraha</dc:creator>
			<dc:creator>Marwah Wirda Ningsih</dc:creator>
			<dc:creator>Zetryana Puteri Tachrim</dc:creator>
			<dc:creator>Yuta Murai</dc:creator>
			<dc:creator>Makoto Hashimoto</dc:creator>
		<dc:identifier>doi: 10.3390/M2158</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2158</prism:startingPage>
		<prism:doi>10.3390/M2158</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2158</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2157">

	<title>Molbank, Vol. 2026, Article M2157: (+)-(3S)-8-(3-Methylbut-2-en-1-yl)-7-Methoxy-6,2&amp;prime;,4&amp;prime;-Trihydroxyisoflavan</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2157</link>
	<description>Phytochemical investigation of Millettia racemosa Benth. led to the identification of an undescribed isoflavan, (+)-(3S)-8-(3-methylbut-2-en-1-yl)-7-methoxy-6,2&amp;amp;prime;,4&amp;amp;prime;-trihydroxyisoflavan, namely milletiaisoflavan (1). The structure of the isolate was elucidated by spectroscopic evidence (one- and two-dimensional nuclear magnetic resonance, ultraviolet, mass spectrometry, and circular dichroism spectra).</description>
	<pubDate>2026-04-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2157: (+)-(3S)-8-(3-Methylbut-2-en-1-yl)-7-Methoxy-6,2&amp;prime;,4&amp;prime;-Trihydroxyisoflavan</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2157">doi: 10.3390/M2157</a></p>
	<p>Authors:
		Hye Jin Kim
		Kye Jung Shin
		Khin Myo Htwe
		Kee Dong Yoon
		</p>
	<p>Phytochemical investigation of Millettia racemosa Benth. led to the identification of an undescribed isoflavan, (+)-(3S)-8-(3-methylbut-2-en-1-yl)-7-methoxy-6,2&amp;amp;prime;,4&amp;amp;prime;-trihydroxyisoflavan, namely milletiaisoflavan (1). The structure of the isolate was elucidated by spectroscopic evidence (one- and two-dimensional nuclear magnetic resonance, ultraviolet, mass spectrometry, and circular dichroism spectra).</p>
	]]></content:encoded>

	<dc:title>(+)-(3S)-8-(3-Methylbut-2-en-1-yl)-7-Methoxy-6,2&amp;amp;prime;,4&amp;amp;prime;-Trihydroxyisoflavan</dc:title>
			<dc:creator>Hye Jin Kim</dc:creator>
			<dc:creator>Kye Jung Shin</dc:creator>
			<dc:creator>Khin Myo Htwe</dc:creator>
			<dc:creator>Kee Dong Yoon</dc:creator>
		<dc:identifier>doi: 10.3390/M2157</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2157</prism:startingPage>
		<prism:doi>10.3390/M2157</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2157</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2156">

	<title>Molbank, Vol. 2026, Article M2156: (E)-3-(3,4-Di-(2,3,4,6-tetra-O-acetyl-&amp;beta;-d-glucopyranosyloxy)phenyl) Acrylic Acid</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2156</link>
	<description>Phenolic acids are widely known for their antioxidant and biological properties, which make them attractive scaffolds for structural modification. In this short note, we report the synthesis of a new 3,4-di-glucosylated caffeic acid analogue. The (E)-3-(3,4-di-(2,3,4,6-tetra-O-acetyl-&amp;amp;beta;-d-glucopyranosyloxy)phenyl) acrylic acid was obtained through a two-step synthesis, starting with a phase-transfer-catalyzed glycosylation of 3,4-dihydroxybenzaldehyde with 2,3,4,6-tetra-O-acetyl-&amp;amp;alpha;-d-glucopyranosyl bromide followed by a Dobner-modified Knoevenagel condensation. Consistent with the 2-O-acetyl neighbouring participation and the resulting Walden-type inversion at the anomeric centre, both glucopyranosyl units were assigned the &amp;amp;beta;-configuration.</description>
	<pubDate>2026-04-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2156: (E)-3-(3,4-Di-(2,3,4,6-tetra-O-acetyl-&amp;beta;-d-glucopyranosyloxy)phenyl) Acrylic Acid</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2156">doi: 10.3390/M2156</a></p>
	<p>Authors:
		Sara Ghazi
		Mohamed Touaibia
		</p>
	<p>Phenolic acids are widely known for their antioxidant and biological properties, which make them attractive scaffolds for structural modification. In this short note, we report the synthesis of a new 3,4-di-glucosylated caffeic acid analogue. The (E)-3-(3,4-di-(2,3,4,6-tetra-O-acetyl-&amp;amp;beta;-d-glucopyranosyloxy)phenyl) acrylic acid was obtained through a two-step synthesis, starting with a phase-transfer-catalyzed glycosylation of 3,4-dihydroxybenzaldehyde with 2,3,4,6-tetra-O-acetyl-&amp;amp;alpha;-d-glucopyranosyl bromide followed by a Dobner-modified Knoevenagel condensation. Consistent with the 2-O-acetyl neighbouring participation and the resulting Walden-type inversion at the anomeric centre, both glucopyranosyl units were assigned the &amp;amp;beta;-configuration.</p>
	]]></content:encoded>

	<dc:title>(E)-3-(3,4-Di-(2,3,4,6-tetra-O-acetyl-&amp;amp;beta;-d-glucopyranosyloxy)phenyl) Acrylic Acid</dc:title>
			<dc:creator>Sara Ghazi</dc:creator>
			<dc:creator>Mohamed Touaibia</dc:creator>
		<dc:identifier>doi: 10.3390/M2156</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-04-01</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-04-01</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2156</prism:startingPage>
		<prism:doi>10.3390/M2156</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2156</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2155">

	<title>Molbank, Vol. 2026, Article M2155: 1-(2-Aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2155</link>
	<description>This work reports the isolation and structural characterization of 1-(2-aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone (1), a &amp;amp;beta;-hydroxyketone intermediate that crystallized unexpectedly during the base-catalyzed aldol condensation of 2-aminoacetophenone with pyridine-4-carbaldehyde, a reaction intended to afford the corresponding pyridyl chalcone (2). The formation of (1) highlights the sensitivity of Claisen&amp;amp;ndash;Schmidt reactions to the electronic and steric features of the substrates and to the applied reaction conditions. Single-crystal X-ray diffraction unambiguously confirmed the molecular structure of (1), revealing a hydrogen-bonding network involving the amino, carbonyl, and &amp;amp;beta;-hydroxyl functionalities. These interactions contribute to the solid-state stabilization of the &amp;amp;beta;-hydroxyketone and hinder its dehydration to chalcone (2). The present results provide experimental insight into the mechanistic landscape of aldol condensations and emphasize the relevance of isolable intermediates as structurally defined precursors for further synthetic transformations.</description>
	<pubDate>2026-03-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2155: 1-(2-Aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2155">doi: 10.3390/M2155</a></p>
	<p>Authors:
		Yahaira Cuenú Ibargüen
		Fernando Cuenú-Cabezas
		Jovanny A. Gómez Castaño
		</p>
	<p>This work reports the isolation and structural characterization of 1-(2-aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone (1), a &amp;amp;beta;-hydroxyketone intermediate that crystallized unexpectedly during the base-catalyzed aldol condensation of 2-aminoacetophenone with pyridine-4-carbaldehyde, a reaction intended to afford the corresponding pyridyl chalcone (2). The formation of (1) highlights the sensitivity of Claisen&amp;amp;ndash;Schmidt reactions to the electronic and steric features of the substrates and to the applied reaction conditions. Single-crystal X-ray diffraction unambiguously confirmed the molecular structure of (1), revealing a hydrogen-bonding network involving the amino, carbonyl, and &amp;amp;beta;-hydroxyl functionalities. These interactions contribute to the solid-state stabilization of the &amp;amp;beta;-hydroxyketone and hinder its dehydration to chalcone (2). The present results provide experimental insight into the mechanistic landscape of aldol condensations and emphasize the relevance of isolable intermediates as structurally defined precursors for further synthetic transformations.</p>
	]]></content:encoded>

	<dc:title>1-(2-Aminophenyl)-3-(4-pyridyl)-3-hydroxy-1-propanone</dc:title>
			<dc:creator>Yahaira Cuenú Ibargüen</dc:creator>
			<dc:creator>Fernando Cuenú-Cabezas</dc:creator>
			<dc:creator>Jovanny A. Gómez Castaño</dc:creator>
		<dc:identifier>doi: 10.3390/M2155</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-25</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-25</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2155</prism:startingPage>
		<prism:doi>10.3390/M2155</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2155</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2154">

	<title>Molbank, Vol. 2026, Article M2154: 3a-Phenylhexahydropentalene-1,6-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2154</link>
	<description>Bicyclo[3.3.0]skeleton is a common structural motif present in many natural products and pharmaceutical agents. Here we have synthesized a rigid 3a-arylhexahydropentalene-1,6-dione from cyclopent-2-en-1-one which is an easy and readily available starting material.</description>
	<pubDate>2026-03-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2154: 3a-Phenylhexahydropentalene-1,6-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2154">doi: 10.3390/M2154</a></p>
	<p>Authors:
		Yongyao Li
		Hongtao Kong
		Xiaoying Huang
		Maxwell Ampomah-Wireko
		Cedric Dzidzor Kodjo Amengor
		En Zhang
		Yihong Zhao
		</p>
	<p>Bicyclo[3.3.0]skeleton is a common structural motif present in many natural products and pharmaceutical agents. Here we have synthesized a rigid 3a-arylhexahydropentalene-1,6-dione from cyclopent-2-en-1-one which is an easy and readily available starting material.</p>
	]]></content:encoded>

	<dc:title>3a-Phenylhexahydropentalene-1,6-dione</dc:title>
			<dc:creator>Yongyao Li</dc:creator>
			<dc:creator>Hongtao Kong</dc:creator>
			<dc:creator>Xiaoying Huang</dc:creator>
			<dc:creator>Maxwell Ampomah-Wireko</dc:creator>
			<dc:creator>Cedric Dzidzor Kodjo Amengor</dc:creator>
			<dc:creator>En Zhang</dc:creator>
			<dc:creator>Yihong Zhao</dc:creator>
		<dc:identifier>doi: 10.3390/M2154</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-18</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-18</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2154</prism:startingPage>
		<prism:doi>10.3390/M2154</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2154</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2153">

	<title>Molbank, Vol. 2026, Article M2153: Naphthalene-Based Schiff Base Compounds</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2153</link>
	<description>The synthesis of a salen-type ligand functionalized with naphthalene moieties, as well as its precursor, are reported. The compounds were characterized by 1H and 13C NMR, ESI-MS spectrometry and single crystal X-ray diffraction.</description>
	<pubDate>2026-03-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2153: Naphthalene-Based Schiff Base Compounds</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2153">doi: 10.3390/M2153</a></p>
	<p>Authors:
		Jocelyn Pradegan
		Aurélien Crochet
		Katharina M. Fromm
		</p>
	<p>The synthesis of a salen-type ligand functionalized with naphthalene moieties, as well as its precursor, are reported. The compounds were characterized by 1H and 13C NMR, ESI-MS spectrometry and single crystal X-ray diffraction.</p>
	]]></content:encoded>

	<dc:title>Naphthalene-Based Schiff Base Compounds</dc:title>
			<dc:creator>Jocelyn Pradegan</dc:creator>
			<dc:creator>Aurélien Crochet</dc:creator>
			<dc:creator>Katharina M. Fromm</dc:creator>
		<dc:identifier>doi: 10.3390/M2153</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-17</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-17</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2153</prism:startingPage>
		<prism:doi>10.3390/M2153</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2153</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2152">

	<title>Molbank, Vol. 2026, Article M2152: N-(3,4-Dimethoxyphenethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2152</link>
	<description>In this Short Note type article, we report the synthesis of a new hybrid molecule, N-(3,4-dimethoxyphenethyl)-2-propylpentanamide, using a solvent-minimized mechanochemical method that provides a simple and efficient synthetic approach. The process achieved high yield. The compound was confirmed by melting-point analysis, 1H and 13C NMR, IR spectroscopy, and mass spectrometry.</description>
	<pubDate>2026-03-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2152: N-(3,4-Dimethoxyphenethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2152">doi: 10.3390/M2152</a></p>
	<p>Authors:
		Diyana Dimitrova
		Nikol Dimova
		Dimitrina Velikova
		Iliyan Ivanov
		Dimitar Bojilov
		Stanimir Manolov
		</p>
	<p>In this Short Note type article, we report the synthesis of a new hybrid molecule, N-(3,4-dimethoxyphenethyl)-2-propylpentanamide, using a solvent-minimized mechanochemical method that provides a simple and efficient synthetic approach. The process achieved high yield. The compound was confirmed by melting-point analysis, 1H and 13C NMR, IR spectroscopy, and mass spectrometry.</p>
	]]></content:encoded>

	<dc:title>N-(3,4-Dimethoxyphenethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Nikol Dimova</dc:creator>
			<dc:creator>Dimitrina Velikova</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2152</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2152</prism:startingPage>
		<prism:doi>10.3390/M2152</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2152</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2151">

	<title>Molbank, Vol. 2026, Article M2151: Synthesis, Structural Characterization, and SHG Behavior of a Lanthanum/&amp;beta;-d-Fructose-Based Metal&amp;ndash;Organic Framework</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2151</link>
	<description>Interest in non-centrosymmetric crystalline materials exhibiting second harmonic generation (SHG) has increased due to their potential applications in optical sensing and biosensing. Saccharide-based metal complexes are particularly attractive systems, as chiral sugars can promote non-centrosymmetric crystal packing. In this work, a new lanthanum&amp;amp;ndash;&amp;amp;beta;-d-fructose compound, [La(C6H12O6)(H2O)5]Cl3 (LaFRUCl), was synthesized using a simple and low-cost method and characterized by single-crystal X-ray diffraction. The compound crystallizes in the orthorhombic space group P212121 and consists of infinite (La3+&amp;amp;ndash;fructose)n chains extending along the [001] direction, forming a one-dimensional Metal&amp;amp;ndash;Organic Framework. The nonlinear optical response was evaluated using the Kurtz&amp;amp;ndash;Perry powder technique with a Nd:YAG laser (1064 nm) and compared to a sucrose reference. The measured SHG efficiency is comparable to that of previously reported alkaline earth metal&amp;amp;ndash;sugar analogs. While the compound&amp;amp;rsquo;s SHG emission is significant, evaluation of its structural stability under aqueous or physiological conditions is be required before considering biological applications.</description>
	<pubDate>2026-03-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2151: Synthesis, Structural Characterization, and SHG Behavior of a Lanthanum/&amp;beta;-d-Fructose-Based Metal&amp;ndash;Organic Framework</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2151">doi: 10.3390/M2151</a></p>
	<p>Authors:
		Domenica Marabello
		Paola Benzi
		</p>
	<p>Interest in non-centrosymmetric crystalline materials exhibiting second harmonic generation (SHG) has increased due to their potential applications in optical sensing and biosensing. Saccharide-based metal complexes are particularly attractive systems, as chiral sugars can promote non-centrosymmetric crystal packing. In this work, a new lanthanum&amp;amp;ndash;&amp;amp;beta;-d-fructose compound, [La(C6H12O6)(H2O)5]Cl3 (LaFRUCl), was synthesized using a simple and low-cost method and characterized by single-crystal X-ray diffraction. The compound crystallizes in the orthorhombic space group P212121 and consists of infinite (La3+&amp;amp;ndash;fructose)n chains extending along the [001] direction, forming a one-dimensional Metal&amp;amp;ndash;Organic Framework. The nonlinear optical response was evaluated using the Kurtz&amp;amp;ndash;Perry powder technique with a Nd:YAG laser (1064 nm) and compared to a sucrose reference. The measured SHG efficiency is comparable to that of previously reported alkaline earth metal&amp;amp;ndash;sugar analogs. While the compound&amp;amp;rsquo;s SHG emission is significant, evaluation of its structural stability under aqueous or physiological conditions is be required before considering biological applications.</p>
	]]></content:encoded>

	<dc:title>Synthesis, Structural Characterization, and SHG Behavior of a Lanthanum/&amp;amp;beta;-d-Fructose-Based Metal&amp;amp;ndash;Organic Framework</dc:title>
			<dc:creator>Domenica Marabello</dc:creator>
			<dc:creator>Paola Benzi</dc:creator>
		<dc:identifier>doi: 10.3390/M2151</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2151</prism:startingPage>
		<prism:doi>10.3390/M2151</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2151</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2150">

	<title>Molbank, Vol. 2026, Article M2150: Synthesis of 3-[(2-Ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one and 3-[(2-Ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2150</link>
	<description>Suzuki&amp;amp;ndash;Miyaura coupling of 3-chloro-5-[(2-ethylhexyl)amino]-4H-1,2,6-thiadiazin-4-one with phenylboronic acid, at ca. 100 &amp;amp;deg;C, gave 3-[(2-ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one in 69% yield. Another nucleophilic substitution reaction of 3-chloro-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one with 2-ethylhexan-1-amine at ca. 100 &amp;amp;deg;C gave 3-[(2-ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one in 93% yield.</description>
	<pubDate>2026-03-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2150: Synthesis of 3-[(2-Ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one and 3-[(2-Ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2150">doi: 10.3390/M2150</a></p>
	<p>Authors:
		Andreas S. Kalogirou
		Panayiotis A. Koutentis
		</p>
	<p>Suzuki&amp;amp;ndash;Miyaura coupling of 3-chloro-5-[(2-ethylhexyl)amino]-4H-1,2,6-thiadiazin-4-one with phenylboronic acid, at ca. 100 &amp;amp;deg;C, gave 3-[(2-ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one in 69% yield. Another nucleophilic substitution reaction of 3-chloro-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one with 2-ethylhexan-1-amine at ca. 100 &amp;amp;deg;C gave 3-[(2-ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one in 93% yield.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 3-[(2-Ethylhexyl)amino]-5-phenyl-4H-1,2,6-thiadiazin-4-one and 3-[(2-Ethylhexyl)amino]-5-[(4-oxo-5-phenyl-4H-1,2,6-thiadiazin-3-yl)amino]-4H-1,2,6-thiadiazin-4-one</dc:title>
			<dc:creator>Andreas S. Kalogirou</dc:creator>
			<dc:creator>Panayiotis A. Koutentis</dc:creator>
		<dc:identifier>doi: 10.3390/M2150</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2150</prism:startingPage>
		<prism:doi>10.3390/M2150</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2150</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2149">

	<title>Molbank, Vol. 2026, Article M2149: HAT-Initiated Fragmentation of 4-(Dimethylamino)-1-((3-methylbut-2-en-1-yl)oxy)-3-phenylbut-3-en-2-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2149</link>
	<description>An alkene-tethered enaminone 7 was synthesized in four steps from bromoacetic acid and 3,3-dimethylallyl alcohol. The enaminone was fully characterized, including UV-Vis spectra. TBADT-catalyzed HAT of the alkene-tethered enaminone initiated a fragmentation that yielded the literature-known phenylacetone-derived enaminone.</description>
	<pubDate>2026-03-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2149: HAT-Initiated Fragmentation of 4-(Dimethylamino)-1-((3-methylbut-2-en-1-yl)oxy)-3-phenylbut-3-en-2-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2149">doi: 10.3390/M2149</a></p>
	<p>Authors:
		Andrej Bogataj
		Luka Ciber
		Nejc Petek
		Franc Požgan
		Jurij Svete
		Bogdan Štefane
		Uroš Grošelj
		</p>
	<p>An alkene-tethered enaminone 7 was synthesized in four steps from bromoacetic acid and 3,3-dimethylallyl alcohol. The enaminone was fully characterized, including UV-Vis spectra. TBADT-catalyzed HAT of the alkene-tethered enaminone initiated a fragmentation that yielded the literature-known phenylacetone-derived enaminone.</p>
	]]></content:encoded>

	<dc:title>HAT-Initiated Fragmentation of 4-(Dimethylamino)-1-((3-methylbut-2-en-1-yl)oxy)-3-phenylbut-3-en-2-one</dc:title>
			<dc:creator>Andrej Bogataj</dc:creator>
			<dc:creator>Luka Ciber</dc:creator>
			<dc:creator>Nejc Petek</dc:creator>
			<dc:creator>Franc Požgan</dc:creator>
			<dc:creator>Jurij Svete</dc:creator>
			<dc:creator>Bogdan Štefane</dc:creator>
			<dc:creator>Uroš Grošelj</dc:creator>
		<dc:identifier>doi: 10.3390/M2149</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2149</prism:startingPage>
		<prism:doi>10.3390/M2149</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2149</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2148">

	<title>Molbank, Vol. 2026, Article M2148: Two-Stage Synthesis of 3-(4-Hydroxyphenyl)-1&amp;prime;,3&amp;prime;,6-trimethyl-2&amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;prime;-pyrimidine]-2&amp;prime;,4,4&amp;prime;,6&amp;prime;(1&amp;prime;H,3&amp;prime;H)-tetraone</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2148</link>
	<description>Spirocyclic compounds are experiencing a research surge due to their unique 3D structure, offering enhanced pharmacological, industrial, and material applications. They are increasingly used in medicinal chemistry to improve drug-like properties, such as solubility and target binding, and are also being utilized for advanced material applications, including electronics and photonics. In this communication, 3-(4-hydroxyphenyl)-1&amp;amp;prime;,3&amp;amp;prime;,6-trimethyl-2&amp;amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;amp;prime;-pyrimidine]-2&amp;amp;prime;,4,4&amp;amp;prime;,6&amp;amp;prime;(1&amp;amp;prime;H,3&amp;amp;prime;H)-tetraone was prepared via a two-stage transformation including a tandem Knoevenagel&amp;amp;ndash;Michael reaction and NBS-induced cyclization. At the first stage, a previously unknown ionic scaffold, morpholin-4-ium 5-((4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)(4-hydroxyphenyl)methyl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate was also isolated. Structures of the newly synthesized compounds were established by 1H and 13C NMR, IR spectroscopy, high-resolution mass spectrometry, and elemental analysis.</description>
	<pubDate>2026-03-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2148: Two-Stage Synthesis of 3-(4-Hydroxyphenyl)-1&amp;prime;,3&amp;prime;,6-trimethyl-2&amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;prime;-pyrimidine]-2&amp;prime;,4,4&amp;prime;,6&amp;prime;(1&amp;prime;H,3&amp;prime;H)-tetraone</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2148">doi: 10.3390/M2148</a></p>
	<p>Authors:
		Michail N. Elinson
		Varvara M. Kalashnikova
		Yuliya E. Ryzhkova
		Oleg A. Rakitin
		</p>
	<p>Spirocyclic compounds are experiencing a research surge due to their unique 3D structure, offering enhanced pharmacological, industrial, and material applications. They are increasingly used in medicinal chemistry to improve drug-like properties, such as solubility and target binding, and are also being utilized for advanced material applications, including electronics and photonics. In this communication, 3-(4-hydroxyphenyl)-1&amp;amp;prime;,3&amp;amp;prime;,6-trimethyl-2&amp;amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;amp;prime;-pyrimidine]-2&amp;amp;prime;,4,4&amp;amp;prime;,6&amp;amp;prime;(1&amp;amp;prime;H,3&amp;amp;prime;H)-tetraone was prepared via a two-stage transformation including a tandem Knoevenagel&amp;amp;ndash;Michael reaction and NBS-induced cyclization. At the first stage, a previously unknown ionic scaffold, morpholin-4-ium 5-((4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)(4-hydroxyphenyl)methyl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate was also isolated. Structures of the newly synthesized compounds were established by 1H and 13C NMR, IR spectroscopy, high-resolution mass spectrometry, and elemental analysis.</p>
	]]></content:encoded>

	<dc:title>Two-Stage Synthesis of 3-(4-Hydroxyphenyl)-1&amp;amp;prime;,3&amp;amp;prime;,6-trimethyl-2&amp;amp;prime;H,3H,4H-spiro[furo[3,2-c]pyran-2,5&amp;amp;prime;-pyrimidine]-2&amp;amp;prime;,4,4&amp;amp;prime;,6&amp;amp;prime;(1&amp;amp;prime;H,3&amp;amp;prime;H)-tetraone</dc:title>
			<dc:creator>Michail N. Elinson</dc:creator>
			<dc:creator>Varvara M. Kalashnikova</dc:creator>
			<dc:creator>Yuliya E. Ryzhkova</dc:creator>
			<dc:creator>Oleg A. Rakitin</dc:creator>
		<dc:identifier>doi: 10.3390/M2148</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-11</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-11</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2148</prism:startingPage>
		<prism:doi>10.3390/M2148</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2148</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2147">

	<title>Molbank, Vol. 2026, Article M2147: N-(3,6-Dimethoxy-2-nitrophenyl)acetamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2147</link>
	<description>1,4-Dimethoxy-2,3-dinitrobenzene (1) reduction using sodium hydrosulfite resulted in 3,6-dimethoxybenzene-1,2-diamine (2) and 3,6-dimethoxy-2-nitroaniline (3) in 24% and 59% yields, respectively. Nitroaniline 3 was acetylated with acetyl chloride to give N-(3,6-dimethoxy-2-nitrophenyl)acetamide (4) in a 65% yield and with acetic anhydride to give N-acetyl-N-(3,6-dimethoxy-2-nitrophenyl)acetamide (5) in 78% yield. Novel compounds 4 and 5 were characterized by FT-IR, 1H and 13C-NMR, and HRMS. The X-ray crystal structure of acetamide 4 is also presented.</description>
	<pubDate>2026-03-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2147: N-(3,6-Dimethoxy-2-nitrophenyl)acetamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2147">doi: 10.3390/M2147</a></p>
	<p>Authors:
		Lina A. Al-Dulaimi
		Joseph C. Bear
		Jeremy K. Cockcroft
		Giuseppe Trigiante
		Fawaz Aldabbagh
		</p>
	<p>1,4-Dimethoxy-2,3-dinitrobenzene (1) reduction using sodium hydrosulfite resulted in 3,6-dimethoxybenzene-1,2-diamine (2) and 3,6-dimethoxy-2-nitroaniline (3) in 24% and 59% yields, respectively. Nitroaniline 3 was acetylated with acetyl chloride to give N-(3,6-dimethoxy-2-nitrophenyl)acetamide (4) in a 65% yield and with acetic anhydride to give N-acetyl-N-(3,6-dimethoxy-2-nitrophenyl)acetamide (5) in 78% yield. Novel compounds 4 and 5 were characterized by FT-IR, 1H and 13C-NMR, and HRMS. The X-ray crystal structure of acetamide 4 is also presented.</p>
	]]></content:encoded>

	<dc:title>N-(3,6-Dimethoxy-2-nitrophenyl)acetamide</dc:title>
			<dc:creator>Lina A. Al-Dulaimi</dc:creator>
			<dc:creator>Joseph C. Bear</dc:creator>
			<dc:creator>Jeremy K. Cockcroft</dc:creator>
			<dc:creator>Giuseppe Trigiante</dc:creator>
			<dc:creator>Fawaz Aldabbagh</dc:creator>
		<dc:identifier>doi: 10.3390/M2147</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2147</prism:startingPage>
		<prism:doi>10.3390/M2147</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2147</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2146">

	<title>Molbank, Vol. 2026, Article M2146: Synthesis of 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one Derivatives</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2146</link>
	<description>Owing to their distinctive physicochemical features, their structural analogues of benzene ring bioisosteres, and their strong affinity for biomacromolecules, pyridine derivatives function both as core structural scaffolds in pharmacologically active compounds and as versatile elements for optimizing key drug-like properties, such as water solubility, membrane permeability, and metabolic stability. In this study, we synthesized five pyridine-fused heterocyclic compounds using common synthetic intermediates as precursors.</description>
	<pubDate>2026-03-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2146: Synthesis of 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one Derivatives</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2146">doi: 10.3390/M2146</a></p>
	<p>Authors:
		Yong-Yao Li
		Zhi-Hao Li
		Xiao-Ying Huang
		Maxwell Ampomah-Wireko
		Cedric Dzidzor Kodjo Amengor
		En Zhang
		Yi-Hong Zhao
		</p>
	<p>Owing to their distinctive physicochemical features, their structural analogues of benzene ring bioisosteres, and their strong affinity for biomacromolecules, pyridine derivatives function both as core structural scaffolds in pharmacologically active compounds and as versatile elements for optimizing key drug-like properties, such as water solubility, membrane permeability, and metabolic stability. In this study, we synthesized five pyridine-fused heterocyclic compounds using common synthetic intermediates as precursors.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one Derivatives</dc:title>
			<dc:creator>Yong-Yao Li</dc:creator>
			<dc:creator>Zhi-Hao Li</dc:creator>
			<dc:creator>Xiao-Ying Huang</dc:creator>
			<dc:creator>Maxwell Ampomah-Wireko</dc:creator>
			<dc:creator>Cedric Dzidzor Kodjo Amengor</dc:creator>
			<dc:creator>En Zhang</dc:creator>
			<dc:creator>Yi-Hong Zhao</dc:creator>
		<dc:identifier>doi: 10.3390/M2146</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2146</prism:startingPage>
		<prism:doi>10.3390/M2146</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2146</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2145">

	<title>Molbank, Vol. 2026, Article M2145: Synthesis, Crystal Structure, and Properties of a Dinuclear Zinc(II) Complex Featuring a Bromo-Functionalized Semicarbazone Schiff Base Ligand</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2145</link>
	<description>This study investigates the rational design of a dinuclear zinc(II) coordination polymer, (C36H34Br2N8O4S2Zn2), to explore how halogen substitution and ligand choice modulate structural architecture, contributing to the development of functional coordination polymers with tailored properties. The complex was synthesized from a bromo-substituted semicarbazone Schiff base ligand (L1) and a rigid bipyridine linker (L2) under solvothermal conditions, and its structure was elucidated using single-crystal X-ray diffraction (SCXRD), complemented by characterization via powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA), and infrared (IR) spectroscopy. Crystallographic analysis reveals that the complex crystallizes in the triclinic space group P-1, forming discrete dinuclear units where each Zn(II) center adopts a distorted square&amp;amp;ndash;pyramidal geometry; these units are extended into one-dimensional chains by bridging L2 ligands and further assembled into a three-dimensional supramolecular network through hydrogen-bonding interactions. PXRD confirms the high phase purity of the bulk material, TGA indicates notable thermal stability up to 130 &amp;amp;deg;C, and IR spectroscopy validates the coordination modes and hydrogen-bonding network. This work elucidates the critical role of the bromo substituent and rigid ancillary ligands in modulating the solid-state structure of the zinc(II) complex. The revealed structure-directing principles provide a valuable reference for the rational design of functional coordination polymers.</description>
	<pubDate>2026-03-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2145: Synthesis, Crystal Structure, and Properties of a Dinuclear Zinc(II) Complex Featuring a Bromo-Functionalized Semicarbazone Schiff Base Ligand</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2145">doi: 10.3390/M2145</a></p>
	<p>Authors:
		Cuicui Wang
		Jinhua Wang
		Yunkai Zhang
		Azura A. Rashid
		Siew Kooi Ong
		</p>
	<p>This study investigates the rational design of a dinuclear zinc(II) coordination polymer, (C36H34Br2N8O4S2Zn2), to explore how halogen substitution and ligand choice modulate structural architecture, contributing to the development of functional coordination polymers with tailored properties. The complex was synthesized from a bromo-substituted semicarbazone Schiff base ligand (L1) and a rigid bipyridine linker (L2) under solvothermal conditions, and its structure was elucidated using single-crystal X-ray diffraction (SCXRD), complemented by characterization via powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA), and infrared (IR) spectroscopy. Crystallographic analysis reveals that the complex crystallizes in the triclinic space group P-1, forming discrete dinuclear units where each Zn(II) center adopts a distorted square&amp;amp;ndash;pyramidal geometry; these units are extended into one-dimensional chains by bridging L2 ligands and further assembled into a three-dimensional supramolecular network through hydrogen-bonding interactions. PXRD confirms the high phase purity of the bulk material, TGA indicates notable thermal stability up to 130 &amp;amp;deg;C, and IR spectroscopy validates the coordination modes and hydrogen-bonding network. This work elucidates the critical role of the bromo substituent and rigid ancillary ligands in modulating the solid-state structure of the zinc(II) complex. The revealed structure-directing principles provide a valuable reference for the rational design of functional coordination polymers.</p>
	]]></content:encoded>

	<dc:title>Synthesis, Crystal Structure, and Properties of a Dinuclear Zinc(II) Complex Featuring a Bromo-Functionalized Semicarbazone Schiff Base Ligand</dc:title>
			<dc:creator>Cuicui Wang</dc:creator>
			<dc:creator>Jinhua Wang</dc:creator>
			<dc:creator>Yunkai Zhang</dc:creator>
			<dc:creator>Azura A. Rashid</dc:creator>
			<dc:creator>Siew Kooi Ong</dc:creator>
		<dc:identifier>doi: 10.3390/M2145</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2145</prism:startingPage>
		<prism:doi>10.3390/M2145</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2145</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2144">

	<title>Molbank, Vol. 2026, Article M2144: Synthesis of Ethyl 2-Amino-6-hydroxy-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate and Ethyl 6-(Acetyloxy)-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2144</link>
	<description>An effective one-step synthetic procedure for preparation of hydroxylated analogues of ethyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate as novel promising multifunctional building blocks for drug discovery based on the Gewald procedure was developed.</description>
	<pubDate>2026-03-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2144: Synthesis of Ethyl 2-Amino-6-hydroxy-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate and Ethyl 6-(Acetyloxy)-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2144">doi: 10.3390/M2144</a></p>
	<p>Authors:
		Andrii Yu. Myshastyi
		Sergiy V. Vlasov
		Hanna I. Severina
		Georgiy G. Yakovenko
		Andrii R. Khairulin
		</p>
	<p>An effective one-step synthetic procedure for preparation of hydroxylated analogues of ethyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate as novel promising multifunctional building blocks for drug discovery based on the Gewald procedure was developed.</p>
	]]></content:encoded>

	<dc:title>Synthesis of Ethyl 2-Amino-6-hydroxy-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate and Ethyl 6-(Acetyloxy)-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate</dc:title>
			<dc:creator>Andrii Yu. Myshastyi</dc:creator>
			<dc:creator>Sergiy V. Vlasov</dc:creator>
			<dc:creator>Hanna I. Severina</dc:creator>
			<dc:creator>Georgiy G. Yakovenko</dc:creator>
			<dc:creator>Andrii R. Khairulin</dc:creator>
		<dc:identifier>doi: 10.3390/M2144</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2144</prism:startingPage>
		<prism:doi>10.3390/M2144</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2144</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/2/M2143">

	<title>Molbank, Vol. 2026, Article M2143: (4S*,10aS*,11S*)-4-Hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/2/M2143</link>
	<description>The reaction of 4,4-dimethyl-8-(4-methylbenzoyl)-3,4-dihydro-1H-pyrrolo[2,1-c][1,4]oxazine-1,6,7-trione with thioacetamide in a 1:1 ratio when refluxed in dichloromethane gives (4S*,10aS*,11S*)-4-hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione with a good yield. This compound was fully characterized.</description>
	<pubDate>2026-03-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2143: (4S*,10aS*,11S*)-4-Hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/2/M2143">doi: 10.3390/M2143</a></p>
	<p>Authors:
		Nikita A. Tretyakov
		Andrey N. Maslivets
		</p>
	<p>The reaction of 4,4-dimethyl-8-(4-methylbenzoyl)-3,4-dihydro-1H-pyrrolo[2,1-c][1,4]oxazine-1,6,7-trione with thioacetamide in a 1:1 ratio when refluxed in dichloromethane gives (4S*,10aS*,11S*)-4-hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione with a good yield. This compound was fully characterized.</p>
	]]></content:encoded>

	<dc:title>(4S*,10aS*,11S*)-4-Hydroxy-2,7,7-trimethyl-11-(4-methylbenzoyl)-7,8-dihydro-10H-4,10a-methano[1,4]oxazino[3,4-d][1,3,5]thiadiazepine-5,10(4H)-dione</dc:title>
			<dc:creator>Nikita A. Tretyakov</dc:creator>
			<dc:creator>Andrey N. Maslivets</dc:creator>
		<dc:identifier>doi: 10.3390/M2143</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-03-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-03-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2143</prism:startingPage>
		<prism:doi>10.3390/M2143</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/2/M2143</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2142">

	<title>Molbank, Vol. 2026, Article M2142: 8-Phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2142</link>
	<description>A DABCO-catalyzed one-pot synthesis of a novel pentacyclic heterocycle featuring an unprecedented benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine scaffold from 2-(cyanomethyl)benzimidazole and 3-trifluoroacetyl-4-phenyl-4H-chromene has been developed. This hybrid architecture merges three privileged pharmacophores&amp;amp;mdash;benzimidazole, chromene, and pyridine&amp;amp;mdash;into a rigid, nearly planar &amp;amp;pi;-extended system decorated with trifluoromethyl and nitrile groups. The structure of 8-phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile was unambiguously confirmed through NMR spectroscopy and X-ray diffraction analysis. A plausible mechanism involves Michael addition, hemiaminal formation, ring opening, recyclization, and oxidation.</description>
	<pubDate>2026-02-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2142: 8-Phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2142">doi: 10.3390/M2142</a></p>
	<p>Authors:
		Dmitry V. Osipov
		Pavel E. Krasnikov
		Vitaly A. Osyanin
		</p>
	<p>A DABCO-catalyzed one-pot synthesis of a novel pentacyclic heterocycle featuring an unprecedented benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine scaffold from 2-(cyanomethyl)benzimidazole and 3-trifluoroacetyl-4-phenyl-4H-chromene has been developed. This hybrid architecture merges three privileged pharmacophores&amp;amp;mdash;benzimidazole, chromene, and pyridine&amp;amp;mdash;into a rigid, nearly planar &amp;amp;pi;-extended system decorated with trifluoromethyl and nitrile groups. The structure of 8-phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile was unambiguously confirmed through NMR spectroscopy and X-ray diffraction analysis. A plausible mechanism involves Michael addition, hemiaminal formation, ring opening, recyclization, and oxidation.</p>
	]]></content:encoded>

	<dc:title>8-Phenyl-13a-(trifluoromethyl)-13aH-benzo[4,5]imidazo[1,2-a]chromeno[3,2-e]pyridine-6-carbonitrile</dc:title>
			<dc:creator>Dmitry V. Osipov</dc:creator>
			<dc:creator>Pavel E. Krasnikov</dc:creator>
			<dc:creator>Vitaly A. Osyanin</dc:creator>
		<dc:identifier>doi: 10.3390/M2142</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-23</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-23</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2142</prism:startingPage>
		<prism:doi>10.3390/M2142</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2142</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2141">

	<title>Molbank, Vol. 2026, Article M2141: (E)-Methyl 3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2141</link>
	<description>The synthesis of methyl (E)-3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate 3 was accomplished using a Schlosser-modified Wittig reaction. Complete 1H and 13C NMR signal assignments confirm the formation of E-alkene.</description>
	<pubDate>2026-02-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2141: (E)-Methyl 3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2141">doi: 10.3390/M2141</a></p>
	<p>Authors:
		Jorge Trilleras
		Efraín Polo-Cuadrado
		Jairo Quiroga
		</p>
	<p>The synthesis of methyl (E)-3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate 3 was accomplished using a Schlosser-modified Wittig reaction. Complete 1H and 13C NMR signal assignments confirm the formation of E-alkene.</p>
	]]></content:encoded>

	<dc:title>(E)-Methyl 3-(2-amino-4-chloro-6-morpholinopyrimidin-5-yl)acrylate</dc:title>
			<dc:creator>Jorge Trilleras</dc:creator>
			<dc:creator>Efraín Polo-Cuadrado</dc:creator>
			<dc:creator>Jairo Quiroga</dc:creator>
		<dc:identifier>doi: 10.3390/M2141</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2141</prism:startingPage>
		<prism:doi>10.3390/M2141</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2141</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2140">

	<title>Molbank, Vol. 2026, Article M2140: (5R,5aR,8aR,9S)-9-(2-Bromo-3,4,5-trimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&amp;prime;,4&amp;prime;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 3,4,5-trimethoxybenzoate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2140</link>
	<description>In this report, we describe the synthesis and full spectroscopic characterization of a previously unreported podophyllotoxin (PTOX) analogue bearing a second 3,4,5-trimethoxyphenyl (TMP) unit at the C-4 position through an ester linkage. This dual-TMP PTOX derivative is obtained from a brominated PTOX intermediate. In this precursor, the bromine atom is located on the TMP aromatic ring at the 2&amp;amp;prime;-position. The new compound was fully characterized by proton (1H), carbon-13 (13C), heteronuclear single-quantum coherence (HSQC), and distortionless enhancement by polarization transfer (DEPT) NMR spectroscopy. Ultraviolet&amp;amp;ndash;visible (UV-Vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, mass spectrometry and elemental analysis were also performed to confirm the structure and purity of the synthesized ester derivative.</description>
	<pubDate>2026-02-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2140: (5R,5aR,8aR,9S)-9-(2-Bromo-3,4,5-trimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&amp;prime;,4&amp;prime;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 3,4,5-trimethoxybenzoate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2140">doi: 10.3390/M2140</a></p>
	<p>Authors:
		Yuhan Xie
		Alessandra Gianoncelli
		Imran Khan
		Giovanni Ribaudo
		Paolo Coghi
		</p>
	<p>In this report, we describe the synthesis and full spectroscopic characterization of a previously unreported podophyllotoxin (PTOX) analogue bearing a second 3,4,5-trimethoxyphenyl (TMP) unit at the C-4 position through an ester linkage. This dual-TMP PTOX derivative is obtained from a brominated PTOX intermediate. In this precursor, the bromine atom is located on the TMP aromatic ring at the 2&amp;amp;prime;-position. The new compound was fully characterized by proton (1H), carbon-13 (13C), heteronuclear single-quantum coherence (HSQC), and distortionless enhancement by polarization transfer (DEPT) NMR spectroscopy. Ultraviolet&amp;amp;ndash;visible (UV-Vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, mass spectrometry and elemental analysis were also performed to confirm the structure and purity of the synthesized ester derivative.</p>
	]]></content:encoded>

	<dc:title>(5R,5aR,8aR,9S)-9-(2-Bromo-3,4,5-trimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&amp;amp;prime;,4&amp;amp;prime;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 3,4,5-trimethoxybenzoate</dc:title>
			<dc:creator>Yuhan Xie</dc:creator>
			<dc:creator>Alessandra Gianoncelli</dc:creator>
			<dc:creator>Imran Khan</dc:creator>
			<dc:creator>Giovanni Ribaudo</dc:creator>
			<dc:creator>Paolo Coghi</dc:creator>
		<dc:identifier>doi: 10.3390/M2140</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2140</prism:startingPage>
		<prism:doi>10.3390/M2140</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2140</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2139">

	<title>Molbank, Vol. 2026, Article M2139: Diisopropyl(6-(phenyl(phenylthio)arsaneyl)-1,2-dihydroacenaphthylen-5-yl)phosphane</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2139</link>
	<description>Peri-substituted bis(tertiary) phosphine-arsine Acenap(PiPr2)(As(SPh)Ph) (4, Acenap = acenaphthene-5,6-diyl) was synthesized by the reaction of the chloroarsine (PiPr2)(AsPhCl) with PhSLi. The X-ray crystal structure of this compound reveals an intramolecular P&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;As&amp;amp;ndash;Cl pnictogen bond, with the phosphorus lone pair donating into the As&amp;amp;ndash;S &amp;amp;sigma;* orbital.</description>
	<pubDate>2026-02-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2139: Diisopropyl(6-(phenyl(phenylthio)arsaneyl)-1,2-dihydroacenaphthylen-5-yl)phosphane</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2139">doi: 10.3390/M2139</a></p>
	<p>Authors:
		Laurence J. Taylor
		Philip Pickett
		David B. Cordes
		Petr Kilian
		</p>
	<p>Peri-substituted bis(tertiary) phosphine-arsine Acenap(PiPr2)(As(SPh)Ph) (4, Acenap = acenaphthene-5,6-diyl) was synthesized by the reaction of the chloroarsine (PiPr2)(AsPhCl) with PhSLi. The X-ray crystal structure of this compound reveals an intramolecular P&amp;amp;#8729;&amp;amp;#8729;&amp;amp;#8729;As&amp;amp;ndash;Cl pnictogen bond, with the phosphorus lone pair donating into the As&amp;amp;ndash;S &amp;amp;sigma;* orbital.</p>
	]]></content:encoded>

	<dc:title>Diisopropyl(6-(phenyl(phenylthio)arsaneyl)-1,2-dihydroacenaphthylen-5-yl)phosphane</dc:title>
			<dc:creator>Laurence J. Taylor</dc:creator>
			<dc:creator>Philip Pickett</dc:creator>
			<dc:creator>David B. Cordes</dc:creator>
			<dc:creator>Petr Kilian</dc:creator>
		<dc:identifier>doi: 10.3390/M2139</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2139</prism:startingPage>
		<prism:doi>10.3390/M2139</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2139</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2138">

	<title>Molbank, Vol. 2026, Article M2138: Crystal Structure of [1046127-79-0], 3,3&amp;prime;-(n-Hexane-1,6-diyl)bis(1-vinylimidazolium) Bromide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2138</link>
	<description>Vinylimidazolium salts constitute a highly relevant class of polymerizable heterocycles, especially in the field of so-called polymer ionic liquids (PILs), and they are frequently used as components of polyelectrolytes. Therefore, crystallographic characterizations, in particular studies of charge distribution and conformational features, can provide fundamental insights concerning ion&amp;amp;ndash;ion and ion&amp;amp;ndash;dipole interactions. The structure of the title compound [1046127-79-0] has the space group symmetry P21/c. Its asymmetric unit contains one formula unit, consisting of two bromide anions and the halves of two cation moieties. The cation units possess inversion symmetry, and their C6H12 chains adopt an all-trans conformation.</description>
	<pubDate>2026-02-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2138: Crystal Structure of [1046127-79-0], 3,3&amp;prime;-(n-Hexane-1,6-diyl)bis(1-vinylimidazolium) Bromide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2138">doi: 10.3390/M2138</a></p>
	<p>Authors:
		Thomas Gelbrich
		Johanna Freilinger
		Gabriel Partl
		Herwig Schottenberger
		Volker Kahlenberg
		Jan Back
		Sven Nerdinger
		</p>
	<p>Vinylimidazolium salts constitute a highly relevant class of polymerizable heterocycles, especially in the field of so-called polymer ionic liquids (PILs), and they are frequently used as components of polyelectrolytes. Therefore, crystallographic characterizations, in particular studies of charge distribution and conformational features, can provide fundamental insights concerning ion&amp;amp;ndash;ion and ion&amp;amp;ndash;dipole interactions. The structure of the title compound [1046127-79-0] has the space group symmetry P21/c. Its asymmetric unit contains one formula unit, consisting of two bromide anions and the halves of two cation moieties. The cation units possess inversion symmetry, and their C6H12 chains adopt an all-trans conformation.</p>
	]]></content:encoded>

	<dc:title>Crystal Structure of [1046127-79-0], 3,3&amp;amp;prime;-(n-Hexane-1,6-diyl)bis(1-vinylimidazolium) Bromide</dc:title>
			<dc:creator>Thomas Gelbrich</dc:creator>
			<dc:creator>Johanna Freilinger</dc:creator>
			<dc:creator>Gabriel Partl</dc:creator>
			<dc:creator>Herwig Schottenberger</dc:creator>
			<dc:creator>Volker Kahlenberg</dc:creator>
			<dc:creator>Jan Back</dc:creator>
			<dc:creator>Sven Nerdinger</dc:creator>
		<dc:identifier>doi: 10.3390/M2138</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-10</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-10</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2138</prism:startingPage>
		<prism:doi>10.3390/M2138</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2138</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2137">

	<title>Molbank, Vol. 2026, Article M2137: (2R,3R,5R,6S)-5-Bromo-2-{[(2R,3R,5R)-3-bromo-5-(propa-1,2-dien-1-yl)tetrahydro-furan-2-yl]methyl}-6-ethyltetrahydro-2H-pyran-3-ol</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2137</link>
	<description>As a part of an SAR study aimed at testing the antitumor activity of some C15 acetogenins related to mycalin A, we report here the synthesis of the C-1 debromo-derivative of laurenciallene, a substance recently isolated from the red alga Laurencia obtusa. This new substance has been obtained by the selective, reductive debromination of the terminal bromoallene moiety of laurenciallene with Zn/AcOH. Its structure has been fully characterized by spectral methods, including 2D-NMR spectra.</description>
	<pubDate>2026-02-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2137: (2R,3R,5R,6S)-5-Bromo-2-{[(2R,3R,5R)-3-bromo-5-(propa-1,2-dien-1-yl)tetrahydro-furan-2-yl]methyl}-6-ethyltetrahydro-2H-pyran-3-ol</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2137">doi: 10.3390/M2137</a></p>
	<p>Authors:
		Vincenzo Piccialli
		Nicola Borbone
		Monica Terracciano
		</p>
	<p>As a part of an SAR study aimed at testing the antitumor activity of some C15 acetogenins related to mycalin A, we report here the synthesis of the C-1 debromo-derivative of laurenciallene, a substance recently isolated from the red alga Laurencia obtusa. This new substance has been obtained by the selective, reductive debromination of the terminal bromoallene moiety of laurenciallene with Zn/AcOH. Its structure has been fully characterized by spectral methods, including 2D-NMR spectra.</p>
	]]></content:encoded>

	<dc:title>(2R,3R,5R,6S)-5-Bromo-2-{[(2R,3R,5R)-3-bromo-5-(propa-1,2-dien-1-yl)tetrahydro-furan-2-yl]methyl}-6-ethyltetrahydro-2H-pyran-3-ol</dc:title>
			<dc:creator>Vincenzo Piccialli</dc:creator>
			<dc:creator>Nicola Borbone</dc:creator>
			<dc:creator>Monica Terracciano</dc:creator>
		<dc:identifier>doi: 10.3390/M2137</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2137</prism:startingPage>
		<prism:doi>10.3390/M2137</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2137</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2136">

	<title>Molbank, Vol. 2026, Article M2136: 2,3,4,6-Tetra(9H-carbazol-9-yl)benzonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2136</link>
	<description>Here, we synthesized 2,3,4,6-tetra(9H-carbazol-9-yl)benzonitrile (4CzHPN) via visible-light-driven photocatalytic monodecyanation using the versatile metal-free catalyst 4CzIPN. Characterized by NMR, IR, X-ray diffraction, and DFT calculations, it features a 3.49 eV HOMO-LUMO gap and shows blue-shifted absorption/emission, emerging as a promising advanced metal-free photoredox catalyst.</description>
	<pubDate>2026-02-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2136: 2,3,4,6-Tetra(9H-carbazol-9-yl)benzonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2136">doi: 10.3390/M2136</a></p>
	<p>Authors:
		Qing-Qing Wan
		Zhi-Cheng Fu
		</p>
	<p>Here, we synthesized 2,3,4,6-tetra(9H-carbazol-9-yl)benzonitrile (4CzHPN) via visible-light-driven photocatalytic monodecyanation using the versatile metal-free catalyst 4CzIPN. Characterized by NMR, IR, X-ray diffraction, and DFT calculations, it features a 3.49 eV HOMO-LUMO gap and shows blue-shifted absorption/emission, emerging as a promising advanced metal-free photoredox catalyst.</p>
	]]></content:encoded>

	<dc:title>2,3,4,6-Tetra(9H-carbazol-9-yl)benzonitrile</dc:title>
			<dc:creator>Qing-Qing Wan</dc:creator>
			<dc:creator>Zhi-Cheng Fu</dc:creator>
		<dc:identifier>doi: 10.3390/M2136</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2136</prism:startingPage>
		<prism:doi>10.3390/M2136</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2136</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2135">

	<title>Molbank, Vol. 2026, Article M2135: 2-Iodopyridin-3-yl acetate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2135</link>
	<description>The title compound 2-iodopyridin-3-yl acetate was obtained by acetylation of the OH group of 2-iodo-3-hydroxypyridine. Knowing that the hydroxyl group, as a strong H-bond donor in halogenated hydroxypyridines, usually directs supramolecular packing and might enforce possible halogen&amp;amp;ndash;halogen contacts, we crystallized 2-iodo-3-acetoxypyridine with the aim of disrupting the most important H-bond donor and assessing the propensity of the iodine for halogen bond formation. Indeed, in the compound 2-iodopyridin-3-yl acetate, the crystal packing is characterized by infinite 3D chains bonded through I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O=C and C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;I contacts between adjacent molecules. These chains are interconnected by weak C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O contacts, implying the presence of oxygen in the ester. The I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;H contact with the C-H axis perpendicular to the electron belt of the iodine atom can enhance the &amp;amp;sigma;-hole of the iodine and act cooperatively in crystal cohesion. No halogen&amp;amp;ndash;halogen contacts were present.</description>
	<pubDate>2026-02-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2135: 2-Iodopyridin-3-yl acetate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2135">doi: 10.3390/M2135</a></p>
	<p>Authors:
		Mihaela Cristea
		Sergiu Shova
		Marcel Mirel Popa
		Florea Dumitrascu
		</p>
	<p>The title compound 2-iodopyridin-3-yl acetate was obtained by acetylation of the OH group of 2-iodo-3-hydroxypyridine. Knowing that the hydroxyl group, as a strong H-bond donor in halogenated hydroxypyridines, usually directs supramolecular packing and might enforce possible halogen&amp;amp;ndash;halogen contacts, we crystallized 2-iodo-3-acetoxypyridine with the aim of disrupting the most important H-bond donor and assessing the propensity of the iodine for halogen bond formation. Indeed, in the compound 2-iodopyridin-3-yl acetate, the crystal packing is characterized by infinite 3D chains bonded through I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O=C and C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;I contacts between adjacent molecules. These chains are interconnected by weak C-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O contacts, implying the presence of oxygen in the ester. The I&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;H contact with the C-H axis perpendicular to the electron belt of the iodine atom can enhance the &amp;amp;sigma;-hole of the iodine and act cooperatively in crystal cohesion. No halogen&amp;amp;ndash;halogen contacts were present.</p>
	]]></content:encoded>

	<dc:title>2-Iodopyridin-3-yl acetate</dc:title>
			<dc:creator>Mihaela Cristea</dc:creator>
			<dc:creator>Sergiu Shova</dc:creator>
			<dc:creator>Marcel Mirel Popa</dc:creator>
			<dc:creator>Florea Dumitrascu</dc:creator>
		<dc:identifier>doi: 10.3390/M2135</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2135</prism:startingPage>
		<prism:doi>10.3390/M2135</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2135</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2134">

	<title>Molbank, Vol. 2026, Article M2134: Synthesis and Characteristics of New 3-(Dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2134</link>
	<description>The previously unknown compounds&amp;amp;mdash;3-(dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones&amp;amp;mdash;have been synthesized and structurally characterized via single-crystal X-ray diffraction, 1H, 13C&amp;amp;ndash;{1H}, 1H&amp;amp;ndash;13C HMQC and 1H&amp;amp;ndash;13C HMBC NMR spectroscopy, IR, and UV spectroscopy.</description>
	<pubDate>2026-02-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2134: Synthesis and Characteristics of New 3-(Dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2134">doi: 10.3390/M2134</a></p>
	<p>Authors:
		Ilia A. Pilipenko
		Olga Yu. Ozerova
		Oleg P. Demidov
		Ruslan I. Baichurin
		Oussama A. Mammeri
		Sergey V. Makarenko
		</p>
	<p>The previously unknown compounds&amp;amp;mdash;3-(dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones&amp;amp;mdash;have been synthesized and structurally characterized via single-crystal X-ray diffraction, 1H, 13C&amp;amp;ndash;{1H}, 1H&amp;amp;ndash;13C HMQC and 1H&amp;amp;ndash;13C HMBC NMR spectroscopy, IR, and UV spectroscopy.</p>
	]]></content:encoded>

	<dc:title>Synthesis and Characteristics of New 3-(Dichloromethyl)-2-nitro-6,7-dihydro-1-benzofuran-4(5H)-ones</dc:title>
			<dc:creator>Ilia A. Pilipenko</dc:creator>
			<dc:creator>Olga Yu. Ozerova</dc:creator>
			<dc:creator>Oleg P. Demidov</dc:creator>
			<dc:creator>Ruslan I. Baichurin</dc:creator>
			<dc:creator>Oussama A. Mammeri</dc:creator>
			<dc:creator>Sergey V. Makarenko</dc:creator>
		<dc:identifier>doi: 10.3390/M2134</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2134</prism:startingPage>
		<prism:doi>10.3390/M2134</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2134</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2133">

	<title>Molbank, Vol. 2026, Article M2133: 2-(3&amp;prime;,5&amp;prime;-Bis((dodecyloxy)carbonyl)-2&amp;prime;,6&amp;prime;-dimethyl-1&amp;prime;,4&amp;prime;-dihydro-[3,4&amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2133</link>
	<description>Indane-1,3-dione and 1,4-dihydropyridine (1,4-DHP) scaffolds are of significant interest in medicinal chemistry. Herein, we report the synthesis characterization of a new lipid-like indane-1,3-dione&amp;amp;ndash;1,4-DHP betaine, 2-(3&amp;amp;prime;,5&amp;amp;prime;-bis((dodecyloxy)carbonyl)-2&amp;amp;prime;,6&amp;amp;prime;-dimethyl-1&amp;amp;prime;,4&amp;amp;prime;-dihydro-[3,4&amp;amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide (3). Compound 3 was synthesized from 2,2-dicyanomethylideneindan-1,3-dione (1) oxide and a didodecyl-substituted 1,4-DHP derivative 2 and characterized by UV&amp;amp;ndash;Vis spectroscopy, 1H-NMR, 13C-NMR, and HRMS. The obtained results demonstrate a promising strategy for the design of delivery agents, exploiting the lipid-like properties of the synthesized betaine.</description>
	<pubDate>2026-02-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2133: 2-(3&amp;prime;,5&amp;prime;-Bis((dodecyloxy)carbonyl)-2&amp;prime;,6&amp;prime;-dimethyl-1&amp;prime;,4&amp;prime;-dihydro-[3,4&amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2133">doi: 10.3390/M2133</a></p>
	<p>Authors:
		Mara Plotniece
		Krista Arule
		Karlis Pajuste
		Aiva Plotniece
		Arkadij Sobolev
		</p>
	<p>Indane-1,3-dione and 1,4-dihydropyridine (1,4-DHP) scaffolds are of significant interest in medicinal chemistry. Herein, we report the synthesis characterization of a new lipid-like indane-1,3-dione&amp;amp;ndash;1,4-DHP betaine, 2-(3&amp;amp;prime;,5&amp;amp;prime;-bis((dodecyloxy)carbonyl)-2&amp;amp;prime;,6&amp;amp;prime;-dimethyl-1&amp;amp;prime;,4&amp;amp;prime;-dihydro-[3,4&amp;amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide (3). Compound 3 was synthesized from 2,2-dicyanomethylideneindan-1,3-dione (1) oxide and a didodecyl-substituted 1,4-DHP derivative 2 and characterized by UV&amp;amp;ndash;Vis spectroscopy, 1H-NMR, 13C-NMR, and HRMS. The obtained results demonstrate a promising strategy for the design of delivery agents, exploiting the lipid-like properties of the synthesized betaine.</p>
	]]></content:encoded>

	<dc:title>2-(3&amp;amp;prime;,5&amp;amp;prime;-Bis((dodecyloxy)carbonyl)-2&amp;amp;prime;,6&amp;amp;prime;-dimethyl-1&amp;amp;prime;,4&amp;amp;prime;-dihydro-[3,4&amp;amp;prime;-bipyridin]-1-ium-1-yl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide</dc:title>
			<dc:creator>Mara Plotniece</dc:creator>
			<dc:creator>Krista Arule</dc:creator>
			<dc:creator>Karlis Pajuste</dc:creator>
			<dc:creator>Aiva Plotniece</dc:creator>
			<dc:creator>Arkadij Sobolev</dc:creator>
		<dc:identifier>doi: 10.3390/M2133</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2133</prism:startingPage>
		<prism:doi>10.3390/M2133</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2133</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2132">

	<title>Molbank, Vol. 2026, Article M2132: N-(4-Methoxyphenethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2132</link>
	<description>Herein, we report the mechanochemical synthesis of a novel hybrid molecule, N-(4-methoxyphenethyl)-2-propylpentanamide. This solvent-minimized synthesis aligns with the principles of Green Chemistry and exemplifies the emerging paradigm of medicinal mechanochemistry, offering an efficient, sustainable route to pharmaceutically relevant amides. The newly synthesized compound was fully characterized by melting point determination, 1H and 13C NMR spectroscopy, infrared (IR) spectroscopy, and mass spectrometry.</description>
	<pubDate>2026-02-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2132: N-(4-Methoxyphenethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2132">doi: 10.3390/M2132</a></p>
	<p>Authors:
		Diyana Dimitrova
		Tsvetelina Marinova
		Reni Bozhanova
		Iliyan Ivanov
		Dimitar Bojilov
		Gabriel Marc
		Stanimir Manolov
		</p>
	<p>Herein, we report the mechanochemical synthesis of a novel hybrid molecule, N-(4-methoxyphenethyl)-2-propylpentanamide. This solvent-minimized synthesis aligns with the principles of Green Chemistry and exemplifies the emerging paradigm of medicinal mechanochemistry, offering an efficient, sustainable route to pharmaceutically relevant amides. The newly synthesized compound was fully characterized by melting point determination, 1H and 13C NMR spectroscopy, infrared (IR) spectroscopy, and mass spectrometry.</p>
	]]></content:encoded>

	<dc:title>N-(4-Methoxyphenethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Tsvetelina Marinova</dc:creator>
			<dc:creator>Reni Bozhanova</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Gabriel Marc</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2132</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2132</prism:startingPage>
		<prism:doi>10.3390/M2132</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2132</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2131">

	<title>Molbank, Vol. 2026, Article M2131: Molecular Structure of the Monohydrate Hydrochloride Salt of the Antimalarial Drug Chloroquine</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2131</link>
	<description>We report the crystallization and single-crystal X-ray analysis of the monohydrate hydrochloride salt of chloroquine(CQ), abbreviated CQHCl&amp;amp;middot;H2O, an antimalarial drug with the formula C18H26ClN3. The crystal structure reveals a well-defined supramolecular architecture stabilized by an extensive hydrogen-bonding network involving CQH+ cations, chloride anions, and water molecules. Notably, this study provides the first crystallographic characterization of a monoprotonated chloroquine salt. Additionally, our findings demonstrate the feasibility of isolating pseudo-polymorphic forms of a commercially available CQ salt via heterogeneous crystallization.</description>
	<pubDate>2026-02-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2131: Molecular Structure of the Monohydrate Hydrochloride Salt of the Antimalarial Drug Chloroquine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2131">doi: 10.3390/M2131</a></p>
	<p>Authors:
		Silvia Rizzato
		Massimo Moret
		</p>
	<p>We report the crystallization and single-crystal X-ray analysis of the monohydrate hydrochloride salt of chloroquine(CQ), abbreviated CQHCl&amp;amp;middot;H2O, an antimalarial drug with the formula C18H26ClN3. The crystal structure reveals a well-defined supramolecular architecture stabilized by an extensive hydrogen-bonding network involving CQH+ cations, chloride anions, and water molecules. Notably, this study provides the first crystallographic characterization of a monoprotonated chloroquine salt. Additionally, our findings demonstrate the feasibility of isolating pseudo-polymorphic forms of a commercially available CQ salt via heterogeneous crystallization.</p>
	]]></content:encoded>

	<dc:title>Molecular Structure of the Monohydrate Hydrochloride Salt of the Antimalarial Drug Chloroquine</dc:title>
			<dc:creator>Silvia Rizzato</dc:creator>
			<dc:creator>Massimo Moret</dc:creator>
		<dc:identifier>doi: 10.3390/M2131</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-03</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-03</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2131</prism:startingPage>
		<prism:doi>10.3390/M2131</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2131</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2130">

	<title>Molbank, Vol. 2026, Article M2130: (2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2130</link>
	<description>(2RS,3aRS,9aRS)-3a-methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one hydrobromide was first synthesized via a tandem aza-Cope rearrangement and Mannich reaction from (1RS,2SR)-2-amino-1-(prop-1-en-2-yl)-2,3-dihydro-1H-inden-1-ol, which, in turn, was obtained in four steps from commercially available 2,3-dihydro-1H-inden-1-one. The molecular and crystal structure features of the new compounds were characterized using NMR spectroscopy (1H, 13C spectra).</description>
	<pubDate>2026-02-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2130: (2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2130">doi: 10.3390/M2130</a></p>
	<p>Authors:
		Denis A. Tiunov
		Victor A. Tafeenko
		Alexander V. Kurkin
		</p>
	<p>(2RS,3aRS,9aRS)-3a-methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one hydrobromide was first synthesized via a tandem aza-Cope rearrangement and Mannich reaction from (1RS,2SR)-2-amino-1-(prop-1-en-2-yl)-2,3-dihydro-1H-inden-1-ol, which, in turn, was obtained in four steps from commercially available 2,3-dihydro-1H-inden-1-one. The molecular and crystal structure features of the new compounds were characterized using NMR spectroscopy (1H, 13C spectra).</p>
	]]></content:encoded>

	<dc:title>(2RS,3aRS,9aRS)-3a-Methyl-2-phenyl-3,3a,9,9a-tetrahydro-1H-benzo[f]indol-4(2H)-one Hydrobromide</dc:title>
			<dc:creator>Denis A. Tiunov</dc:creator>
			<dc:creator>Victor A. Tafeenko</dc:creator>
			<dc:creator>Alexander V. Kurkin</dc:creator>
		<dc:identifier>doi: 10.3390/M2130</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-02-02</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-02-02</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2130</prism:startingPage>
		<prism:doi>10.3390/M2130</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2130</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2129">

	<title>Molbank, Vol. 2026, Article M2129: Synthesis of 1-(Naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea and Determination of Its Crystal Structure</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2129</link>
	<description>The addition of 3-isocyanatopropyltriethoxysilane and 2-aminonaphthalene in THF affords the title compound 1-(naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea 1. A determination of the crystal structure of this naphthyl urea reveals the occurrence of strong intermolecular N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O hydrogen bonds, giving rise to a 1D supramolecular ribbon, whose interactions have also been assessed by a Hirshfeld surface analysis. The propensity of 1 to sense halide ions by intramolecular trapping through N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;Hal bonding was also investigated by UV-vis spectroscopy and fluorescence measurements.</description>
	<pubDate>2026-01-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2129: Synthesis of 1-(Naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea and Determination of Its Crystal Structure</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2129">doi: 10.3390/M2129</a></p>
	<p>Authors:
		Abderrahim Khatyr
		Isabelle Jourdain
		Michael Knorr
		Carsten Strohmann
		Tobias Schrimpf
		</p>
	<p>The addition of 3-isocyanatopropyltriethoxysilane and 2-aminonaphthalene in THF affords the title compound 1-(naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea 1. A determination of the crystal structure of this naphthyl urea reveals the occurrence of strong intermolecular N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;O hydrogen bonds, giving rise to a 1D supramolecular ribbon, whose interactions have also been assessed by a Hirshfeld surface analysis. The propensity of 1 to sense halide ions by intramolecular trapping through N-H&amp;amp;middot;&amp;amp;middot;&amp;amp;middot;Hal bonding was also investigated by UV-vis spectroscopy and fluorescence measurements.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 1-(Naphthalen-2-yl)-3-(3-(triethoxysilyl)propyl)urea and Determination of Its Crystal Structure</dc:title>
			<dc:creator>Abderrahim Khatyr</dc:creator>
			<dc:creator>Isabelle Jourdain</dc:creator>
			<dc:creator>Michael Knorr</dc:creator>
			<dc:creator>Carsten Strohmann</dc:creator>
			<dc:creator>Tobias Schrimpf</dc:creator>
		<dc:identifier>doi: 10.3390/M2129</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-28</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-28</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2129</prism:startingPage>
		<prism:doi>10.3390/M2129</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2129</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2128">

	<title>Molbank, Vol. 2026, Article M2128: 2-((6,7-Dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2128</link>
	<description>2-({3-[2-(1-cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}sulfanyl)-N-(4-ethylphenyl)butanamide (K284-6111; K284), the representative CHI3L1 inhibitor, has interesting biological activities, including anti-cancer and anti-inflammatory effects on neuroinflammation. Following our hit-to-lead program, we report the most active novel derivative, named CBJL-025, 2-((6,7-dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide. The title compound, CBJL-025, was successfully synthesized by S-alkylation of the p-trifluoromethyl phenethyl group possessing quinazoline and the corresponding bromide. The structure of CBJL-025 was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).</description>
	<pubDate>2026-01-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2128: 2-((6,7-Dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2128">doi: 10.3390/M2128</a></p>
	<p>Authors:
		Young Hee Lee
		Jae-Kyung Jung
		</p>
	<p>2-({3-[2-(1-cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}sulfanyl)-N-(4-ethylphenyl)butanamide (K284-6111; K284), the representative CHI3L1 inhibitor, has interesting biological activities, including anti-cancer and anti-inflammatory effects on neuroinflammation. Following our hit-to-lead program, we report the most active novel derivative, named CBJL-025, 2-((6,7-dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide. The title compound, CBJL-025, was successfully synthesized by S-alkylation of the p-trifluoromethyl phenethyl group possessing quinazoline and the corresponding bromide. The structure of CBJL-025 was confirmed by 1H and 13C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS).</p>
	]]></content:encoded>

	<dc:title>2-((6,7-Dimethoxy-4-oxo-3-(4-(trifluoromethyl)phenethyl)-3,4-dihydroquinazolin-2-yl)thio)-N-(4-ethylphenyl)butanamide</dc:title>
			<dc:creator>Young Hee Lee</dc:creator>
			<dc:creator>Jae-Kyung Jung</dc:creator>
		<dc:identifier>doi: 10.3390/M2128</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-26</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-26</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2128</prism:startingPage>
		<prism:doi>10.3390/M2128</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2128</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2127">

	<title>Molbank, Vol. 2026, Article M2127: Ethyl 2-(2-((6-Methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)thiazole-4-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2127</link>
	<description>This study presents the synthesis of a new compound, ethyl 2-(2-((6-methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)thiazole-4-carboxylate, obtained by the Hantzsch heterocyclisation reaction. The compound was analyzed through melting point determination, 1H and 13C NMR spectroscopy, infrared, and UV spectroscopy.</description>
	<pubDate>2026-01-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2127: Ethyl 2-(2-((6-Methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)thiazole-4-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2127">doi: 10.3390/M2127</a></p>
	<p>Authors:
		Adriana Grozav
		Cristina Azarov
		Gabriel Marc
		Adrian Pîrnău
		Stanimir Manolov
		Ovidiu Oniga
		Ovidiu Crișan
		</p>
	<p>This study presents the synthesis of a new compound, ethyl 2-(2-((6-methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)thiazole-4-carboxylate, obtained by the Hantzsch heterocyclisation reaction. The compound was analyzed through melting point determination, 1H and 13C NMR spectroscopy, infrared, and UV spectroscopy.</p>
	]]></content:encoded>

	<dc:title>Ethyl 2-(2-((6-Methyl-4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)thiazole-4-carboxylate</dc:title>
			<dc:creator>Adriana Grozav</dc:creator>
			<dc:creator>Cristina Azarov</dc:creator>
			<dc:creator>Gabriel Marc</dc:creator>
			<dc:creator>Adrian Pîrnău</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
			<dc:creator>Ovidiu Oniga</dc:creator>
			<dc:creator>Ovidiu Crișan</dc:creator>
		<dc:identifier>doi: 10.3390/M2127</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-22</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-22</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2127</prism:startingPage>
		<prism:doi>10.3390/M2127</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2127</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2126">

	<title>Molbank, Vol. 2026, Article M2126: Structural and Electronic Insights into Arylalkanones from Myristica ceylanica</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2126</link>
	<description>A phytochemical investigation of Myristica ceylanica resulted in the identification of seven arylalkanone-derived phenolic compounds, comprising one new naturally occurring arylalkanone (A), two derivatives (A1 and A2) prepared by chemical synthesis, and four known malabaricones (B&amp;amp;ndash;E). Density functional theory (DFT) calculations were conducted to evaluate the geometries, electronic properties, and charge distributions of the newly identified arylalkanone and its derivatives and to compare them with those of malabaricones B&amp;amp;ndash;E. The arylalkanones exhibited geometrical features comparable to those of the malabaricones, whereas frontier molecular orbital analysis revealed similar HOMO&amp;amp;ndash;LUMO energy gaps for the malabaricones but a progressive widening of the gap among the arylalkanone derivatives, indicating enhanced electronic stabilisation. Mulliken population analysis identified oxygen atoms as the principal electron-rich sites in both series, with arylalkanones displaying greater charge polarisation and increased sensitivity to structural substitution.</description>
	<pubDate>2026-01-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2126: Structural and Electronic Insights into Arylalkanones from Myristica ceylanica</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2126">doi: 10.3390/M2126</a></p>
	<p>Authors:
		Navaratnarajah Kuganathan
		Tharmarajah Manoranjan
		</p>
	<p>A phytochemical investigation of Myristica ceylanica resulted in the identification of seven arylalkanone-derived phenolic compounds, comprising one new naturally occurring arylalkanone (A), two derivatives (A1 and A2) prepared by chemical synthesis, and four known malabaricones (B&amp;amp;ndash;E). Density functional theory (DFT) calculations were conducted to evaluate the geometries, electronic properties, and charge distributions of the newly identified arylalkanone and its derivatives and to compare them with those of malabaricones B&amp;amp;ndash;E. The arylalkanones exhibited geometrical features comparable to those of the malabaricones, whereas frontier molecular orbital analysis revealed similar HOMO&amp;amp;ndash;LUMO energy gaps for the malabaricones but a progressive widening of the gap among the arylalkanone derivatives, indicating enhanced electronic stabilisation. Mulliken population analysis identified oxygen atoms as the principal electron-rich sites in both series, with arylalkanones displaying greater charge polarisation and increased sensitivity to structural substitution.</p>
	]]></content:encoded>

	<dc:title>Structural and Electronic Insights into Arylalkanones from Myristica ceylanica</dc:title>
			<dc:creator>Navaratnarajah Kuganathan</dc:creator>
			<dc:creator>Tharmarajah Manoranjan</dc:creator>
		<dc:identifier>doi: 10.3390/M2126</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-20</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-20</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2126</prism:startingPage>
		<prism:doi>10.3390/M2126</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2126</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2125">

	<title>Molbank, Vol. 2026, Article M2125: Synthesis of 5&amp;prime;-Chlorospiro(benzo[d][1,3]dioxole-2,4&amp;prime;-[1,2,6]thiadiazin)-3&amp;prime;-amine and 10-Chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2125</link>
	<description>Reactions of 3&amp;amp;prime;,5&amp;amp;prime;-dichlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazine) or 6,10-dichloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-diene with ammonia in MeCN, at ca. 20 &amp;amp;deg;C, gave 5&amp;amp;prime;-chlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazin)-3&amp;amp;prime;-amine and 10-chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine, respectively, in near quantitative yields.</description>
	<pubDate>2026-01-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2125: Synthesis of 5&amp;prime;-Chlorospiro(benzo[d][1,3]dioxole-2,4&amp;prime;-[1,2,6]thiadiazin)-3&amp;prime;-amine and 10-Chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2125">doi: 10.3390/M2125</a></p>
	<p>Authors:
		Andreas S. Kalogirou
		Panayiotis A. Koutentis
		</p>
	<p>Reactions of 3&amp;amp;prime;,5&amp;amp;prime;-dichlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazine) or 6,10-dichloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-diene with ammonia in MeCN, at ca. 20 &amp;amp;deg;C, gave 5&amp;amp;prime;-chlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazin)-3&amp;amp;prime;-amine and 10-chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine, respectively, in near quantitative yields.</p>
	]]></content:encoded>

	<dc:title>Synthesis of 5&amp;amp;prime;-Chlorospiro(benzo[d][1,3]dioxole-2,4&amp;amp;prime;-[1,2,6]thiadiazin)-3&amp;amp;prime;-amine and 10-Chloro-1,4-dioxa-8-thia-7,9-diazaspiro[4.5]deca-6,9-dien-6-amine</dc:title>
			<dc:creator>Andreas S. Kalogirou</dc:creator>
			<dc:creator>Panayiotis A. Koutentis</dc:creator>
		<dc:identifier>doi: 10.3390/M2125</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-16</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-16</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2125</prism:startingPage>
		<prism:doi>10.3390/M2125</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2125</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2124">

	<title>Molbank, Vol. 2026, Article M2124: Methyl 2-(Chloromethoxy-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-3-carboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2124</link>
	<description>Overexpression of protein phosphatase 5 (PP5) is implicated in tumor cell growth, establishing PP5 as a compelling target for small-molecule anticancer therapy. Building on prior success in achieving selectivity within the PP2A domain through scaffold functionalization that maximizes active-site interactions, we propose a parallel strategy for PP5 inhibition. Norcantharidin, the demethylated cousin of cantharidin, is a potent yet unselective phosphatase inhibitor, making its bicyclic framework an attractive platform for systematic derivatization. The approach reported herein exploits anhydride reactivity to generate a carboxylic acid derivative that is transformed into a chloromethyl ester. Chloromethyl ester functionality serves as a strategically activated intermediate enabling downstream functional-group diversification under mild, neutral conditions while preserving scaffold integrity. This modular synthetic strategy establishes a foundation for the development of PP5-selective norcantharidin derivatives with improved tumor selectivity, potency, and synthetic feasibility.</description>
	<pubDate>2026-01-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2124: Methyl 2-(Chloromethoxy-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-3-carboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2124">doi: 10.3390/M2124</a></p>
	<p>Authors:
		Hannah K. Lawley
		Bailey N. Baxter
		Caleb N. Lopansri
		Mary Helene Marmande
		Kathryn N. Mayeaux
		Lucy A. Orr
		David C. Forbes
		</p>
	<p>Overexpression of protein phosphatase 5 (PP5) is implicated in tumor cell growth, establishing PP5 as a compelling target for small-molecule anticancer therapy. Building on prior success in achieving selectivity within the PP2A domain through scaffold functionalization that maximizes active-site interactions, we propose a parallel strategy for PP5 inhibition. Norcantharidin, the demethylated cousin of cantharidin, is a potent yet unselective phosphatase inhibitor, making its bicyclic framework an attractive platform for systematic derivatization. The approach reported herein exploits anhydride reactivity to generate a carboxylic acid derivative that is transformed into a chloromethyl ester. Chloromethyl ester functionality serves as a strategically activated intermediate enabling downstream functional-group diversification under mild, neutral conditions while preserving scaffold integrity. This modular synthetic strategy establishes a foundation for the development of PP5-selective norcantharidin derivatives with improved tumor selectivity, potency, and synthetic feasibility.</p>
	]]></content:encoded>

	<dc:title>Methyl 2-(Chloromethoxy-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-3-carboxylate</dc:title>
			<dc:creator>Hannah K. Lawley</dc:creator>
			<dc:creator>Bailey N. Baxter</dc:creator>
			<dc:creator>Caleb N. Lopansri</dc:creator>
			<dc:creator>Mary Helene Marmande</dc:creator>
			<dc:creator>Kathryn N. Mayeaux</dc:creator>
			<dc:creator>Lucy A. Orr</dc:creator>
			<dc:creator>David C. Forbes</dc:creator>
		<dc:identifier>doi: 10.3390/M2124</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-13</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-13</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2124</prism:startingPage>
		<prism:doi>10.3390/M2124</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2124</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2123">

	<title>Molbank, Vol. 2026, Article M2123: N-(2-(1H-Indol-3-yl)ethyl)-2-propylpentanamide</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2123</link>
	<description>Herein we describe the synthesis of N-(2-(1H-indol-3-yl)ethyl)-2-propylpentanamide. The compound was comprehensively characterized using melting-point analysis, 1H and 13C NMR spectroscopy, infrared spectroscopy, and mass spectrometry. The collective analytical results confirm the successful synthesis and structural integrity of the target molecule.</description>
	<pubDate>2026-01-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2123: N-(2-(1H-Indol-3-yl)ethyl)-2-propylpentanamide</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2123">doi: 10.3390/M2123</a></p>
	<p>Authors:
		Diyana Dimitrova
		Iliyan Ivanov
		Simona Ilieva
		Ivelina Cherneva
		Dimitar Bojilov
		Stanimir Manolov
		</p>
	<p>Herein we describe the synthesis of N-(2-(1H-indol-3-yl)ethyl)-2-propylpentanamide. The compound was comprehensively characterized using melting-point analysis, 1H and 13C NMR spectroscopy, infrared spectroscopy, and mass spectrometry. The collective analytical results confirm the successful synthesis and structural integrity of the target molecule.</p>
	]]></content:encoded>

	<dc:title>N-(2-(1H-Indol-3-yl)ethyl)-2-propylpentanamide</dc:title>
			<dc:creator>Diyana Dimitrova</dc:creator>
			<dc:creator>Iliyan Ivanov</dc:creator>
			<dc:creator>Simona Ilieva</dc:creator>
			<dc:creator>Ivelina Cherneva</dc:creator>
			<dc:creator>Dimitar Bojilov</dc:creator>
			<dc:creator>Stanimir Manolov</dc:creator>
		<dc:identifier>doi: 10.3390/M2123</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-09</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-09</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2123</prism:startingPage>
		<prism:doi>10.3390/M2123</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2123</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2122">

	<title>Molbank, Vol. 2026, Article M2122: Synthesis and Investigation of a Symmetrical Bis(methoxycarbonyl)-Substituted Rubrene Derivative</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2122</link>
	<description>A symmetrical rubrene derivative, 5,6-bis(4-(methoxycarbonyl)phenyl)-11,12-diphenyltetracene, was synthesized via the thermal dimerization of 1,1-diphenyl-3-[4-(methoxycarbonyl)phenyl]-3-chloroallene. The reaction proceeded with the low selectivity typical of the classical &amp;amp;ldquo;rubrenic synthesis&amp;amp;rdquo; under these conditions, affording the target tetracene and the bis(alkylidene)cyclobutene by-product in nearly equal yields of 25% each. The optical characteristics of this rubrene derivative were investigated, revealing bright orange fluorescence in a CHCl3 solution (&amp;amp;lambda;em = 565 nm, &amp;amp;Phi;F = 0.81, &amp;amp;tau; = 11.41 ns), which is strongly quenched in the solid state (&amp;amp;Phi;F = 0.01) due to aggregation.</description>
	<pubDate>2026-01-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2122: Synthesis and Investigation of a Symmetrical Bis(methoxycarbonyl)-Substituted Rubrene Derivative</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2122">doi: 10.3390/M2122</a></p>
	<p>Authors:
		Roman A. Irgashev
		Alexander S. Steparuk
		Gennady L. Rusinov
		Ildar R. Sayarov
		Alexey E. Aleksandrov
		Alexey R. Tameev
		</p>
	<p>A symmetrical rubrene derivative, 5,6-bis(4-(methoxycarbonyl)phenyl)-11,12-diphenyltetracene, was synthesized via the thermal dimerization of 1,1-diphenyl-3-[4-(methoxycarbonyl)phenyl]-3-chloroallene. The reaction proceeded with the low selectivity typical of the classical &amp;amp;ldquo;rubrenic synthesis&amp;amp;rdquo; under these conditions, affording the target tetracene and the bis(alkylidene)cyclobutene by-product in nearly equal yields of 25% each. The optical characteristics of this rubrene derivative were investigated, revealing bright orange fluorescence in a CHCl3 solution (&amp;amp;lambda;em = 565 nm, &amp;amp;Phi;F = 0.81, &amp;amp;tau; = 11.41 ns), which is strongly quenched in the solid state (&amp;amp;Phi;F = 0.01) due to aggregation.</p>
	]]></content:encoded>

	<dc:title>Synthesis and Investigation of a Symmetrical Bis(methoxycarbonyl)-Substituted Rubrene Derivative</dc:title>
			<dc:creator>Roman A. Irgashev</dc:creator>
			<dc:creator>Alexander S. Steparuk</dc:creator>
			<dc:creator>Gennady L. Rusinov</dc:creator>
			<dc:creator>Ildar R. Sayarov</dc:creator>
			<dc:creator>Alexey E. Aleksandrov</dc:creator>
			<dc:creator>Alexey R. Tameev</dc:creator>
		<dc:identifier>doi: 10.3390/M2122</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Communication</prism:section>
	<prism:startingPage>M2122</prism:startingPage>
		<prism:doi>10.3390/M2122</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2122</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2121">

	<title>Molbank, Vol. 2026, Article M2121: 6-((2-Oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2121</link>
	<description>A novel unsymmetrical azine, 6-((2-oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one, was synthesized through a condensation reaction between tryptanthrin-6-hydrazone and isatin in chloroform under reflux conditions. Structural characterization revealed the compound exists as a mixture of geometric isomers with one predominant form. Density functional theory (DFT) calculations identified the E,E configuration as the most stable isomer. The isomerization barriers for both C=N bonds were calculated at approximately 18.5 kcal/mol via nitrogen inversion. Given the established biological activities of tryptanthrin and isatin derivatives, this hybrid azine represents a promising lead compound for developing bifunctional drug candidates.</description>
	<pubDate>2026-01-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2121: 6-((2-Oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2121">doi: 10.3390/M2121</a></p>
	<p>Authors:
		Elizaveta I. Samorodova
		Anastasia R. Kovrizhina
		Andrei I. Khlebnikov
		</p>
	<p>A novel unsymmetrical azine, 6-((2-oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one, was synthesized through a condensation reaction between tryptanthrin-6-hydrazone and isatin in chloroform under reflux conditions. Structural characterization revealed the compound exists as a mixture of geometric isomers with one predominant form. Density functional theory (DFT) calculations identified the E,E configuration as the most stable isomer. The isomerization barriers for both C=N bonds were calculated at approximately 18.5 kcal/mol via nitrogen inversion. Given the established biological activities of tryptanthrin and isatin derivatives, this hybrid azine represents a promising lead compound for developing bifunctional drug candidates.</p>
	]]></content:encoded>

	<dc:title>6-((2-Oxoindolin-3-ylidene)hydrazineylidene)indolo[2,1-b]quinazolin-12(6H)-one</dc:title>
			<dc:creator>Elizaveta I. Samorodova</dc:creator>
			<dc:creator>Anastasia R. Kovrizhina</dc:creator>
			<dc:creator>Andrei I. Khlebnikov</dc:creator>
		<dc:identifier>doi: 10.3390/M2121</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-06</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-06</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2121</prism:startingPage>
		<prism:doi>10.3390/M2121</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2121</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2120">

	<title>Molbank, Vol. 2026, Article M2120: (Benzo[h]quinoline-&amp;kappa;2C,N)-[2,2&amp;prime;-bis(diphenylphosphino)-1,1&amp;prime;-binaphthalene-&amp;kappa;2P,P&amp;prime;]-platinum(II) Hexafluorophosphate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2120</link>
	<description>A cyclometalated platinum(II) complex [Pt(bzq)(BINAP)]PF6 bearing a 2,2&amp;amp;prime;-bis(diphenylphosphino)-1,1&amp;amp;prime;-binaphthalene (BINAP) auxiliary ligand and a cyclometalated benzo[h]quinoline (bzq) ligand have been prepared. Structural characterization was achieved through X-ray crystallography, 1H, 13C and 31P NMR spectroscopy, ESI&amp;amp;minus;MS, and elemental analysis.</description>
	<pubDate>2026-01-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2120: (Benzo[h]quinoline-&amp;kappa;2C,N)-[2,2&amp;prime;-bis(diphenylphosphino)-1,1&amp;prime;-binaphthalene-&amp;kappa;2P,P&amp;prime;]-platinum(II) Hexafluorophosphate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2120">doi: 10.3390/M2120</a></p>
	<p>Authors:
		Haoni Wang
		Meiting Zhang
		Jianwei Wu
		Junqi Zhang
		Xianglong Meng
		Yuliang Yang
		</p>
	<p>A cyclometalated platinum(II) complex [Pt(bzq)(BINAP)]PF6 bearing a 2,2&amp;amp;prime;-bis(diphenylphosphino)-1,1&amp;amp;prime;-binaphthalene (BINAP) auxiliary ligand and a cyclometalated benzo[h]quinoline (bzq) ligand have been prepared. Structural characterization was achieved through X-ray crystallography, 1H, 13C and 31P NMR spectroscopy, ESI&amp;amp;minus;MS, and elemental analysis.</p>
	]]></content:encoded>

	<dc:title>(Benzo[h]quinoline-&amp;amp;kappa;2C,N)-[2,2&amp;amp;prime;-bis(diphenylphosphino)-1,1&amp;amp;prime;-binaphthalene-&amp;amp;kappa;2P,P&amp;amp;prime;]-platinum(II) Hexafluorophosphate</dc:title>
			<dc:creator>Haoni Wang</dc:creator>
			<dc:creator>Meiting Zhang</dc:creator>
			<dc:creator>Jianwei Wu</dc:creator>
			<dc:creator>Junqi Zhang</dc:creator>
			<dc:creator>Xianglong Meng</dc:creator>
			<dc:creator>Yuliang Yang</dc:creator>
		<dc:identifier>doi: 10.3390/M2120</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-05</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-05</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2120</prism:startingPage>
		<prism:doi>10.3390/M2120</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2120</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2119">

	<title>Molbank, Vol. 2026, Article M2119: 4-(4-Chlorophenyl)-6-phenyl-2-(prop-2-yn-1-yloxy)nicotinonitrile</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2119</link>
	<description>We report an efficient and transition-metal-free protocol for the propargylation of 4-(4-chlorophenyl)-2-oxo-6-phenyl-1,2-dihydropyridine-3-carbonitrile using propargyl bromide in the presence of cesium carbonate in dimethylsulfoxide under mild conditions. This synthetic transformation proceeds with marked chemoselectivity, furnishing the O-propargylated pyridine and the N-propargylated 2-pyridone in 75% and 8% yields, respectively. Both products were fully characterized by IR and NMR spectroscopy, as well as high-resolution mass spectrometry, confirming their molecular structures.</description>
	<pubDate>2026-01-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2119: 4-(4-Chlorophenyl)-6-phenyl-2-(prop-2-yn-1-yloxy)nicotinonitrile</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2119">doi: 10.3390/M2119</a></p>
	<p>Authors:
		Diana Becerra
		Diana Hurtado-Rodríguez
		Juan-Carlos Castillo
		</p>
	<p>We report an efficient and transition-metal-free protocol for the propargylation of 4-(4-chlorophenyl)-2-oxo-6-phenyl-1,2-dihydropyridine-3-carbonitrile using propargyl bromide in the presence of cesium carbonate in dimethylsulfoxide under mild conditions. This synthetic transformation proceeds with marked chemoselectivity, furnishing the O-propargylated pyridine and the N-propargylated 2-pyridone in 75% and 8% yields, respectively. Both products were fully characterized by IR and NMR spectroscopy, as well as high-resolution mass spectrometry, confirming their molecular structures.</p>
	]]></content:encoded>

	<dc:title>4-(4-Chlorophenyl)-6-phenyl-2-(prop-2-yn-1-yloxy)nicotinonitrile</dc:title>
			<dc:creator>Diana Becerra</dc:creator>
			<dc:creator>Diana Hurtado-Rodríguez</dc:creator>
			<dc:creator>Juan-Carlos Castillo</dc:creator>
		<dc:identifier>doi: 10.3390/M2119</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2119</prism:startingPage>
		<prism:doi>10.3390/M2119</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2119</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2118">

	<title>Molbank, Vol. 2026, Article M2118: 4&amp;rsquo;-Ethyl 1,2-dimethyl 1&amp;rsquo;,5-dibenzyl-4,4-dicyano-2&amp;rsquo;-oxo-5&amp;rsquo;-phenyl-1&amp;rsquo;,2&amp;rsquo;,4a,5-tetrahydro-4H-spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;rsquo;-pyrrole]-1,2,4&amp;rsquo;-tricarboxylate</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2118</link>
	<description>The 1,4-dipolar cycloaddition of the ylidene derivative of 1H-pyrrole-2,3-dione to a dipole generated in situ from 1-benzylbenzimidazole and dimethyl acetylenedicarboxylate proceeds via the exocyclic multiple bond of the ylidene derivative and affords a mixture of diastereomeric spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;amp;rsquo;-pyrroles], which slowly epimerized in a solution.</description>
	<pubDate>2026-01-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2118: 4&amp;rsquo;-Ethyl 1,2-dimethyl 1&amp;rsquo;,5-dibenzyl-4,4-dicyano-2&amp;rsquo;-oxo-5&amp;rsquo;-phenyl-1&amp;rsquo;,2&amp;rsquo;,4a,5-tetrahydro-4H-spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;rsquo;-pyrrole]-1,2,4&amp;rsquo;-tricarboxylate</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2118">doi: 10.3390/M2118</a></p>
	<p>Authors:
		Anna A. Moroz
		Maksim V. Dmitriev
		Andrey N. Maslivets
		</p>
	<p>The 1,4-dipolar cycloaddition of the ylidene derivative of 1H-pyrrole-2,3-dione to a dipole generated in situ from 1-benzylbenzimidazole and dimethyl acetylenedicarboxylate proceeds via the exocyclic multiple bond of the ylidene derivative and affords a mixture of diastereomeric spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;amp;rsquo;-pyrroles], which slowly epimerized in a solution.</p>
	]]></content:encoded>

	<dc:title>4&amp;amp;rsquo;-Ethyl 1,2-dimethyl 1&amp;amp;rsquo;,5-dibenzyl-4,4-dicyano-2&amp;amp;rsquo;-oxo-5&amp;amp;rsquo;-phenyl-1&amp;amp;rsquo;,2&amp;amp;rsquo;,4a,5-tetrahydro-4H-spiro[benzo[4,5]imidazo[1,2-a]pyridine-3,3&amp;amp;rsquo;-pyrrole]-1,2,4&amp;amp;rsquo;-tricarboxylate</dc:title>
			<dc:creator>Anna A. Moroz</dc:creator>
			<dc:creator>Maksim V. Dmitriev</dc:creator>
			<dc:creator>Andrey N. Maslivets</dc:creator>
		<dc:identifier>doi: 10.3390/M2118</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2118</prism:startingPage>
		<prism:doi>10.3390/M2118</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2118</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2117">

	<title>Molbank, Vol. 2026, Article M2117: (RS)-6,6,7&amp;prime;,7&amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;prime;,7&amp;prime;-tetrahydro-2H,2&amp;prime;H,4H,4&amp;prime;H,5&amp;prime;H-spiro[thiopyran-3,3&amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;prime;-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2117</link>
	<description>The reaction of aliphatic aldehydes with the tautomers 6,6-dimethyl-4-hydroxy-2H-thiopyrane-2-thione and 6,6-dimethyl-2-mercapto-4H-thiopyrane-4-one is reported to yield spiro compounds. However, the spiro compound of the reaction with formaldehyde is postulated, but has not been isolated to date. Due to a change in reaction conditions, we managed to isolate (RS)-6,6,7&amp;amp;prime;,7&amp;amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;amp;prime;,7&amp;amp;prime;-tetrahydro-2H,2&amp;amp;prime;H,4H,4&amp;amp;prime;H,5&amp;amp;prime;H-spiro[thiopyran-3,3&amp;amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;amp;prime;-dione for the first time. The structure was proven with the help of a single X-ray crystal analysis. Furthermore, the new compound was fully characterized using one- and two- dimensional NMR techniques such as 1H, 13C, DEPT, COSY, HSQC and HMBC spectra, as well as IR and HRMS measurements.</description>
	<pubDate>2026-01-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2117: (RS)-6,6,7&amp;prime;,7&amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;prime;,7&amp;prime;-tetrahydro-2H,2&amp;prime;H,4H,4&amp;prime;H,5&amp;prime;H-spiro[thiopyran-3,3&amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;prime;-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2117">doi: 10.3390/M2117</a></p>
	<p>Authors:
		Werner Seebacher
		Antoine Dupé
		Eva-Maria Pferschy-Wenzig
		Robert Saf
		Theresa Hermann
		Robert Weis
		</p>
	<p>The reaction of aliphatic aldehydes with the tautomers 6,6-dimethyl-4-hydroxy-2H-thiopyrane-2-thione and 6,6-dimethyl-2-mercapto-4H-thiopyrane-4-one is reported to yield spiro compounds. However, the spiro compound of the reaction with formaldehyde is postulated, but has not been isolated to date. Due to a change in reaction conditions, we managed to isolate (RS)-6,6,7&amp;amp;prime;,7&amp;amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;amp;prime;,7&amp;amp;prime;-tetrahydro-2H,2&amp;amp;prime;H,4H,4&amp;amp;prime;H,5&amp;amp;prime;H-spiro[thiopyran-3,3&amp;amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;amp;prime;-dione for the first time. The structure was proven with the help of a single X-ray crystal analysis. Furthermore, the new compound was fully characterized using one- and two- dimensional NMR techniques such as 1H, 13C, DEPT, COSY, HSQC and HMBC spectra, as well as IR and HRMS measurements.</p>
	]]></content:encoded>

	<dc:title>(RS)-6,6,7&amp;amp;prime;,7&amp;amp;prime;-Tetramethyl-2-sulfanylidene-5,6,6&amp;amp;prime;,7&amp;amp;prime;-tetrahydro-2H,2&amp;amp;prime;H,4H,4&amp;amp;prime;H,5&amp;amp;prime;H-spiro[thiopyran-3,3&amp;amp;prime;-thiopyrano [2,3-b]thiopyran]-4,5&amp;amp;prime;-dione</dc:title>
			<dc:creator>Werner Seebacher</dc:creator>
			<dc:creator>Antoine Dupé</dc:creator>
			<dc:creator>Eva-Maria Pferschy-Wenzig</dc:creator>
			<dc:creator>Robert Saf</dc:creator>
			<dc:creator>Theresa Hermann</dc:creator>
			<dc:creator>Robert Weis</dc:creator>
		<dc:identifier>doi: 10.3390/M2117</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2026-01-04</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2026-01-04</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2117</prism:startingPage>
		<prism:doi>10.3390/M2117</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2117</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/1422-8599/2026/1/M2116">

	<title>Molbank, Vol. 2026, Article M2116: (Z)-8-Hydroxy-6-(2-hydroxyphenyl)-9-(4-methylbenzoyl)-2-(((E)-2-oxoindolin-3-ylidene)hydrazineylidene)-1-thia-3,6-diazaspiro[4.4]non-8-ene-4,7-dione</title>
	<link>https://www.mdpi.com/1422-8599/2026/1/M2116</link>
	<description>A novel spiro-pyrrolothiazole derivative bearing a 2-oxindole substituent was synthesized and characterized. The compound was prepared via a catalyst-free reaction under mild conditions and isolated using a straightforward workup procedure. The structure of the synthesized title compound was confirmed with 1H, 13C NMR spectra and X-Ray diffraction data.</description>
	<pubDate>2025-12-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>Molbank, Vol. 2026, Article M2116: (Z)-8-Hydroxy-6-(2-hydroxyphenyl)-9-(4-methylbenzoyl)-2-(((E)-2-oxoindolin-3-ylidene)hydrazineylidene)-1-thia-3,6-diazaspiro[4.4]non-8-ene-4,7-dione</b></p>
	<p>Molbank <a href="https://www.mdpi.com/1422-8599/2026/1/M2116">doi: 10.3390/M2116</a></p>
	<p>Authors:
		Dzhamilia N. Belozerova
		Maksim V. Dmitriev
		Irina V. Mashevskaya
		</p>
	<p>A novel spiro-pyrrolothiazole derivative bearing a 2-oxindole substituent was synthesized and characterized. The compound was prepared via a catalyst-free reaction under mild conditions and isolated using a straightforward workup procedure. The structure of the synthesized title compound was confirmed with 1H, 13C NMR spectra and X-Ray diffraction data.</p>
	]]></content:encoded>

	<dc:title>(Z)-8-Hydroxy-6-(2-hydroxyphenyl)-9-(4-methylbenzoyl)-2-(((E)-2-oxoindolin-3-ylidene)hydrazineylidene)-1-thia-3,6-diazaspiro[4.4]non-8-ene-4,7-dione</dc:title>
			<dc:creator>Dzhamilia N. Belozerova</dc:creator>
			<dc:creator>Maksim V. Dmitriev</dc:creator>
			<dc:creator>Irina V. Mashevskaya</dc:creator>
		<dc:identifier>doi: 10.3390/M2116</dc:identifier>
	<dc:source>Molbank</dc:source>
	<dc:date>2025-12-29</dc:date>

	<prism:publicationName>Molbank</prism:publicationName>
	<prism:publicationDate>2025-12-29</prism:publicationDate>
	<prism:volume>2026</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Short Note</prism:section>
	<prism:startingPage>M2116</prism:startingPage>
		<prism:doi>10.3390/M2116</prism:doi>
	<prism:url>https://www.mdpi.com/1422-8599/2026/1/M2116</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
    
<cc:License rdf:about="https://creativecommons.org/licenses/by/4.0/">
	<cc:permits rdf:resource="https://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
